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Abstract
Myocardial Perfusion Imaging (MPI) plays a very important role in the management of 
patients with suspected Coronary Artery Disease and its use has grown despite the 
shortcomings of the technique. Significant progress has been made in identifying the causes 
of these shortcomings and many solutions been suggested in the literature but the clinical 
sensitivity and specificity of the technique is still well below optimum.
Monte Carlo Simulation is a very useful tool in identifying and guiding the understanding of
the existing problems in MPI and this present study utilised this method to establish the basis
of the simulations to be used and the way to analyse the results so that many of the causes
of the attenuation defects, when using MPI, could be identified. This was achieved by
investigating the effect that the different anatomical parts of the thorax have on the
attenuation defects caused. A further aspect investigated was the impact that self-absorption
in the heart has on these defects. The variability of these defects were further investigated by
altering the position and orientation of the heart itself within the thorax and determining the
effect it has on the attenuation defects caused. Results indicate that the attenuation caused
is a very complicated process, that the self-absorption of the heart plays an extremely
important role and the impact of the different positions and orientation of the heart inside the
thorax are also significant. The distortion caused on the images by these factors was
demonstrated by the intensity losses in the basal part and an over-estimation in the apical
parts, which were clearly observable on the final clinical images, with the potential to affect 
clinical interpretation.
Attenuation correction procedures using transmission sources, have been available for some 
time, but have not been adopted widely, amidst concern that they introduce additional 
artefacts. This study determined the effectiveness of these methods by establishing the level 
of correction obtained and whether additional artefacts were introduced. This included the 
effectiveness of the compensation achieved with the use of the latest commercially available 
comprehensive correction techniques. The technique investigated was “Flash3D" from 
Siemens providing transmission based attenuation correction, depth-dependent resolution 
recovery and scatter correction. The comparison between the defects and intensity losses 
predicted by the Monte Carlo Simulations and the corrections provided by this commercial 
correction technique revealed that solution is compensating almost entirely for these 
problems and therefore do provide substantial progress in overcoming the limitations of MPI. 
As a result of the improvements gained from applying these commercially available 
techniques and the accuracy established in this study for the mentioned technique it is 
strongly recommended that these new techniques be embraced by the wider Nuclear 
Medicine community so that the limitations in MPI can be reduced in clinical environment.
Non-withstanding the above gains made there remains room for improvement by overcoming
the of use transmission attenuation correction techniques by replacing them with emission
based techniques. In this study two new related emission based attenuation correction
techniques have been suggested and investigated and provide a promising prospect of 
overcoming these limitations.
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Chapter 1 - Introduction
Coronary artery disease (CAD) is the most important cardiac pathology in the adult 
population of the Western world (and therefore in the UK as well) and therefore makes it the 
most common form of heart disease1. CAD and its complications, like angina pectoris, 
arrhythmia and heart attack, are the leading causes of death in the Western world2. Coronary 
artery disease (CAD) is the UK's biggest killer, around one in five men and one in seven 
women die from the disease. CAD is the leading cause of death in women in the USA and 
more than twice as many women die from cardiovascular disease as from all forms of cancer 
combined3. Coronary Heart Disease (CHD) causes around 94,000 deaths in the UK each 
year4.
CAD is a complex degenerative disease that causes reduced or absent blood flow in one or 
more of the arteries that encircle and supply the heart. CAD may affect just a small branch 
vessel far from the aortic root (distal) or a larger vessel near its origin (proximal). CAD may 
affect any or all three of the major supply arteries to the heart, - the left anterior descending 
(LAD) artery, the left circumflex artery (LCX), and the right coronary artery (RCA). Thus, a 
simple ranking of disease severity is noted as 1-, 2-, or 3-vessel disease.
During the last 30 years, scintigraphy, ultrasonography, computed tomography, and 
magnetic resonance imaging have emerged as invaluable tools to delineate abnormalities in 
the cardiovascular system. The optimal roles of the various methods of noninvasive 
evaluation continue to evolve as refinements are developed. Faster, stronger, and more 
efficient hardware and associated faster and more flexible digital processing are now 
providing faster scan times, as well as nearly real-time physiologic information. Quantitative 
and semiquantitative analysis and the development of new contrast and radiopharmaceutical 
agents have further improved the accuracy of anatomic and physiologic noninvasive testing.
The protocol that has been used in Nuclear Medicine to determine abnormalities in the blood 
supply to the myocardium, and therefore CAD, is called Myocardial Perfusion Imaging (MPI). 
The effectiveness of MPI in detecting blood supply abnormalities to the heart associated with 
CAD has been the subject of many studies567. Most have assessed the sensitivity and 
specificity of the technique using coronary angiography as the gold standard.
Although Myocardial Perfusion Imaging is a well-established approach for the assessment of
Coronary Artery Disease and Myocardial Viability, there still exists uncertainty in different
areas and therefore the need to address these uncertainties exists. This study will address
the most visible of these uncertainties to further enhance the assessment of CAD and 
Myocardial Viability.
1
Chapter 1 - Introduction
The study will provide a thorough evaluation of current practices and identification of their 
limitations. These will include Attenuation Correction, Scatter Correction, Partial Volume 
Effect and Resolution Recovery. The remainder of this study consists of addressing the 
limitations of the current practises of MPI as well as a proposal to address those limitations.
Chapter 2 looks at the limitations of Myocardial Perfusion Imaging as described in the 
literature. The most substantial limitations are considered, and their impact on the final 
reconstructed images reviewed. Corrections for the limitations are suggested, some of which 
have been developed commercially, and their suitability and acceptance in clinical use 
considered.
Chapter 2 also indicates that although a vast amount of investigation has been done into the 
subject of attenuation in the thorax substantial areas still exist where there is still no clear 
understanding of the effect of attenuation on the final reconstructed images. In this study 
Monte Carlo simulation studies were used to investigate certain areas and chapter 3 
describes in more detail how these techniques can be used to study the effects of non- 
uniform thoracic attenuation.
Chapter 4 describes how these techniques can be used to discover the effect of the different 
anatomical parts on the total attenuation caused in the final reconstructed images, something 
that has not been reported in the literature and will represent new and original work. The 
distortion of these final reconstructed images has also been investigated in much more detail 
to highlight aspects of attenuation which are not that well known or has not been highlighted 
yet.
Chapter 5 looks at the effect on the final reconstructed images for variations in the orientation 
and positioning of the heart within the thorax. The position and orientation of the heart varies 
substantially from patient to patient and this can have a potentially substantial impact on the 
amount of attenuation in the final reconstructed images but this aspect has not been reported 
or analysed by others.
A wide range of commercially available solutions have become available in recent times. The 
extent of the correction achieved by such a commercially available attenuation correction 
technique, together with the correction for scatter and depth-dependent collimator blurring of 
the gamma camera, is the topic of chapter 6.
Chapter 2 shows that real progress has been made with dealing with the inherent limitations 
of Myocardial Perfusion Imaging with the exception of attenuation correction. A lot of work 
has been done on this subject and commercially available systems are in use today but the 
use of attenuation correction has not obtained universal acceptance. There are still 
widespread resistance to its implementation. In view of the findings in Chapters 4 and 5, it is 
clear that there is a real need for an accurate universally accepted attenuation correction
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technique to ensure accurate and improved reporting. The technique of inferred anatomy 
seemed a very attractive alternative method which can be implemented with the use of 
software only. This method has been introduced for brain studies in the literature but in this 
study it has been developed specifically to cover the thorax as well. Chapter 7 describes the 
image manipulation and segmentation techniques necessary for such an implementation. 
Chapter 7 also touches slightly on another possibility of an emission based attenuation 
correction technique, referred to as derived anatomy.
Chapter 8 summarises the results obtained in the previous chapters and the contribution 
made in this study to get a better understanding of the limitations in Myocardial Perfusion 
Imaging, as well as the new and original work introduced. It also summarises the possibility 
of methods for improving the areas where there is not a universally accepted method of 
correcting for these limitations and how further work can contribute to get a complete 
universally accepted correction for all the described limitations.
This study was conducted during a period when the institution was planning and 
commissioning a nuclear cardiology suite, but were not conducting clinical studies. With the 
approval of the Local Ethics Committee data were obtained from another institution and 
software was developed in-house by the candidate so that this project could be developed 
The exception to this is the data and analysis described in chapter 6 when MPI studies were 
performed at the research institution when the hardware and software for performing, 
reconstructing and analysing these images became available.
Chapter 2 - Limitations of 
Myocardial Perfusion Imaging:
a Literature Study
2.1 Myocardial Perfusion Imaging (MPI)
Myocardial Perfusion Imaging (MPI), a Nuclear Medicine imaging technique using radio-
isotopes, is most frequently performed in symptomatic patients with low to intermediate 
probability for CAD8. It is also useful in patients with non-diagnostic ECGs as well as in 
patients unable to exercise sufficiently to get an accurate picture of the heart under stress. 
The effectiveness of myocardial perfusion scintigraphy in detecting perfusion abnormalities 
associated with Coronary Artery Disease (CAD) has been the subject of many studies5,6,7. 
Most have assessed the sensitivity and specificity of the technique using coronary 
angiography as the standard.
The words "sensitivity" and "specificity" have their origins in screening tests for diseases. 
When a single test is performed, the person may in fact have the disease or the person may 
be disease free. The test result may be positive, indicating the presence of disease, or the 
test result may be negative, indicating the absence of the disease.
Test Presence of Disease
Result Yes No
Positive
True positive False positive
(TP) (FP)
Negative
False negative 
(FN)
True negative 
(TN)
Statistical terms
False Positive: A false positive occurs when the test reports a positive result for a person
who does not have the specific disease that the test is designed to detect. Ideally this value 
should be zero.
False Negative: A false negative occurs when the test reports a negative result for a person 
who actually has specific disease that the test is designed to detect.
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Sensitivity measures the proportion of patients who actually have the disease which are 
correctly identified as such (e.g. the percentage of patients with CAD who are correctly 
identified as having CAD). Specificity measures the proportion of patients who do not have 
the disease which are correctly identified (e.g. the percentage of patients without CAD who 
are correctly identified as not having CAD).
Before Single Photon Emission Computerized Tomography (SPECT) technology became
widely available, two-dimensional planar imaging was used for blood pool and all myocardial
perfusion imaging9. The MUGA (multigated acquisition) scan has been used for decades to
evaluate global and regional wall motion, to calculate the excursion of blood from the left or
right ventricles, determine ventricular volumes and to obtain a stroke volume ratio. Until the
advent of gated myocardial SPECT, physicians relied on the MUGA scan to get valuable
ventricular function data on patients with any number of heart conditions but Important
technical limitations remain, including the relatively restricted spatial resolution of standard
Anger cameras, precluding precise evaluation of regional LV abnormalities, and overlap of
atria and ventricles during equilibrium studies, even in the standard left anterior oblique view,
limiting precision in measuring LV and RV volumes exists. New developments in
radiopharmaceuticals, as well as in imaging hardware and computer technology, have
contributed substantially to the development of gated SPECT10. The technecium-99m based
perfusion tracers, because of their higher count rates and stable myocardial perfusion with
time, permit evaluation of regional wall motion and wall thickening throughout the cardiac
cycle. The development of automatic algorithms to quantitatively measure left ventricular
volume and ejection fraction, and even regional myocardial wall motion and thickening from
gated SPECT rapidly and accurately, with minimal operator interaction, has contributed to its 
widespread use.
As stated before, the clinical evaluation of these SPECT myocardial perfusion scans are 
usually compared with the results of coronary angiography" 12' 13. However, angiography
does have some important limitations raising the question of whether coronary angiography 
is the best reference method available.
First, coronary angiography does not show myocardial perfusion but, rather, the morphology 
of coronary blood vessels providing a silhouette view of the vessel, showing luminal 
irregularities and discrete obstructions, but not actual atherosclerosis in coronary arterial 
walls. This does not include information on the possible malfunction of endothelial cells, 
which leads to perfusion defects14. The presence of endothelial dysfunction may therefore 
reduce the specificity of MPI as compared with coronary angiography. Another drawback of 
performing coronary angiography routinely is the risk of the procedure15 A mortality of 1 per 
1000 and myocardial infarction in 1 per 2000 were reported. Vascular complications and
2.1 Myocardial Perfusion Imaging (MPI)
contrast reactions occurred in 1 per 250 patients, while cerebrovascular accident occurred in 
1 per 1400 patients.
On the other hand, myocardial perfusion might be preserved even in supply areas of 
coronary vessels with major stenosis if collateral blood flow is present16. In this case, MPI will 
appear to have a reduced sensitivity. Furthermore, due to the variability of the supply areas 
of coronary vessels and due to the possible stenosis of secondary coronary branches, 
perfusion defects are sometimes assigned to the wrong coronary artery.
Despite these limitations, coronary angiography remains the best practical reference
standard due to its availability, proven utility, and the ability to guide revascularisation when 
required.
MPI uses the technique of Single photon Emission Tomography (SPECT) and has been 
used extensively in the non-invasive study of myocardial perfusion and viability. The current 
techniques rely generally on the visual interpretation of the tracer studies as well as relative 
quantification of the tracer uptake but the ultimate goal is to achieve absolute quantification - 
that is, to make an absolute measurement of Becquerels of tracer per gram of tissue in a 
specified region which will overcome the problems with balanced triple vessel disease as 
discussed in section 2.2.
The original cardiac scintigraphic studies utilise 201Thallium as tracer. The major limitation of
2 0  ^  _
Tl scintigraphy is the high false-positive rate observed which is predominantly attributed to 
attenuation artefacts and variants of normal that are interpreted as defects17. Although 
quantification of 201TI images improves specificity, the false-positive rate remains 
problematic, particularly in women and in obese patients because the low photon energy of 
the thallium gamma ray gets rapidly attenuated by tissue. Breast attenuation artefacts in
women are sometimes difficult to distinguish from perfusion abnormalities secondary to 
inducible ischemia or myocardial scar18.
The introduction of " mTc-labeled perfusion agents (energy of 140 keV, half-life of 6 hours, 
etc.) into clinical practice enhanced the specificity of MPI and provided additional information 
regarding regional and global left ventricular systolic function via ECG gating of images19. 
The quality of images obtained with " mTc-labeled radionuclides is superior to that of images 
obtained with 201TI because of the more favourable physical characteristics of " mTc imaging 
with a gamma camera. With " mTc, patient injected activities of ~10 to 20 times higher than 
those that are feasible with 201TI can be administered, yielding images with higher count 
density for the same patient radiation dose. " mTc images demonstrate less scatter and 
attenuation than 201TI, and there are fewer image artefacts using " mTc in patients with no 
underlying CAD20. More importantly, " mTc-sestarnibi or " mTc-tetrofosrnin21 imaging allows 
easy gated acquisition, permitting the simultaneous evaluation of regional systolic thickening,
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global left ventricular function, and myocardial perfusion22. Sestamibi is a coordination
complex of the radioisotope technetium-99m with the ligand methoxyisobutylisonitrile (MIBI)
which, when injected intravenously into a patient, distributes in the myocardium
proportionally to the myocardial blood flow. Tetrofosmin is the ether functionalized
diphosphine ligand 1,2-bis[bis(2-ethoxyethyl)phosphino]ethane and is chelated by two 1,2-
bis[di-(2-ethoxyethyl)phosphino]ethane ligands which belong to the group of diphosphines
and which are referred to as tetrofosmin. Tetrofosmin is rapidly taken up by myocardial 
tissue.
Regardless of the radiopharmaceutical used, SPECT imaging is performed at rest and during 
stress to produce images of myocardial regional uptake that reflect relative regional 
myocardial blood flow in each case. During maximal exercise or vasodilator stress, 
myocardial blood flow is typically increased three- to fivefold compared to rest. In the 
presence of a substantial coronary stenosis, myocardial perfusion will not increase as 
expected in the stress study. In patients who are unable to undergo physical exercise, either 
one of the two coronary vasodilatory drugs, adenosine or dipyridamole, may be used to 
stimulate the required increase in blood flow.
Several " mTc labelled agents have been developed, including teboroxime (A MIBI variant), 
tetrofosmin, and sestamibi. Sestamibi is the most studied of these agents, and is currently 
the most widely used. Tetrofosmin was developed after sestamibi and has been the subject 
of far fewer studies. Both tetrofosmin and sestamibi distribute to the myocardium in relation to 
blood flow. Their uptake requires a viable myocardial cell and an intact cell membrane.
2.2 Quantitative Myocardial Perfusion SPECT Scintigrams
With the use of planar 201TI imaging and visual assessment to interpreted myocardial 
scintigrams, sensitivity and specificity for detection of CAD averaged 82% and 88%, 
respectively, in -4000 patients combined from multiple published series. When quantitative 
analysis, instead of qualitative analysis, was used the sensitivity and specificity of planar 201TI 
scintigraphy were significantly higher at 91% and 89%, respectively, in 682 patients from 
studies published in the literature23. The overall sensitivity and specificity for planar " mTc 
exercise MPI studies were 90% and 70% respectively24. Qualitative and quantitative methods 
of interpreting planar " mTc images after stress showed similar results25.
Quantitative SPECT perfusion imaging could be considered as one of the most important 
advances in MPI and significant higher sensitivities of 89% were obtained at the expense of 
specificity (76%) for studies performed with 201TI26. In the case of " mTc agents the 
introduction of SPECT imaging has not appreciably improved these measures in two 
studies19 27 performed on a total of 157 patients, using both quantitative and qualitative 
methods. The sensitivity was 85% and the specificity was 79% for the detection of CAD
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Other studies did find the sensitivity of exercise MPI to be comparable to that of 2O1j | 20 29. 
These equivalent (and occasionally reduced) specificities compared to 201TI planar and 
SPECT images are most likely attributed to a referral bias in which patients with abnormal 
scans are more likely to be referred for coronary angiography than patients with normal 
scans in more recent studies30.
It is of interest that the sensitivity of SPECT remains high (85%) for CAD detection in patients 
without prior myocardial infarction. As expected, the sensitivity for detection of single-vessel 
disease with SPECT 201TI imaging averaged 83% compared with 93% for patients with 
angiographic 2-vessel disease and 95% for patients with 3-vessel disease23. In the case of 3- 
vessel disease there is a reduction of intensity in all the regions which can be interpreted as 
reduced intensities in the study or by adjusting the intensity levels such a study can be 
interpreted as normal.
The lower specificity for myocardial perfusion imaging is mostly related to false-positive 
defects on the inferior wall31. This phenomenon is created by a loss in depth-dependent 
resolution and by attenuation of the signal.
2.2.1 ECG-Gating of Myocardial Perfusion SPECT Scintigrams
The simultaneous assessment of myocardial function together with myocardial perfusion
from a single procedure became available with the introduction of ECG-gated
(electrocardiographically-gated) myocardial perfusion SPECT imaging32. It is currently one of
the most commonly performed cardiology procedures in a nuclear medicine department
replacing the SPECT only MPI studies. Automation of the image processing and
quantification has made this technique highly reproducible, practical and user friendly in the
clinical setting. It is now routinely used to assess, in addition to myocardial perfusion, global
and regional left ventricular function33'34. The main parameter of global function that is
measured is left ventricular ejection fraction. Other important parameters of global function
that are measured are end-diastolic volume, end-systolic volume, stroke volume and
myocardial mass. For assessment of regional LV function both myocardial wall motion and
wall thickening is determined. Incorporating ECG-gating as a routine during SPECT cardiac
perfusion scintigraphy is appropriate for at least four reasons: there is an extensive peer-
reviewed literature35-36,37 attesting to its value; the practice is now widespread; practitioners in
diverse settings (academia and private practice) regularly employ it; and the hardware and 
software requirements are widely available.
2.3 Reported Sensitivity and Specificity of SPECT MPI
2.2.2 Absolute Quantification
The ultimate goal in myocardial SPECT is to achieve absolute quantification - that is, to make 
an absolute measurement of Becquerels of tracer per gram of tissue in a specified region of 
the left ventricular myocardium. Unfortunately, photon attenuation, scatter radiation, partial- 
volume errors, and other complications compromise absolute quantification of the 
radionuclide uptake from SPECT3839-40. According to a study which has been done on a 
porcine model without any corrections, the measured in vivo activity concentration in the 
porcine myocardium was only 10% of the true value41. Correcting for object-specific 
attenuation improved the accuracy of this measurement but resulted in values that were still 
only 42% of the true value. By correcting for both attenuation and partial-volume errors, they 
were able to achieve absolute quantification with an accuracy error near 10%.
2.3 Reported Sensitivity and Specificity of SPECT MPI
SPECT MPI has important prognostic value and sensitivity in the region of 85%. However, 
the specificity of SPECT has been commonly reported to be as 65% low indicating a number 
of false-positive readings in studies42,43 44.
Among several physical factors that degrade image quality and quantitative accuracy in
SPECT, photon attenuation is believed to be the major cause of false-positive cardiac 
SPECT perfusion images45,46,47,48
2.4 Permutations in Emission Tomography
There are several factors that degrade the image quality and the quantitative accuracy of 
emission tomography reconstructions and these factors have to be addressed for the 
optimisation of the reconstruction process. These factors include the following41,49,50:
Attenuation of the photons travelling toward the detector,
The detection of scattered as well as primary photons,
Depth-dependent collimator response correction (frequency-distance principle),
The finite spatial resolution of the imaging systems or partial-volume effect.
Patient motion during the scan.
Whereas all of these effects limit practical quantitative emission tomography, the most 
important effects are the photon absorption in the object and the contribution in the images of 
events arising from photons scattered in the patient (the object) 40,51 52. Both absorption and 
scattering are components of the general process of photon attenuation and in order to 
Improve quantitative assessment, these factors have to be addressed. Extensive work has 
been done to reduce the effect of these factors and solutions have been provided but there is 
still a need to improve these techniques because the current specificity of the technique is 
still too low causing a significant number of false-positive reports. This means that about 20%
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of patients will be diagnosed as having a positive scan and will undergo additional testing but 
they will not be suffering from CAD. This places unnecessary stress to the patients involved 
and has a substantial impact on cost. As an example, for a District General Hospital doing on 
average 1500 MPI studies per year, about 300 patients without CAD will undergo additional 
testing incurring an extra cost to the hospital. False negative MPI studies are uncommon53, 
but include the difficult to diagnose ‘balanced triple vessel disease’ where perfusion to all 
myocardial territories is equally reduced and therefore no normal myocardium exists for 
comparison. Sometimes no identifiable explanation exists for a false negative result but it can 
also be as a result of the existence of collated circulation, also known as “collaterals”, which 
restore a substantial amount of blood flow but the person is not disease free.
2.4.1 The Problem of Photon Attenuation in Emission Tomography
Photons emitted by the radiopharmaceutical will interact with tissue and other materials as
they pass through the body. This forms the physical basis of photon attenuation. For photon
energies encountered in nuclear medicine (i.e., from 68-80 keV for 201TI to 511 keV for
positron emitters), photons emitted by radiopharmaceuticals can undergo photoelectric
interactions and Compton incoherent scattering within the patient. In the case of
photoelectric interactions the incident photon is completely absorbed. In the case of Compton
scattering, the primary radionuclide photon interacts with loosely bound electrons in the
surrounding material and is scattered. The scattered photons have a trajectory which
generally carries it in a different direction than that of the primary photon. The energy of the
scattered photon can be lower than, in the case of Compton incoherent scattering, or be the
same as, in the case of coherent scattering, than that of the incident photon. The more
medium in the trajectory of the photon, the bigger the chance for it to be stopped or 
scattered.
Many solutions have been proposed to compensate for the effect of photon attenuation and 
this will be discussed in detail in section 2.4.5.
2.4.2 The Problem of Photon Scatter in Emission Tomography
Another source of degradation inherent in SPECT imaging which distorts the projection data 
is the inclusion of scatter in the projections and although Compton scatter is part of the 
attenuation process, scatter is normally considered to be a separate problem and can be 
treated as such. Scattered photons are diverted from their original path with some loss in 
energy. Due to scatter, the photons reaching the Gamma Camera will have energies with a 
broad band ranging from close to zero to the maximum energy of the isotope. Most of the 
photons with energy lower than the maximum energy can be eliminated with the use of an 
energy window. This will discriminate the photons based on their energy and only photons
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close to the maximum energy will be detected reducing the number of scattered events that 
are detected. Making the window too small will lead to extensive scanning times which will 
limit the usefulness of the test. Therefore, although the window size can be used to limit the 
number of scattered photons, its size cannot be reduced to a value which will completely 
remove all scattered photons and approximately 30% of the scattered photons will still be 
detected and these can lead to artefacts in the reconstruction as well as loss of contrast. The 
problem with scatter is that photons originating from a position which would not have been 
detected can be scattered in a different direction so they will be detected. Sohlberg et al 
suggest that scatter appears to be a greater problem when attenuation correction is 
performed54. This leads to the inclusion of photons in the projections that normally would not 
have been detected. The ratio of scattered to primary photons in the photopeak energy 
window (scatter fraction) is typically 0.34 for " mTc55 and 0.95 for 201TI56 when using a 20% 
energy window.
Scatter correction results in improvement in image contrast and it is essential if absolute
quantification is desired. In cardiac studies, performing attenuation correction alone tends to
result in reduction of contrast compared with results without attenuation correction (in fact the
apparent contrast is artificially high without attenuation correction due to the errors in
reconstruction). As a result some form of scatter correction is desirable to restore visual 
contrast.
There have been many methods of scatter correction suggested and this is still a topic for 
continuing research. Unfortunately there is no single method that is universally accepted. 
Generally, the methods of scatter correction can be divided into two different categories57,58. 
The first category, referred to as scatter estimation, consists of those methods that estimate 
the scatter contributions to the projections based on the acquired emission data. The data 
used may be information from the energy spectrum or a combination of the photopeak data 
and an approximation of scatter Point Spread Functions (PSFs). The scatter estimate can be 
used for scatter correction before, during, or after reconstruction. The second category 
consists of those methods that model the scatter PSFs during the reconstruction process. 
The second approach will be called reconstruction-based scatter compensation.
Whereas attenuation and collimator blurring can nowadays be corrected in clinically
acceptable computation times, accurate and efficient scatter correction has been proven to 
be a more difficult problem.
In the triple-energy window scatter compensation method59 the count of scattered photons is 
subtracted from that acquired with a photopeak window at each pixel in each planar image of 
single-photon emission computed tomography (SPECT). The subtraction is carried out using 
two sets of data: one set is acquired with a main window centered at photopeak energy and 
the other is acquired with two subwindows on both sides of the main window. The scattered
11
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photons included in the main window are estimated from the counts acquired with the 
subwindows and then they are subtracted from the count acquired with the main windows.
One very promising recently presented scatter compensation method is the Monte Carlo 
(MC)-based scatter correction60. In this method, a MC simulator is used as a forward- 
projector for scatter in the ordered subset expectation maximization (OS-EM) algorithm. MC- 
based scatter modelling is expected to be especially advantageous in areas where the 
attenuating media is highly non-uniform such as the thorax because it can faithfully produce 
the complex shape of the scatter response function. The MC-based scatter compensation 
has been shown to outperform the common triple-energy window scatter compensation 
method in terms of contrast and myocardial lesion detectability61. Unfortunately, despite the 
considerable advances made in MC based scatter compensation its widespread utilisation in 
clinical practice can still be limited by long computation times.
To overcome this limitation two simple and effective acceleration methods62 for 
reconstruction-based scatter compensation have been presented. The first of these 
approaches is the coarse grid scatter modelling method, which calculates the scatter 
contribution using sparser grid than is used in the actual reconstruction. The second 
approach is the intermittent scatter modelling method, where scatter is modelled only during 
the first couple of OS-EM iterations and then held as a constant additive factor for the later 
iterations. Both of these approaches are based on the assumption that the scatter response 
contains mainly low-frequency components and can thus be modelled with a relatively large 
voxel size and not during the last OS-EM iterations.
In a study63 to implement the coarse grid and intermittent scatter modelling methods for MC- 
based scatter compensation a substantial reduction in the reconstruction time has been 
achieved making both the coarse grid and the intermittent scatter modelling methods suitable 
for everyday accelerating MC-based scatter compensation, and with these methods MC- 
based scatter compensation is available for routine use in clinical cardiac SPECT today.
2.4.3 The Problem of the Partial Volume Effect in Emission
Tomography
The spatial resolution in the reconstructed images in SPECT is limited (about 12 to 16 mm at
FWHM (Full Width Half Maximum))64, especially in small structures which results in the
underestimation of peak activity in small structures. This finite spatial resolution is also called 
the partial-volume effect.
The partial volume effect is part of a set of effects which occur due to the finite size of the 
detection elements or resolution elements (voxels which are the pixel size in 3 dimensions). 
When the object varies rapidly over distances comparable or less than the spatial resolution,
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the image value will reflect the mean value over the resolution element. This partial volume 
averaging is also called the partial volume effect and is illustrated in figure 2.1.
(a) (b)
Figure 2-1: Illustrating the partial volume effect with the real image (a) and the displayed image (b) as a result of 
the PVE.
In SPECT a point source of radioactivity yields a blurred image. The PSF is an index of this 
blur, which limits the ability to resolve small objects. This intrinsic blur also limits the 
quantitative accuracy of SPECT measurements and results in an incorrect estimate of 
radioactivity concentration in small structures65. The observed radioactivity concentration in 
small structures differs from the true concentration because of "spillover" effects between 
regions, i.e. blurring of counts out of the structure (“spill-out”) and blurring of counts into the 
structure from surrounding radioactivity (“spill-in”).
To correct for the partial volume effect (PVE) in SPECT data sets is an important though 
complex issue. Two main approaches for PVE correction can be distinguished: a voxel- 
based66 and a region-of-interest (ROI) based method67. Although other methods have been 
proposed, they either represent a combination of the above techniques68, or have not been 
fully validated69. Although the ROI-based approach is of interest on a theoretical basis, it 
does not allow actual mapping of the resulting PVE-corrected data sets, so the voxel-based 
approach would have wider applications despite its limitations.
Different methods have been proposed that use well defined information from either MR
and/or CT data together with the SPECT data to correct for the partial volume effect50'70 The
accuracy of SPECT is limited by the relatively poor resolution compared to these anatomy- 
oriented systems.
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Correction for PVEs must account for both the signal loss from the limited extent of the 
region observed compared to the spatial resolution of the tomographic system, and the
"spillover" or signal contamination from surrounding tissue with different tracer uptake and 
kinetics.
A simple convolution model71 can be used where a 1-dimensional square wave can be 
convolved with a 1-dimensional Gaussian of Full Width Half Maximum (FWHM) to predict the 
underestimation associated with the PVE in the LV wall for spatial resolutions (characterized 
by the FWHM of the PSF). For each spatial resolution, the ratio maxobs/max between the 
observed maximum of the square wave after convolution (maxobs) and its true maximum 
(max) can be used to deduce the underestimation associated with the PVE in the LV wall, 
and the recovery coefficient is then defined as max/maXobs. The activity measured in the LV 
wall can then be multiplied by this recovery coefficient for PVE compensation. This recovery 
component can then be incorporated into the iterative reconstruction for each iteration as 
lmagek+1 = lmagek x recovery component. This provides a practical solution which can be 
incorporated in the routine reconstruction of MPI studies without the use of any additional 
hardware.
Resolution element and sampling
The Nyquist-Shannon sampling theorem, named after Harry Nyquist and Claude Shannon, 
is a fundamental result in the field of information theory. Sampling is the process of 
converting a signal (for example, a function of continuous time or space) into a numeric 
sequence (a function of discrete time or space). Shannon's version of the theorem states:72 
If a function x(t) contains no frequencies higher than N hertz, it is completely determined by 
giving its ordinates at a series of points spaced 1/(2N) seconds apart. The theorem is 
commonly called the Nyquist sampling theorem and it is often referred to simply as the 
sampling theorem.
The sampling process
The theorem describes two processes in signal processing: a sampling process, in which a 
continuous time signal is converted to a discrete time signal, and a reconstruction process, in 
which the original continuous signal is recovered from the discrete time signal.
The continuous signal varies over space in a digitised image and the sampling process is 
performed by measuring the continuous signal's value every T units of space, which is called 
the sampling interval. Sampling results in a sequence of numbers, called samples, to 
represent the original signal. Each sample value is associated with the instant in time when it 
was measured. The reciprocal of the sampling interval (1/T) is the sampling frequency 
denoted fs, which is measured in samples per unit of space.
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The theorem gives an upper bound for frequency components, N<fs/2, of the signal to allow 
for perfect reconstruction. This upper bound is the Nyquist frequency, denoted fN. The 
sampling theorem provides a sufficient condition, but not a necessary one, for perfect 
reconstruction.
Nyquist sampling and band limited images
Convolution by a point spread function in an image space is equivalent to multiplication by 
the Fourier transform of the PSF in Fourier space. PSF Fourier transforms are generally low- 
pass filters: they reduce the high frequency components of the image. If a PSF completely 
removes all frequencies higher than some /yc> then the PSF (and any images convolved by 
the PSF) are band limited at /vc.
The sampling of an image determines which Fourier frequencies can be measured from the 
image. If all frequencies lower than the band limit can be extracted, the image is said to be 
critically sampled. If the image is oversampled, then it is sampled more frequently than 
necessary.
If we oversample the image, we might preserve noise that otherwise would be lost, but no 
signal.
Under sampling the image (preserving too few pixels to measure all Fourier components out 
to the band limit) has the same result as multiplying the Fourier transform by a square 
function. The Fourier transform of a square function is a sine, and a multiplication in Fourier 
space is a convolution in image space, so this resampling results in a convolution by a sine 
function.
Of all the limitations mentioned in 2.4, the one outstanding point is correcting for the partial 
volume effect. There is no very good and easy "global" solution for the partial volume effect 
available yet73. Collimator modelling reduces the partial volume effect, but does not fully 
correct for it. Reconstruction with anatomical prior information could also reduce the partial 
volume effect, but incorporating anatomical information is not always so easy (there are 
several reconstruction methods available which can do this74), but clinically there still are a lot 
of problems (e.g. accurate alignment, respiratory and cardiac motion, etc).
2.4.4 The Problem of Depth-Dependent Collimator Response
Because collimator holes are not infinitely narrow, the photons that traverse the collimator 
will not all come from a direction that is exactly aligned with the holes. This leads to a 
substantial loss of resolution in the gamma-camera images and in the reconstructions. The 
amount of resolution also depends on the distance of the camera head from the patient, the 
further away the detector are, the worst the resolution as depicted in figure 2.2. The 
acceptance angle of a collimator is defined by the length of the collimator and the hole
2.4 
diameter. Although decreasing the acceptance angle would decrease the collimator blurring, 
it would also greatly decrease the sensitivity of the collimator. It can be shown that a twofold 
increase of the collimator resolution (typical collimated planar resolution is from 7 to 10 mm
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Figure 2-2: Illustrating the effect of distance on the shape of the PSF.
Correcting for this distance dependent blurring is possible as a result of accurate 
mathematical descriptions of collimator blurring7677. The distance dependent blurring can be 
incorporated into the Fourier transform of the sinogram, making use of the frequency- 
distance principle78. In iterative reconstruction it is possible to incorporate the detector 
response into the projector/back-projector pair to compensate for the distance dependent 
detector response during the acquisition to achieve a 2-fold improvement79.
2.4.5 Commercially Available Correcting Systems
A range of commercially available solutions are available which integrate scatter correction, 
attenuation correction and resolution recovery compensation techniques into an iterative
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reconstruction algorithm to simultaneously address these problems by modelling the camera 
and collimator and imaging parameters used for a specific application so that the degrading 
physical effects can be eliminated and to suppress noise in the image reconstruction 
process. Several such systems are now commercially available and will be briefly discussed. 
All these methods achieved this by modifying the Ordered Subset Expectation Maximization
(OSEM) iterative reconstruction algorithm which is an accelerated Expectation Maximization 
(EM) algorithm.
Most of these systems incorporate noise reduction methods. The reconstructed images 
obtained using the MLEM (Maximum Likelihood Expectation Maximization) algorithm tend to 
become noisy as the number of iterations increases, because noisy reconstructed images 
may yield projections that are very close to the measured noisy projections. The introduction 
of a priori knowledge as a constraint that may favour convergence of the EM process is 
called regularisation. The prior, based on an assumption of what the true image is, is usually 
chosen to penalise the noisy images74. Some of these commercially available 
implementations include the possibility of using maximum a posteriori (MAP) reconstruction 
methods such as penalised weighted least-squares80.
These implementations are the subject of a number of independent verification 
studies81'82,83,84,85, which are still ongoing, and initial results would appear to suggest that the 
improvement achieved is sufficient so that the acquisition time can be halved (or even be a 
quarter) without the loss of sensitivity or specificity.
A. SIEMENS - FLASH 3D
Siemens introduced a 3D OSEM reconstruction algorithm86 utilising Transmission 
Attenuation Correction with 3D Collimator and Detector Response Compensation in both 
forward and back-projection directions by implementing a 3D Gaussian PSF which varies 
with the distance from the collimator. Scatter compensation are achieved with Energy 
Window-based Scatter Correction techniques, i.e. Dual Energy Window (DEW) and Triple 
Energy Window (TEW)-based scatter projection images which are applied additively in the 
forward projection. It utilises multiple-peak isotope acquisitions and each photopeak is 
reconstructed separately with attenuation correction maps and scatter images for each peak 
where the peak reconstructions are summed post acquisition.
The acquisition time can be reduced to between 33% and 50% from the expected 20 
minutes, as compared to acquisition protocols with Filtered Back Projection reconstruction86.
B. PHILIPS - Astonish
Astonish has been developed by Philips Healthcare and is a fast SPECT reconstruction 
algorithm based on the OSEM reconstruction method that includes corrections for photon
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scatter, photon attenuation, and variations in spatial resolution. It also uses built-in noise 
reduction methods during the iterative process.
By measuring the changes in spatial resolution with distance from the collimator corrections 
for variations in spatial resolution are achieved but it is necessary to obtain calibrations for 
each of the collimators initially by the manufacturer. This collimator information is then 
incorporated into both the back projection and the forward projection parts of the 
reconstruction. Resolution Recovery correction can be performed with or without attenuation 
and scatter corrections.
The corrections for the photon scatter are performed by the Effective Scatter Source 
Estimation (ESSE) method62. It can perhaps be best described briefly by quoting from the 
authors’ abstract: “The method requires 3 image space convolutions and an attenuated 
projection for each viewing angle. Implementation in a projector-backprojector pair for use 
with an iterative reconstruction algorithm would require 2 image space Fourier transforms 
and 6 image space inverse Fourier transforms per iteration.” The corrections for the photon 
scatter are performed prior to the Transmission Attenuation Correction in each iterative 
OSEM step. Corrections for attenuation are performed during the forward projection process.
To be able to implement it for clinical use this technique has been tested87 and interpretative 
certainty and diagnostic accuracy were the same for standard FBP reconstruction, full-time 
imaging and half-time imaging.
C. GE Healthcare - Evolution
Evolution for Cardiac has been introduced by GE Healthcare which uses a modification of 
the OSEM algorithm to incorporate resolution recovery. By modelling the integrated 
collimator and detector response function image resolution recovery88 based on a number of 
parameters are achieved. These parameters are collimator hole and septa dimensions, 
collimator to detector gap, intrinsic detector resolution, crystal thickness and projection-angle 
specific centre-of-rotation to collimator face distances89. This is achieved by either using look-
up tables or obtained directly from the raw projection data. Additionally noise suppression is 
incorporated, which is required to prevent hot spots because of the amplification of noise. 
MAP (Maximum a Posteriori estimation) technique is incorporated to control image noise.
D. ULTRASPECT - Wide Beam Reconstruction
A company in Haifa, Israel, UltraSpect has developed a standalone workstation which utilises 
the patented Wide Beam Reconstruction (WBR) algorithm81. This system is available as an 
additional workstation and can reconstruct data from most existing gamma cameras with 
standard collimators. WBR is based on an accurate physical description of the emission 
detection process and on its reconstruction, utilising iterative optimisation methods with no 
post-filtering applied. It is designed to simultaneously suppress noise and improve image
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resolution by eliminating the line spread function limitations from the system resolution. 
During the iterative reconstruction it uses the information regarding the collimator’s geometry 
(such as the dimensions and shape of holes or the septa thickness) and the detector’s 
distance from the patient. WBR applies statistical modelling of the expected photon emission 
and Fourier analysis of projection data to determine the approximate noise level that is 
present in the acquired data. Therefore selection of an optimal noise model to yield the 
appropriate balance between resolution and noise is possible.
A preliminary study of WBR demonstrated equivalent image quality and defect 
characterisation with simulated fast imaging with times as low as one-fourth of standard 
imaging time as compared to full-time standard imaging90.
E. Hermes Medical Solutions -  Hybrid Reconstruction
The company Hermes Medical Solutions is a long standing provider of standalone 
workstations for the processing and analysis of Nuclear Medicine images. A recent 
development is the Hybrid Reconstruction algorithm. This system can reconstruct data from 
most existing gamma cameras with standard collimators. It utilises the Coarse Grid and 
Intermittent Scatter Modelling method to obtain scatter correction63 together with 
Transmission Attenuation Correction and uses Incremental Gaussian Diffusion91 to obtain
compensation for depth-dependent collimator blurring. The use of MAP reconstruction is also 
available.
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The determination of an accurate, patient-specific attenuation map, which represents the 
spatial distribution of linear attenuation coefficients for the region of the patient’s anatomy 
that is included in the radionuclide imaging study, is fundamental to performing attenuation 
compensation. The methods for generating the attenuation map generally can be described 
as falling within these strategies:
► Import and register maps from another modality, i.e. Computerised Tomography (CT) 
and Magnetic Resonance Imaging (MRI);
► Obtain transmission data to construct the attenuation maps using the gamma camera 
employed for emission imaging; and
► Estimate the attenuation map from solely the emission data, i.e. emission based 
methods.
The first two classes include correction methods based on transmission scanning while the 
third class includes transmissionless correction methods based on assumed distribution and 
boundary of attenuation coefficients (calculated methods), statistical modelling for 
simultaneous estimation of attenuation and emission distributions or consistency conditions 
criteria. The reconstructed attenuation coefficients are energy dependent and therefore the
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reconstructed attenuation coefficients need to be transformed to the coefficients of the 
appropriate isotope energy by using suitable techniques.
After the attenuation map is generated it can be used to compensate for photon attenuation. 
The attenuation correction process can be done before reconstruction92, after 
reconstruction93, or it can be integrated within the transition matrix of an iterative 
reconstruction algorithm94.
The iterative reconstruction algorithm uses the fact that the attenuation map accurately 
delineates the contours of structures in the body and contains information about the 
distribution of its linear attenuation coefficients. It uses this information to calculate the 
attenuation to the boundary of each attenuating region for each pixel along the ray between 
the points of emission and detection in SPECT, before the resulting values are summed to 
estimate the projected or back-projected pixel values. If an accurate patient-specific 
attenuation map is available, then non-homogeneous attenuation can be easily implemented 
in the image reconstruction process.
2.5.1 Import and Register Maps from Another Modality
It is well known that x-ray computed tomography (CT) can provide a patient-specific map of 
attenuation coefficients that can be used to compensate radionuclide data from PET or 
SPECT for the effects of photon attenuation95,96. This is a natural observation since the CT 
image inherently represents the three-dimensional spatial distribution of attenuation 
coefficients of the patient. In addition, CT scanners are widely available and can produce 
cross-sectional images quickly with low noise and excellent spatial resolution in comparison 
to transmission images produced with external radionuclide sources and Nuclear Medicine 
Imaging generally. Overall, x-ray transmission techniques offer practical advantages for 
producing attenuation coefficient maps in terms of high photon output and short procedure 
times, excellent decay, lack of physical decay with a source that can be turned off between 
scans and that can be discarded easily at the end of its useful operating life.
Appropriately scaled CT scans can be acquired either independently on separate CT 
Scanners97,98,99,100 or simultaneously on multimodality imaging systems’101,102,103. These 
image sets are then co-registered with the emission data to provide the attenuation map that 
can then be used in the reconstruction algorithm to compensate for the attenuation of the 
patient’s anatomy.
The integration of SPECT and CT systems into a single imaging unit sharing a common 
imaging table provides a substantial advance in technology because this combination 
permits the acquisition of SPECT and CT data sequentially in a single patient study with the 
patient in a fixed position. Thus, the 2 datasets can be acquired in a registered format by
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appropriate calibrations, permitting the acquisition of corresponding slices from the 2 
modalities and avoiding the complications of aligning the two datasets acquired on different 
machines at different times, with slight positional differences. The CT data can then be used 
to correct for tissue attenuation in the SPECT scans on a slice-by-slice basis. Because the 
CT data are acquired in a higher-resolution matrix than the SPECT data, it is necessary to 
decrease the resolution of the CT data to match that of SPECT. In other words, the CT data 
are blurred to match the SPECT data. From the attenuation coefficient data acquired with 
CT, correction factors can then be determined, which can then be used to correct the SPECT 
data for attenuation, yielding the attenuation-corrected SPECT data.
There are numerous advantages in the use of CT data for attenuation correction of emission 
data. First, the CT scan provides a high photon flux that substantially reduces the statistical 
noise associated with the correction in comparison to other techniques (i.e., radionuclides 
used as transmission sources). Also, because of the fast acquisition speed of CT scanners, 
the total imaging time is substantially reduced by using this technology. Another advantage 
related to the high photon flux of CT scanners is that attenuation measurements can be 
made in the presence of radionuclide distributions with negligible contributions from photons 
emitted by the radionuclides (i.e., postinjection CT measurements can be performed). And of 
course the anatomic images acquired with CT can be fused with the emission images to 
provide functional anatomic maps for accurate localization of radiopharmaceutical uptake.
The benefits of using CT for attenuation correction as opposed to a radionuclide transmission 
source include less noise, faster acquisition, no influence on CT data by the SPECT 
radionuclide, and no need to replace decayed transmission sources104.
Unfortunately, a potential disadvantage is that there is sequential acquisition of CT data and 
then SPECT data; therefore, misregistration can occur, with patient movement leading to an 
artefact on the corrected scintigraphic images.
Several artefacts can be encountered with SPECT/CT. Patient movement between
acquisition of the SPECT and CT images will lead to misregistration105, which can produces
an incorrect attenuation map, causing defects on the attenuation-corrected images.
Movement can result from respiratory106 and cardiac motion, sagging of the emission table,
and patient motion between SPECT and CT acquisitions. It is essential that any SPECT/CT
system use a coregistration program and associated quality control phantom on a regular
basis to ensure correct alignment between the SPECT and CT scanners, in addition to
routine quality control for both SPECT and CT. It is also beneficial to have a quality control
program to realign the SPECT/CT data before attenuation-corrected SPECT image 
reconstruction, to correct for patient motion.
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Other sources of error include CT truncation, metal artefacts, and beam-hardening 
artefacts. Truncation, which occurs because the smaller CT field of view compared with that 
of SPECT may not account for part of the patient beyond the field of view, can result in an 
inaccurate attenuation correction map and reduce image quality, particularly in large patients. 
Artefacts from metal or beam hardening can also affect CT image quality and may lead to 
“false positive” focal uptake on attenuation-corrected SPECT images, which is caused by 
incorrect scaling of the Hounsfield units into the SPECT attenuation map.
Physiological misregistration artefacts108 occur when the SPECT emission image scan is 
displaced relative to the CT scan used for attenuation correction when involuntary 
physiological motion is present. This is not only relevant when CT attenuation maps are used 
but can also be relevant when attenuation correction is done with rotating radioactive 
sources emitting gamma rays. CT data are obtained at a speed much faster than a 
respiratory cycle, they depict images in a specific phase of the respitory and cardiac cycles. 
The much longer SPECT data acquisition averages over all respiratory and the cardiac 
positions. SPECT depict the average tidal breathing position of the diaphragm but in CT 
imaging the diaphragm may be caudally displaced relative to this position when the CT is 
acquired with the patient close to end-inspiration or in end-inspiration breath-hold. Such a 
CT-image used for attenuation correction will erroneously place lung tissues in the cranial 
abdominal regions, where on co-registered SPECT there is soft tissue. As the lung CT pixel 
values are low and result in a low attenuation correction, this region will appear as having 
less activity than it actually has. The cranial areas of the liver and the spleen thus appear as 
if they would be part of the lung on the SPECT scans.
It is well known that patient motion may cause image artefacts in myocardial SPECT images 
and affect clinical diagnosis109,110,111,112. Patient motion can be grouped into two categories, 
voluntary and involuntary motions. Voluntary motion includes unpredictable movements of 
the patients during data acquisition. Involuntary motion involves movements of the organs 
such as upward creep in stress perfusion study and respiratory motion. Upward creep is 
probably related to a transient increase in mean total lung volume early following exhaustive 
exercise, resulting in a mean lower position of the diaphragm (and thus the heart) at the 
beginning of imaging113. However, these motion artefacts are often masked by more serious 
effects generated by other image degrading factors, such as attenuation, collimator-detector 
blurring and scatter. Recently, quantitative reconstruction methods are available to reduce 
the effects of these image degrading factors. As a result, motion artefacts and their 
compensation are become increasingly important in quantitative myocardial SPECT imaging.
Upward creep and respiratory motion can produce substantial artefacts114 in myocardial 
SPECT images. Due to changes in attenuation effects from movement of the heart and 
diaphragm and blur from respiratory motion, the artefacts are shown as regional decrease of
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count density in the inferior wall. The magnitudes of the artefacts increase with the extent of 
the motion. The artefacts cannot be reduced by correction. This implies that motion 
corrections are important in myocardial SPECT image reconstruction to obtain quantitatively 
accurate reconstructed images. Upward creep can be corrected simply by appropriate 
translation of the projection data. To correct for respiratory motion, however, respiratory 
gating may be needed.
2.5.2 Radionuclide Transmission Methods
The earlier systems used either " mTc or 201TI transmission sources to produce accurate 
attenuation maps115. More recently the use of either line or point sources with 153Gd, 133Ba or
139
Ce has been developed to compute the attenuation map, depending on practical and cost 
effectiveness issues116.
This section considers the use of radionuclide sources to produce the attenuation map. This 
method acquires transmission data for use in conjunction with conventional emission 
scanning. In a clinical environment, the most widely used attenuation correction techniques 
use transmission data acquired before (preinjection)117, during (simultaneous)118,119, or after 
(postinjection)120 of the emission scan. Technically it is easier to perform sequential 
emission-transmission scanning rather than simultaneous scanning, but it increases the 
imaging time and patient misalignment or motion can cause errors in the image registration 
process. On the other hand, simultaneous acquisition requires no additional time for the 
emission and transmission measurements, which can be an important factor for routine 
clinical use but errors may be introduced due to cross talk between the transmission and 
emission data. A range of approaches have been proposed to minimise or eliminate the 
effects of contamination of emission data by transmission photons and to reduce spillover of 
emission data into the transmission energy window118,121. The attenuation coefficients and 
activity concentrations have been shown to be not significantly different when estimated with 
sequential and simultaneous emission transmission imaging122. The accuracy of the 
transmission and emission maps produced using different transmission-emission source 
combinations has been the subject of many debates and studies123. Different transmission-
scanning geometries have emerged for clinical implementation in SPECT124.
Uncollimated flood or sheet sources have been used in the early designs of transmission 
systems for SPECT cameras. This design has certain advantages, for example, the source 
fully irradiates the opposite head and requires no motion of the source other than that 
provided by the rotation of the camera gantry. Such sources also have drawbacks in that the 
high proportion of scattered photons in the transmission data due to the broad-beam imaging 
conditions. As a result, the attenuation map estimates an effective linear attenuation 
coefficient rather than the value that would be calculated from narrow-beam geometry.
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Collimation of the transmission source can overcome this difficulty in part125 to produce a 
geometry that more accurately represents narrow-beam transmission geometry.
The main radionuclide-based configurations include126:
► a stationary line source fixed at the collimator’s focus with convergent collimation on a 
triple-detector system122,
► scanning line sources with parallel-hole collimation76,
► a multiple line source array with parallel-hole collimation127,
► scanning point sources using either fanbeam and offset fanbeam geometry128, or
► an asymmetric fanbeam geometry acquired by using a high-energy source that emits 
transmission photons capable of penetrating the septa of a parallel-hole collimator129.
The scanning line source geometry has emerged as the most widely implemented 
configuration for commercial transmission acquisition. However, each configuration has its 
unique advantages and drawbacks, and camera manufacturers are still optimising the 
apparatus used to acquire the transmission data.
2.5.3 The Implementation of Transmission Based Methods
The majority of clinical attenuation compensation techniques use maps reconstructed from 
data obtained in transmission scans. Such patient-specific compensation methods, based on 
experimentally measured maps, should create substantially improved images, but serious 
problems with the technique created distrust and leading to heated debates about the value 
of attenuation correction'30. Several reviews have shown that attenuation correction methods 
that are currently available on clinical cameras can introduce artefacts that may be difficult to 
identify and might inadvertently alter diagnoses and study outcomes131. As a result, the 
attenuation correction option is often avoided in clinical practice, even in those centres that 
have all the necessary equipment relying instead on the feeling that an expert reporter will 
observe and correctly identify any artefacts.
2.5.4 Reducing the Time for the Transmission Scan and Emission
Based Methods
Transmission imaging is achieved at substantial costs: increased imaging time, increased 
hardware complexity, and increased financial cost.
Several attempts have been made to overcome these limitations. One such attempt uses 
estimates of tissue density to provide an attenuation map without increasing scan time132. 
Attempts to provide attenuation maps that are based on fast transmission scans, 
simultaneous emission-transmission scans122,76, or exploiting the consistency conditions of 
the attenuated radon transform133 are also examples. The fast and simultaneous 
transmission scan methods were developed to minimise both scan time and the artefacts
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associated with errors in scatter and attenuation correction caused by misaligned emission 
and transmission data114. A method has been developed to extrapolate complete attenuation 
maps from truncated transmission scans135. However, transmission imaging still suffers the 
penalty of requiring extra hardware.
In principle, the attenuation maps containing detailed information about density distribution in 
the body can be computed using only emission data126, but this approach is still too complex 
and time consuming for routine use136-137. Algorithms in this class of methods either assume 
a known body contour in which a (uniform) distribution of attenuation coefficients is assigned 
or try to derive the attenuation map directly from the measured emission data.
Attenuation correction is straightforward in imaging the brain and abdominal areas. In these 
areas soft tissues are the dominant constituent allowing use of a uniform attenuation 
correction. In regions such as the thorax, which are more heterogeneous, and include low 
density air spaces, the attenuation coefficients have a wide range and vary rapidly over very 
short distances. In the brain and abdomen, it is possible to determine the body contour from 
the emission data, then the region within the contour is assigned a uniform linear attenuation 
coefficient value corresponding to that of water or soft tissue to generate the corresponding 
attenuation map. Automatic edge-detection methods can be used to determine the body 
contour or it can be done manually.
In some of the earliest work on emission based methods alternating iterations of the 
reconstruction algorithm were used138 to reconstruct emission tomograms and attenuation 
maps from a set of emission data alone. Many researchers, who applied various optimisation 
techniques, have also used similar philosophies in generating emission tomograms and 
attenuation maps129. The problem can be formulated as an optimisation task in which the 
objective function is a combination of the likelihood and an a priori probability139. The latter 
uses a Gibbs prior distribution to encourage local smoothness and a multimodal distribution 
for the attenuation coefficients. Other methods included the use of the expectation 
maximization (EM) algorithm140 or penalty functions141, 142
An attractive alternative for the estimation of attenuation maps from emission data alone is 
called “inferred anatomy”133. Earlier attempts to infer anatomy include fitting ellipses to 
photopeak- or Compton-window sinograms or thresholding preliminary reconstructions143.
An inferred anatomy method for brain SPECT using attenuation distributions inferred from a 
head atlas144 has been proposed. This method requires a digitised head atlas and a 
registration program. It is simple to implement, because no customised software is required, 
and is computationally feasible on modern desktop computers, requiring only slightly more 
computation time than a typical tomographic reconstruction.
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2.5.5 The Method of Inferred Anatomy and Derived Anatomy
The above mentioned inferred-anatomy algorithm requires a preliminary reconstruction of the 
patient as shown in figure 2.3(a) and an atlas (a brain atlas in the case described by Stodilka 
et. al.) and shown in figure 2.3(b). This preliminary reconstruction does not include scatter 
and attenuation correction. The atlas consists of a functional component (colour) and an 
anatomical component (gray scale). The functional component is then spatially registered to 
the preliminary reconstruction as shown in figure 2.3(c), and this optimal transformation is 
recorded. The patient’s anatomy is then inferred by applying the same transformation to the 
anatomical component of the head atlas, figure 2.3(d).
(a) (b) (c) (d)
Figure 2-3: The inferred-anatomy algorithm. The preliminary reconstruction of the patient (a), the atlas 
consisting out of both the anatomically and functionality parts (b). The registration of the functionality part to the 
preliminary reconstruction (c) and after applying the result of the registration to the anatomical part of the atlas (d).
The brain is a much more homogeneous part of the human anatomy compared to other 
areas such as the thorax but it should be feasible to extend the method of inferred anatomy 
to provide non-uniform attenuation correction in the thorax.
Extending the method of inferred anatomy to the thorax by overcoming the obstacles caused 
by the non-uniform nature of the thorax has not yet been reported. This has been achieved in 
this study and will be the subject of chapter 7. In this instance the 4-dimensional NCAT- 
phantom 5 was used as the atlas to produce the anatomical and functional components. 
This process consisted of an initial reconstruction of a patient, not including attenuation and 
scatter correction. The reconstructed image was spatially registered to the functional
component of the NCAT-phantom and after applying this transformation to the patient's 
anatomy the desired attenuation map was obtained.
The above mentioned method of inferred anatomy in the thorax required various image 
manipulation and segmentation techniques which can be extended to develop another 
emission based method, termed “Derived Anatomy”. This is a unique approach, never 
attempted before, which uses the results of the image segmentation to create a patient 
specific NCAT parameter file. This parameter file can then be used to produce a NCAT- 
phantom relating exactly to the anatomy of the patient under investigation and therefore can
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be used as the attenuation map for that specific patient. This implementation will also be 
discussed in much more detail in chapter 7. It provides a very promising solution for the 
implementation of emission based attenuation correction algorithms.
2.6 New Hardware for the Optimisation of MPI
This chapter would not be complete without looking at developments to improve the 
performance of Gamma Cameras and address the issues which affect Nuclear Medicine 
Imaging generally and address many of the problems discussed in this chapter, as most 
gamma cameras are still using the same design principles introduced with the first anger 
cameras in the 1960’s. There have also been substantial recent efforts to develop new 
imaging systems with increased sensitivity by addressing the main limitations of MPI by 
combining several approaches such as changing the detector geometry and optimising 
tomographic sampling of the field of view for myocardial imaging, improving the detector 
material and collimator design146.
A range of new dedicated hardware camera systems with optimised acquisition geometry, 
collimator design, and associated reconstruction software have been recently introduced by 
different vendors. This include innovative designs of the gantry and detectors which have 
been proposed to allow increased sampling of the myocardial region, and thus allow better 
local sensitivity. These systems combine an improvement in spatial resolution and sensitivity. 
As a consequence of faster imaging times and more comfortable patient positioning, these 
systems have the additional benefit of reducing patient motion during a scan146.
These new developments include:
► Solid state detectors such as pixilated Csl(TI) or cadmium zinc telluride (CZT) 
pixilated detectors.
► Photodiodes instead of photo multiplier tubes.
► Region-of-interest (ROI) or organ-of-interest centred acquisition scanning.
► No visibly moving parts.
► Digital logic and software.
► List mode acquisitions.
► Multi-pinhole or astigmatic collimator design.
► Dual isotope imaging.
2.6.7 DIGIRAD - CARD!US 3 XPO
The Cardius XPO camera dedicated to fast cardiac imaging has been developed by Digirad 
and it uses indirect, solid-state detectors consisting of pixilated Csl(TI) detectors and 
photodiodes. Digital logic, instead of analog systems, is used to process the signals. Data 
acquisition is typically accomplished in TA minutes as compared to 20 minutes on a standard 
anger camera. When comparing its performance to that of a standard dual-headed camera it
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was found that the similar quality could be obtained with 38% reduction in the acquisition
147time
2.6.2 CardiArc
CardiArc has developed a dedicated nuclear cardiology SPECT camera in which the detector 
and collimation are redesigned and optimised specifically for cardiac imaging. This device 
has no visibly moving parts and has a single internally moving part which is hidden from the 
patient. Scan times reported by the company are as short as 2 minutes. An independent 
evaluation concluded that the CardiArc system appears to gain image quality by a factor of 5-
10 when compared to the conventional dual-head camera in these scans148
2.6.3 Spectrum Dynamics -  D-SPECT
Spectrum Dynamics introduced a system using pixilated CZT detector arrays (with a superior 
energy resolution of ~1.7 better than a standard Anger camera at 140 keV), called D-SPECT, 
where acquisition time as short as 2 minutes has been reported149. It utilises region-of- 
interest (ROI)-scanning where a 10-second pre-scan is performed to identify the location of 
the region of interest. Scan limits and timings are then set and the final scan are performed. 
The myocardial count rate was 7 to 8 times higher for D-SPECT149 as compared with a 
standard gamma camera and it has also been demonstrated that, by taking advantage of the 
improved energy resolution of CZT150, simultaneous dual isotope SPECT MPI is feasible
using 201TI and yymTc, and therefore raise the possibility of obtaining the results from both the 
rest and stress study in a single study.
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2.6.4 Multi-Pinhole Collimation Approach
Multi-pinhole collimation has been introduced by some vendors to provide an alternative 
approach to parallel-hole rotational tomography on current Gamma Cameras. Useful results 
have been demonstrated in small animal imaging with multi-pinhole SPECT providing 
improved spatial resolution and detection efficiency in comparison to parallel-hole 
collimation151,152,153. This approach allows many views to be acquired simultaneously 
throughout the entire image acquisition period without the need for motion of the detector, 
collimator or patient.
The approach may be prone to greater formation of artefacts because it inherently produces 
an incomplete tomographic dataset and it acquires images from only limited views154. 
Background activity from other organs may not be seen by all of the views, which could lead 
to inconsistencies in the reconstructed data. It is also known that the resolution and 
sensitivity of pinhole collimators decreases with the distance from the collimator155 and these 
issues need to be addressed for this technique to have clinical value.
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This approach has been introduced by a company called Eagle Heart Imaging who 
integrated multi-pinhole methodology with the Emory Reconstruction Toolbox to provide a 
commercial multi-pinhole upgrade product which they called MP-SPECT to be used on 
existing dual-head SPECT gamma cameras.
A 9-pinhole collimator using 8 mm diameter pinholes was investigated154 and it was found 
that the spatial resolution was 30% less than that achieved by standard parallel-hole 
collimation but the detection efficiency was increased 10-fold predicting a 5-fold increase in 
sensitivity and would provide comparable resolution to that of a standard gamma camera. 
Another issue addressed154 is regarding the minimal number of views and the optimal 
viewing geometry required for clinical cardiac SPECT. There are both advantages and 
disadvantages to having fewer views. As the number of views present in the SPECT data set 
is decreased, the geometric appearance of the heart is visibly altered. This aspect must be 
weighed against the fact that the increased statistical content and simultaneity of these views 
improves the comparability of the stress versus rest data sets acquired on the same patient. 
The improved statistical content of multi-pinhole SPECT images is also a key factor in 
supporting the ability to image multiple isotopes simultaneously. The clinical utility of this 
approach has been demonstrated clinical comparability156 between a three detector 18- 
pinhole SPECT system and a conventional rotational SPECT gamma camera.
2.6.5 GE Healthcare - Ultra Fast Cardiac (UFC) Camera
The multi-pinhole design was also introduced by GE Healthcare in the UFC camera using an 
array of cadmium zinc telluride (CZT) pixilated detectors. Energy and spatial resolution 
improved with the use of CZT detectors. The detectors and collimators do not move during 
acquisition and views from all angles are acquired simultaneously through the proprietary 
multi-pinhole collimator which utilises a large number of pinholes which lead to an improved 
overall sensitivity. It was possible to obtain a 30% reduction of the scatter component as a
result of the asymmetric CZT energy response . The improved energy resolution obtained 
with CZT detectors alone was further improved with the combination of CZT and a pinhole 
collimator158. This may facilitate new applications such as simultaneous dual isotope imaging. 
An improvement of 1.65-fold in energy resolution was demonstrated and an improvement of 
1.7-2.5 fold in spatial resolution and 5-7 fold in sensitivity with UFC energy resolution of 
5.70% and spatial resolution in the 4.3-4.9 mm range159 when compared to a standard 
gamma camera.
2.6.6 SIEMENS - IQ'SPECT
Siemens recently introduced IOSPECT, which consists of three components: an astigmatic 
collimator, an optimized organ-of-interest centred acquisition, and iterative reconstruction.
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The collimator is based on a previously developed astigmatic (cardiofocal) collimator 
concept160. The collimator is designed so that the centre of the field-of-view magnifies the 
heart both in the axial as well as in the trans-axial direction, while the edges sample the 
entire body to avoid truncation artefacts common to single focal collimators when imaging the 
torso. With an appropriate orbit this variable-focus collimator increases the number of 
detected events from the heart by more than a factor of two in each direction compared to 
that of a parallel-hole collimator with equivalent resolution, and magnifying the heart while 
imaging the rest of the torso under traditional conditions160.
In IOSPECT this organ centric orbit acquisition technique is combined with a new 
proprietary iterative reconstruction algorithm based on Flash3D86 which models the 
astigmatic geometry of these collimators. IOSPECT reconstruction also includes state-of- 
the-art distant dependent isotropic (3D) resolution recovery, CT-based attenuation correction, 
and energy window-based scatter correction. The reported image acquisition time of this 
system can be as short as 4 minutes.
2.7 Conclusions
The application of depth-dependent resolution recovery, attenuation correction using external 
source devices, and scatter correction has been proposed to resolve the lack of specificity for 
myocardial perfusion imaging and an improvement in its sensitivity. Substantial advances 
had been made in implementing these solutions. The introduction of new hardware designs 
could also have a substantial impact on the improvement of the sensitivity and specificity of 
MPI but as these are all recent introductions, no published results are available yet. There is 
also currently a fairly large equipment base using the older technology using general gamma 
cameras rather than dedicated cardiac cameras is unlikely to be replaced in the near future 
that would benefit substantially from improved attenuation correction. In addition, an 
improved attenuation correction method is also likely to work on the new equipment, 
therefore increasing the accuracy still further.
Part of these solutions is the application of attenuation correction. The benefits of an 
accurate attenuation correction are universally accepted but it still lacks widespread 
implementation. Some of the reasons for the lack of acceptance of transmission based 
attenuation correction are that it seems to introduce additional artefacts (which will be 
referred to again in later chapters) and its cost and complexity. In contrast, the 
implementation of correction techniques for the other permutations, i.e. scatter, finite 
resolution response and depth-dependent collimator response, seems to be met with far less 
resistance. It is interesting to note that these implementations are all software based as 
compared to the attenuation corrections technique, which is a hardware implementation. The 
lack of the universal implementation of attenuation correction in many cases can also be
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contributing to a lack of understanding of the complexity of attenuation despite the amount of 
research which has been done on the topic, as well as understanding the real impact current 
available attenuation methods can have on improving the outcome of clinical studies. 
Resolving the issues of attenuation correction, so that it becomes universally accepted 
should be a priority.
To add to the understanding of attenuation artefacts and the effect it can have on the 
interpretation of clinical studies this project includes two studies which were devoted to 
studying less well known and some unknown aspects of attenuation to build up a better 
understanding and appreciation of the impact of not applying attenuation correction, as well 
as highlighting the complexity of attenuation artefacts. The hope is that a better 
understanding of the complexity and unpredictability of attenuation will inspire the wider 
implementation of correcting for it.
Although transmission based attenuation correction is viewed with a great deal of scepticism, 
it is current commercially available on most systems. It is often combined with correction 
methods for both depth-dependent collimator blurring and scatter. This project includes a 
study of the evaluation of such a commercially available solution that uses transmission 
scanning, scatter correction and depth-dependent resolution recovery, to determine the level 
of compensation achieved with it despite the reservation about using transmission scanning. 
This will be important because its implementation could substantially improve the outcome of 
Myocardial Perfusion Imaging. Further, it will take a substantial time to develop and verify 
alternative emission based methods which may be able to provide a complete solution 
without the draw backs of transmission scanning.
This project will also introduce two emission based methods to overcome the limitations and 
drawbacks of transmission based attenuation correction methods that can contribute 
substantially to obtaining a more accurate and more universally acceptable attenuation 
correction solution. These methods are software based and will remove the burden of 
substantial additional cost, radiation dose and scan time of many of the other solutions and 
will work on the current generation of Gamma Cameras and will hopefully accept much wider 
acceptance.
It is postulated that these methods of inferred and derived anatomy, together with the 
implementations for scatter, finite resolution response and depth-dependent collimator 
response, can provide a complete solution for the permutations in Myocardial Perfusion 
Imaging which can achieve wide spread implementation.
Chapter 3 - Monte Carlo 
Simulations to Determine the 
Limitations of Myocardial
Perfusion Imaging
3.1 Introduction
As described in the previous chapter the full clinical potential of Myocardial Perfusion 
Imaging (MPI) has not been realised because of numerous factors producing artefacts that 
degrade image quality and result in misinterpretation of the results161. Photon attenuation, 
scatter radiation, partial-volume errors, and other perturbations compromise the accuracy 
obtainable with MPI49.
The range of natural variability in size, shape and position of many organs in the thorax may 
contribute to such artefacts. To gain a better understanding of the effect of these above 
mentioned limitations on the percentage intensity losses and the amount and position of 
defects caused by these intensity losses it was decided to perform two Monte Carlo 
simulation studies to investigate these effects.
The first simulation study was to investigate the contribution of the different individual 
anatomical parts in the thorax and how the amount of intensity losses are caused by the 
heart itself compared to the rest of the anatomical parts in the thorax. This study was 
performed on both male and female patients
The second study was to investigate the percentage of intensities lost, as well as their 
location in the image of left ventricle when the orientation and position of the heart changes 
relative to the thorax. Difference is to be expected between male and female patients and 
therefore this study should be done for both male and female patients. Unfortunately the 
study involves a substantial number of simulations and therefore using both genders is 
impractical. For this reason only male patients were simulated in the second study. Although 
it is possible that this fact somehow limits the usefulness of the study, enough information 
could be gained regarding the influence of all the different anatomical parts on the overall 
attenuation caused.
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These studies will provide a much clearer picture of intensity losses in the image of the left 
ventricle caused by attenuation, scatter and other contributors and will illustrate the need for 
corrections to be done when performing MPI and the potential effect these corrections can 
have.
3.2 Monte Carlo Simulations
The term Monte Carlo as a mathematical method was coined in the 1940s by physicists 
working on nuclear weapon projects in the Los Alamos National Laboratory162. The name 
was popularised by physics researchers Stanislaw Ulam, Enrico Fermi, John von Neumann, 
and Nicholas Metropolis, among others; the name is a reference to a famous casino in 
Monaco where Ulam's uncle gambled with borrowed money163. The use of randomness and 
the repetitive nature of the process are analogous to the activities conducted at a casino.
Monte Carlo simulation is a method for iteratively evaluating a deterministic model using sets 
of random numbers as inputs. It is a class of computational algorithms that rely on repeated 
random sampling to compute their results. Monte Carlo methods are often used when 
simulating physical and mathematical systems. It is well suited to situations where a large 
number of events with variable probability make up the situation that is being modelled.
Perhaps the most famous early use was by Enrico Fermi in 1930, when he used a random 
method to calculate the properties of the newly-discovered neutron. Monte Carlo methods 
were central to the simulations required for the Manhattan Project, though were severely 
limited by the computational tools at the time. Therefore, it was only after electronic 
computers were first built (from 1945 on) that Monte Carlo methods began to be studied in 
depth.
Monte Carlo simulation is also an important technique in nuclear medicine. It is well adapted 
to nuclear medicine with its particle emission, propagation and detection random processes. 
Each photon trajectory can be processed separately. The photon is propagated through the 3 
dimensional volume under consideration where it can be absorbed or scattered conforming 
to suitable random events the likelihood of which depends on the local environment. Various 
Monte Carlo computer codes have been developed and used by various researchers for 
years to simulate and study a wide range of nuclear medicine applications.
In this study Monte Carlo simulations were used to assess the amount of attenuation caused 
by the different organs and body parts in the thorax region as well as variation in attenuation 
as a result of different orientations of the myocardium in the thorax which are found in 
patients.
3.3 Computer Phantoms in Medical Imaging Simulation Techniques
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Simulation involves computer generated “patients”, models of the imaging process, and fast 
computational methods. Computer phantoms provide a model of the subject’s anatomy and 
physiology. Given a model of the physics of the imaging process, acquired data of a 
computer phantom can be generated using the computational methods. A major advantage 
of using computer-generated phantoms in simulation studies, rather than using patient 
studies, is that the exact anatomy and physiological functions of the phantom are known, 
thus providing a gold standard from which to evaluate and improve medical imaging devices 
and image processing and reconstruction techniques. Using computer phantoms has the 
advantage that they are always available and are easy to alter to model different anatomies 
and medical situations providing a large population of subjects from which to perform 
research. A further advantage is that a single factor can be changed so that the change can 
be unambiguously analysed. In addition, it is difficult both ethically and practically to test 
every combination of parameters on large groups of patients under clinical conditions to 
achieve the same ends.
A vital aspect of simulation is to have a realistic phantom or model of the subject's anatomy. 
Without this, the results of the simulation may not be indicative of what would occur in actual 
patients and could, therefore, have limited practical value. The availability of such a realistic 
phantom will make Monte Carlo a valuable first test for this project, but it will still require
some verification by human studies.
Such a realistic phantom is the four-dimensional (4D) NURBS-based cardiac-torso (NCAT) 
digital phantom145 which was developed at the Department of Biomedical Engineering at the 
University of North Carolina to provide a realistic and flexible model of the human anatomy 
and physiology to be used in nuclear medicine imaging research. The organ models are 
based on NURBS, non-uniform rational B-splines, as used in computer graphics and the 
phantom can easily be adjusted for patient size, and size and orientation of the heart to cover 
a wide range of potential simulated patients to match the known variability in patients.
In this study the NCAT phantom will be used to generate the necessary activity and 
attenuation image sets.
3.4 Simulation of SPECT Acquisitions
softwareThe Photon History Generator (PHG)164 is c 
Carlo simulations of photon creation and transport through heterogeneous attenuators for 
both SPECT and PET. The “Simulation System for Emission Tomography” (SimSET) was 
developed by The University of Washington Imaging Research Laboratory165 and the
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package uses Monte Carlo techniques to model the physical processes and instrumentation 
used in emission imaging to simulate a realistic scintillation camera system.
In this study the simulated camera included a Low Energy High Resolution (LEHR) 
collimator, a 9.35 mm Nal(TI) crystal and a 20% energy window, centred on 140 keV. An 
acquisition using 64 SPECT projections was simulated with a circular 180° orbit with 
acquisition steps of 2.8° starting at the Left Anterior Oblique (LAO) angle at 315° and ending 
at the Right Posterior Oblique (RPO) angle, i.e. 135°. Photon attenuation was also included 
in the simulations. The SPECT projections were stored as 128 x 128 matrices with a pixel 
size of 0.49 cm x 0.49 cm which matches the usual settings for patient imaging.
In the simulation studies the percentage intensity losses in different parts of the left ventricle 
will be calculated under different simulated physical conditions. To be able to do that a dual 
simulation will be performed for every condition. The first simulation will be made assuming 
no attenuation by the body tissues, by setting all tissue density to that of air. This will provide 
the result that is obtained in the absence of any attenuation medium, and is known as the “air 
simulation”, and represents the ideal situation when no attenuation occurs. The second 
simulation assumes normal tissue densities, so that attenuation occurs results in intensity 
losses which will exist in that specific patient anatomy, this will be the “real life simulation".
The output of the SIMSET simulation program provides a sinogram, which is an image 
representation of raw data obtained, therefore each set of simulations produces 2 sinograms 
which need to be reconstructed.
3.4.1 Validation of SimSET
The software was obtained as source code written in the C language. It was compiled into a 
binary file by the author of the thesis for use with the Microsoft Windows® operating systems
by using MS Visual Studio 6.0
To validate the software the advice from the providers was followed. The first form of 
validation was to verify the compilation process by ensuring that no errors or warnings were 
received from the compiler.
The second form of validation came from the sample data provided in a "samples" directory 
where a simulation called fastTest resides and this simulation was run and the results 
analysed. This simulation has been chosen because it provides a test of a wide range of the 
features of SimSET. The parameter file and benchmark results were also provided. The 
successful completion of this simulation indicates that the installation performs as expected 
but more subtle problems could still be present. For this reason, all data produced by 
SimSET were approached with a critical eye.
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The choice of the number of events was based on a literature search because the goal was 
to create a simulation as close to a real scan as possible. A publication by El Fakhri et. al.166
was chosen because they also used SimSET and similar analysis techniques as what was 
used in these studies. Furthermore, they also acquired a physical phantom scan to 
determine the amount of events that will mimic a real scan.
Therefore simulations with different number of seeded events were initially run to produce 
results which could be used to determine the amount of photons detected in the final images. 
The final choice of events seeded was determined from the studies which provided similar 
amounts of detected photons as in the published work, i.e. 41 million photons detected in the
“air” simulation and 8 million in a 20% energy window for their “real life” simulations for the
whole simulated phantom.
The choice was made to use the same number of events in this study for both the "air” and 
“real life” simulations because the goal was to detect how many events get “lost” as a result 
of the attenuation media, scatter and the other effects mentioned in 2.4. This was the case 
for all the simulation studies where the same amount of events seeded were used.
The fact that the OSEM reconstruction will reconstruct images on the basis of local statistical 
accuracy in the image was unfortunately not considered in any of the comparison studies 
and could be included in any further similar studies in the future.
3.6 Image Reconstruction
As is standard practice in Nuclear Cardiology image processing and interpretation, all the 
images will be reconstructed with an iterative ML-EM (Maximum-Likelihood Expectation- 
Maximization) algorithm which implements Ordered Subsets. This was done by code written 
by the author (Johan Nuyts) in the Iterative Data Language (IDL)167 which included 
reconstruction routines obtained from Johan Nuyts168 at the Medical Imaging Research 
Center, Katholieke Universiteit Leuven, Belgium. The source code of these routines is 
provided in Appendix A.
The non-attenuation correction reconstructions will be done with the equivalent of 32 full ML-
EM iterations as suggested by the original author of the software routines. Using fewer 
iterations with more subsets results in much faster reconstruction, at the cost of slightly 
increased noise levels and is suitable for the non-attenuation corrected reconstructions. 
When doing attenuation corrected reconstructions, decreasing the number of subsets is 
applied to avoid excessive noise propagation, leading to an increase in the number of 
iterations and therefore the equivalent to 42 full ML-EM iterations were used to ensure 
suitable image quality, again as suggested by the author of the software routines.
3.7 Image Interpretation
Unlike Filtered Back Projection, where noise, in the absence of attenuation correction, is 
constant across the reconstructed field, noise in studies reconstructed using EM is correlated 
with the signal: i.e. the noise amplitude is lower in regions of low counts but as the iteration 
number increases, noise increases.
3.7 Image Interpretation
This study makes extensive use of polar maps (or bull’s eye displays) to do quantitative 
analysis and therefore the origin and use of polar maps are described below.
The advances in camera technology in the late 80s allowed SPECT to be used routinely. By 
the use of reconstruction algorithms, it was possible to estimate and produce transaxial, 
sagittal and coronal sectional images, creating 3D volumes or stacks of short-axis images 
that served as input to the quantitative software. The complexity of the problem when using 
SPECT substantially increased with the myocardium represented as a 3D volume rather than 
planar images.
The first effort to address this problem169 was to carry out a quantitative analysis by 
assessing the circumferential profile curves of the three short-axis (apical, middle and basal) 
of the left ventricle (LV). To assess the apical region, the most central long-axis cutting 
through the apex was also selected. From these images, circumferential maximal count 
profiles of myocardial distribution were obtained.
This method was extended to the entire SPECT volume by introducing the polar map, or 
bull's eye displays, for viewing circumferential profiles170. The polar maps allow a quick and 
comprehensive overview of the circumferential samples from all slices by combining them 
into a single colour-coded image. The points of each circumferential profile are assigned a 
colour based on count values and the coloured profiles are shaped into concentric rings as 
displayed in figure 3.1(a). The slice closest to the apex processed with circumferential 
profiles defined the center of the polar map, and each successive profile from each 
successive short-axis slice is displayed as a new ring surrounding the previous. The slice 
nearest the base of the LV makes up the outermost ring of the polar map.
To be able to get more meaningful results different models can be applied to these polar 
maps. There are a range of models available, a vascular model, which aims to divide the 
polar maps into regions with different arteries which supply oxygen to the left ventricle, a 5- 
segment model (Figure 3.1(b)) and a 9-segment model. There are also 17, 19 and 20- 
segment models available.
In this study polar maps of regional myocardial tracer uptake will be generated using 
commercially available software (4DMSPECT; University of Michigan, USA). Figure 3.1(a) 
shows a polar map (for an “air” simulation). Ideally the polar map will be 100% uniform but in
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most practical situations that will not be the case as a result of the factors such as the non- 
uniform thickness of the myocardium, inclusion of the papillary muscle, etc., but it will closely 
resemble an even distribution, which are normal variations within patients.
The choice of models in the studies to follow will be mainly determined by the practicality of 
using a specific model. Using more segments is desirable because it will provide a far more 
detailed analysis and therefore produce a more accurate localisation than what will be 
obtained with fewer segments. The downside of using more segments is that it results in 
fewer counts per segments and the statistical variation associated with such low counts 
means that the clinical significance of intensity variations cannot be identified. The choice of 
number of segments is therefore a trade off of these two factors. The raw (un-normalised)
intensities will be displayed in the polar maps and for each of these models and the average 
tracer uptake calculated by the 4DMSPECT software for each segment.
In the simulation studies un-normalised average tracer uptake will be measured in either a 5- 
segment model (anterior, septal, inferior, lateral and apical) or 9-segment model (basal- 
anterior, apical-anterior, basal-septal, apical-septal, basal-inferior, apical-inferior, basal-
lateral, apical-lateral and apical) for both the “air” and “real life” simulations.
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Figure 3-1: The polar maps created from reconstructed simulation outputs. The polar map itself (a), the regions 
displaying the 5-segment model (b).
The percentage intensity loss in each segment will be determined from the polar maps as 
displayed in Figure 3.2 for the 5-segment model. By comparing the value of the “real life”
simulation to the “air” simulation, one can calculate the percentage intensity loss as
illustrated below:
%  In tensity  L oss =
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where ATUair is the un-normalised average tracer uptake in a specific segment for the air 
simulation and >AR/reaWfeis the un-normalised average tracer uptake in a specific segment for 
the real life simulation. Please note that the values used are the average value of a specific 
segment in the 5 or 9 segment polar map and not a single pixel value.
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Figure 3-2: Polar maps displaying the 5-segment model. The polar map and the related values for the air 
simulation (a) and the polar map and the related values for the real life simulation (b).
3.8 Statistical Analysis
Statistical analysis will be performed by either using regression (investigating the effect of 
orientation and position of the heart in the thorax on the amount of intensity losses in the left 
ventricle) or by comparing means (calculating the contributions of the different anatomical 
parts to the amount of intensity losses in the left ventricle), which are both parametric tests.
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Most parametric tests based on the normal distribution have four basic assumptions that 
must be met for the test to be accurate. The assumptions are as follows:
► Normally distributed data: The data must be from one or more normally distributed 
populations, this can be done by using the Shapiro-Wilk test.
► Homogeneity of variance (Homoscedasticity): The variances should be the same 
throughout the data and Levene’s test will be used for this.
► Interval data: Equal intervals on the scale represent equal differences in the property 
being measured.
► Independence: This means that the behaviour of one variable does not influence the 
behaviour of another.
These checks have to be carried out before any statistical analysis involving parametric tests 
are carried out.
3.8.1 Regression as a Statistical Model
In regression analysis171 one fits a predictive model to the data and uses that model to 
predict values of the dependent variable from an independent variable. In the following 
equation:
Outcome = (Modelj) + error,
the model can be a linear model (which will give a straight line relation between the outcome 
and the change parameter) or a polynomial model of n degree to predict the outcome (which 
will give a curve relation) plus some kind of error. Regression analysis also allows for errors 
generated by the measurements.
A. The Line of Best Fit
The first step in applying a statistical model to data is to find the straight line or curve which 
fit the data the best. This ‘line of best fit’ is found by ascertaining which line, of all possible 
lines, results in the least amount of difference between the observed data points and the line 
by using a method called the method of least squares172.
B. Deciding Which Model to Use
After fitting data with one or more models, one should evaluate the goodness of fit. A visual 
examination of the fitted curve displayed should be the first step. Beyond that, the following 
methods can be used:
► Residual analysis
► Goodness of fit statistics
► Confidence and prediction bounds
As is common in statistical literature, the term goodness of fit is used here in several senses: 
A "good fit" might be a model
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► that the data could reasonably have come from, given the assumptions of least- 
squares fitting
► in which the model coefficients can be estimated with little uncertainty
► that explains a high proportion of the variability in the data, and is able to predict new 
observations with high certainty
A particular application might dictate still other aspects of model fitting that are important to 
achieving a good fit, such as a simple model that is easy to interpret.
These methods group into two types: graphical and numerical. Plotting residuals and 
prediction bounds are graphical methods that aid visual interpretation, while computing 
goodness-of-fit statistics and coefficient confidence bounds yield numerical measures that 
aid statistical reasoning.
Generally speaking, graphical measures are more beneficial than numerical measures 
because they allow one to view the entire data set at once, and they can easily display a 
wide range of relationships between the model and the data. The numerical measures are 
more narrowly focused on a particular aspect of the data and often try to compress that 
information into a single number. In practice, depending on the data and analysis 
requirements, one might need to use both types to determine the best fit.
Note that it is possible that none of the fits can be considered suitable for the data, based on 
these methods. In this case, it might be necessary to select a different model. It is also 
possible that all the goodness-of-fit measures indicate that a particular fit is suitable. 
However, if the goal is to extract fitted coefficients that have physical meaning, but the model 
does not reflect the physics of the data, the resulting coefficients are useless. In this case, 
understanding what the data represents and how it was measured is just as important as 
evaluating the goodness of fit.
C. U sing  the  M odels
Should any of these models (linear, quadratic or cubic) hold true it can then be used to make 
some predictions on the outcome. This can be achieved by using the following equations:
(Linear) % Intensity Loss = b: x (%UIL) + b0
(Quadratic) % Intensity Loss = b2 x (%UIL)2 + b, x (%UIL) + b0
(Cubic) % Intensity Loss = b3 x (%UIL)3 + b2 x (%UIL)2 + bi x (%UIL) + b0
where %UIL represents a unit change in intensity loss.
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3.8.2 Comparing Two Means as a Statistical Model173
The t-test is well suited to test the difference between two sets of means. There are two 
different t-tests and the one that is used depends on whether the independent variable was 
manipulated using the same or different participants.
The purpose of using the t-test is to decide whether the means of two different manipulations 
differ either a little or a lot and to see whether the difference could happen by chance or 
whether it is as a result of experimental manipulations. To determine this, the null hypothesis 
will be tested, meaning, for it to hold true, the experimental manipulation must have no effect 
on the participants and the sample means will be very similar.
A. C a lcu la tin g  the  e ffe c t s ize
Even if one found the t-statistic to be statistically significant, one cannot necessarily conclude 
that the effect caused by the experiment is important in practical terms. To discover whether 
the effect size is substantive one need to use what is known as the effect size (r), i.e. a 
measurement of the effect of the experiment in a standardised way. This is simply an 
objective and standardised measurement of the magnitude of the observed effect. The fact 
that the measure is standardised means that the result can be compared across different 
studies that have measured different variables. Effect sizes are useful because they provide 
an objective measure of the importance of an effect. The following guidelines can be used to 
measure the importance of an effect (they are not measured on a linear scale):
► r = 0.10 (small effect): the effect accounts for 1% of the total variance.
► r = 0.30 (medium effect): the effect accounts for 9% of the variance.
► r = 0.50 (large effect): the effect accounts for 25% of the variance.
The following equation can be used to convert a t-value into an r-value174:
r
1 t 2
r  = -Jt2 + d f
where df is the degrees of freedom.
The threshold for an effect to be large is 0.5 and values greater than that will represent the 
fact that the effect of the experiment is important in practical terms.
3.9 Patient Selection for Monte Carlo Simulations
By using a parameter file as input to the NCAT phantom software one can “generate" a 
patient. It is therefore possible by varying different parameters to create a range of patients. 
The default values in the NCAT are based on the ‘Visible Human’175,176. The NCAT phantom 
allows for a wide variety of parameters to be set to match the known variability in patients.
3.9 Patient Selection for Monte Carlo Simulations
In order to generate the patients, the following parameters were altered to create 30 male 
and 30 female patients:
1. Body long axis to set body transverse axis.
2. Body short axis to set body antero-posterior axis.
3. Body height to set height of phantom.
4. Rib long axis to set ribcage transverse axis.
5. Rib short axis to set ribcage antero-posterior axis.
6. Rib height to set height of ribcage.
7. Setting the weight of the phantom.
8. Number of Counts
so that the a range of patients can be simulated which will match the variations in a normal 
patient population177. The values used are shown in Tables 3.1 and 3.2.
Table 3-1: Male Patient Selection for the Monte Carlo Simulations
Set
Body Long 
Axis (cm)
Body Short 
Axis
(cm)
Rib Long 
Axis
(cm)
Rib Short 
Axis
(cm)
Height
(cm)
Weight
(kg)
Number
Counts
Reference I 34.5 I 27.5 30 22.7 I 192 I 95.05 I 800000000 I
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
34.5
32.5
30.5
36.5
38.5
34.5
34.5
34.5
34.5
32.5
36.5
36.5
32.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
34.5
27.5
27.5
27.5
27.5
27.5
29.5
31.5
25.5
23.5
25.5
29.5
25.5
29.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
27.5
30
32.2
34.2
30
30
30
30
28
32
32
28
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
22.7
22.7
22.7
22.7
22.7
24.7
26.7
20.7
18.7
20.7
24.7
20.7
24.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
22.7
192
192
192
192
192
192
192
192
192
192
192
192
192
194
196
190
188
186
192
192
192
192
192
192
192
192
192
192
192
192
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
90.05
85.05
80.05
100.05
105.05
95.05
95.05
95.05
95.05
95.05
95.05
95.05
800000000
8
800000000
800000000
800000000
8
800000000
850000000
900000000
950000000
1000000000
750000000
700000000
650000000
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Table 3-2: Female Patient Selection for the Monte Carlo Simulations
Set
Reference
10
30
Body Long 
Axis (cm)
33.0
31. 
29. 
35. 
37.0
33.
35.
35.
31.
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
33.0
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Body Short 
Axis
(cm)
25.0
25.0
0
29. 
29. 
23. 
21. 
23. 
27. i 
23.' 
27.'
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
Rib Long 
Axis
(cm)
28.0
28.0
26. 
24. 
30.0
Rib Short 
Axis
(cm)
21.0
Height Weight
21.0
(cm)
188
188
188
188
188
188
23,
25,
19.
188
188
188
28.0
26.
30.
30.
26.
28.0
19.'
23.i
19J
23.i
188
188
188
188
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
28.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
21.0
188
90 
92 
86 
184 
182
188
(kg)
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
86.00
188
86.00
90.05
85.05
188
188
188
188
188
188
188
188
188
188
100.05
105.05
86.00
86.00
86.00
86.00
86.00
86.00
8 6 .0 0
Number
Counts
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
800000000
This chapter provides the groundwork for two studies which will be described in following 
chapters. In these studies less known and some unknown aspects of attenuation will be 
investigated to build up a better understanding and appreciation of the impact of not applying 
attenuation correction, as well as highlighting the complexity of attenuation artefacts. This 
includes the investigation to find which part of the human anatomy is mostly responsible for 
the creation of attenuation artefacts and in which regions of the left ventricle they are most 
likely to occur. Monte Carlo studies of Cardiac Imaging have been used by other workers in 
the past, but have not been applied in such a systematic way to the wide range of anatomical 
variations, and individual organs. It is hoped in this way to achieve new insights into the
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complexity of attenuation in MPI and the need for accurate attenuation correction. This study 
will apply methods to aspects which have not been reported in the literature before. It will 
also highlight the distortion as a result of the non-uniformity of the thorax and will again 
quantify it. These studies will also highlight and quantify the effect of different positions and 
orientations of the left ventricle within the thorax. These effects and other effects will be 
discussed in the next two chapters. These results will then be used to analyse the extent of 
corrections achieved by a commercially available correction method.
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Chapter 4 - Attenuation and 
Scatter From Individual 
Anatomical Parts in the Thorax
4.1 Introduction
The purpose of the study described in this chapter is to establish the contribution to the 
overall intensity losses in the different segments of the left ventricle from the individual 
anatomical parts in the thorax. This will help to highlight some aspects of the intensity losses 
experienced in the thorax which are not well known or not known at all so that a better 
understanding of these intensity losses can be obtained. This understanding should hopefully 
help to confirm the need for acceptable correction methods, especially attenuation correction, 
to be implemented on a routine basis when MPI is performed.
Current techniques for assessing myocardial perfusion studies generally rely on visual 
interpretation and on analysis of relative tracer activity within the myocardial regions defined 
by an individual SPECT study. Most of these techniques rely on maximal counts derived from 
radial sectors of reconstructed shortaxis slices (maximum count circumferential profiles) 
normalised by count values in regions of peak intensity assumed to represent normally 
perfused regions178 to determine relative tracer activity at rest and after stress. One serious 
limitation of these relative quantification techniques is that there is no guarantee that a 
normally perfused myocardial segment will be present in the patient. Consider patients with 
multivessel disease; although qualitative and relative quantitative analysis may identify the 
most severely stenosed coronary artery, less severely stenosed arteries may not be 
identified without an absolute measure of the radionuclide uptake in the myocardium. In the 
extreme case of balanced triple-vessel disease179, an overall reduction in activity may be 
completely overlooked.
To avoid these problems, the ultimate goal in myocardial SPECT is to achieve absolute 
quantification - that is, to make an absolute measurement of Becquerels of tracer per gram of 
tissue in a specified region of the left ventricular myocardium. Unfortunately, photon 
attenuation, scatter radiation, partial-volume errors, and other perturbations compromise 
absolute quantification of the radionuclide uptake from SPECT38,39,40.
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In a Monte Carlo simulation study investigating the effects of the above mentioned 
corrections on a simulated human, it was found that for the LV wall, activity was 
underestimated by 91.8% when using no correction methods180. According to a study done 
on a porcine model without any corrections, the measured in vivo activity concentration in the 
porcine myocardium was only 10% of the true value49, indicating a loss of about 90% of the 
original counts. By correcting for object-specific attenuation, the authors reported an 
improvement in the accuracy of this measurement but this resulted in values that were still 
only 42% of the true value. By correcting for both attenuation and partial-volume errors, they 
were able to achieve absolute quantification with accuracy close to 10%49.
It has been reported that the intensity loss experienced is more pronounced in the basal 
parts of the left ventricle and this can be attributed to the fact that the basal parts of the left 
ventricle are further away from the body surface and therefore exposed to more attenuation 
media181.
In a study where the usefulness of using low-dose CT devices to produce attenuation maps 
was investigated by using perfusion PET as a reference method182, it was discovered that 
SPECT overestimates the relative perfusion in the apex and in the anterolateral wall. These 
authors proposed that the comparably low resolution of the SPECT system leads to a more 
pronounced partial-volume effect and they concluded that the partial-volume effect might be 
responsible for the accentuation of the apex in the SPECT studies. In another study using the 
MCAT phantom, a physical phantom and a patients study it was found that this over 
estimation could be as high as 20%183. These authors postulated that the partial volume 
effect, interactions between attenuation correction and detector-response blurring, scatter, 
incomplete detector response compensation and noise may contribute to this but further 
work is required to explain this effect.
In the study182 where low-dose CT devices were used to produce attenuation maps it was 
also reported that the inferior wall is the area of the left ventricle to benefit most from 
attenuation correction and therefore it is the area that experiences the most attenuation 
during acquisition. They also reported that they did not find attenuation artefacts in the 
anterolateral wall in females because of breast attenuation but this may be due to their 
patient selection.
It has also been reported in numerous studies that breast tissue attenuation in females may 
produce artifacts in the anterior wall184. In a phantom study to study breast tissue 
attenuation185 it was found that the location of apparent "defects" resulting from attenuation 
was highly variable, depending on the orientation of the myocardium and the precise 
positioning of the breast tissue. Furthermore they found that an asymmetric polar map was 
obtained even without breast tissue due to the nonuniform attenuation of the thorax. The
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authors concluded that although anterior "defects" are commonly produced by breast tissue 
attenuation, false "defects" appear to be possible anywhere in the polar map.
Radioactive tracers are distributed around the body, and emit photons in proportion to their 
concentration. A gamma camera system will detect the photons and their point of origin and 
store this information in a matrix that is used to create the required images. The images 
themselves are displayed as intensities on a computer screen. These intensities reflect the 
relative perfusion in different parts of the myocardium and are used to decide what the 
perfusion in the different segments of the myocardium is.
In practice, however, some photons are scattered or absorbed in their passage through the 
body, and this effect is greater in denser organs and larger patients. Scattered photons have 
a lower energy than the original photon, and gamma camera systems can be set up to detect 
only photons in a specific energy range. However, the sensitivity of the gamma camera 
system is modest, and so the “window” of photon energies detected is sufficiently broad to 
detect some scattered photons, which the camera system register as being emitted from 
certain parts of the myocardium while the original photons were actually emitted from a 
different part. There are other inherent limitations in the imaging and processing system 
which also affect the final image.
When some of the photons emitted do not reach the gamma camera system, as a result of 
attenuation, scatter, etc., then the intensity representing that part of the myocardium will be 
lower than the true value and the relative perfusion will be under estimated. Should it be the 
case that the intensity values are higher than the true value as a result of the partial-volume 
effect186,187, non-uniform attenuation, depth-dependent detector response, scatter and 
statistical noise187, then the relative perfusion will be over-estimated.
The fact that the intensity losses in the basal parts of the left ventricle is more pronounced 
and that there could be an over estimation of the apical parts will lead to a distortion of the 
final reconstructed left ventricular images. This, together with the fact that it has been 
reported that the inferior wall is more subject to experience intensity losses and that breast 
tissue can produce attenuation artifacts in female patients will lead to the non-uniform 
distribution of the intensities in the final images (i.e. artefact or false positive) even if the 
original activity distribution in the left ventricle were to be uniform.
Typical images of Monte Carlo simulated patients produced by the methods in Chapter 3, 
section 3.8, can be seen in figure 4.1. This illustrates the fact that attenuation is more 
pronounced in the basal parts of the left ventricle as indicated by the yellow arrows as well as 
in the inferior wall as shown by the white arrow.
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(a) (b) (c)
Figure 4-1: The non-attenuated (air simulation) (NA) images and attenuation (A) images displays the typical 
effect of attenuation in (a). The images in (b) show the “shortening” of the ventricular cavity. The sagittal images in 
(c) shows the effect attenuation has on the anterior and inferior wall, with the inferior wall clearly experiencing a 
bigger loss of intensities.
The contribution of the individual anatomical parts in the thorax to the position and perfusion 
values in the final acquired image in patient studies is not well known. Very little is also 
known about the amount of scatter caused by the individual anatomical parts in the thorax 
and the effect that these anatomical parts have on the overall distribution of the photons as a 
result of this scatter. Therefore there is a need for a systematic study to get a better 
understanding of the “defects” caused in the left ventricle by these anatomical parts and to 
investigate the points mentioned above. This study will attempt to answer the following 
questions:
1. What is the extent of the distortion caused by these problems?
2. Do the basal parts of the final left ventricular images experience substantial intensity 
losses as compared to the rest of the left ventricle?
3. If found to be true, what is the extent of the intensity losses in the basal parts of the 
left ventricle as compared to that in the apical regions and how does it contribute to 
the “distortion” of the images of the reconstructed left ventricle?
4. Is there an over estimation of the apical region in the non-attenuation corrected 
images and does it contribute to the “distortion” of the images of the reconstructed left 
ventricle and what is the extent of this “distortion”?
5. What is the contribution of the individual anatomical parts to the overall intensity 
losses experienced in the final reconstructed images of the left ventricle when no 
corrections (attenuation, scatter, partial-volume, etc.) are applied?
6. What is the contribution of the heart (myocardium, pericardium and bloodpool of all 4 
chambers) to the overall intensity losses experienced and “distortion” caused?
7. Which part or parts of the thorax are responsible for the intensity losses experienced 
in the regions which are most affected?
8. Which parts of the left ventricular images experience the most substantial intensity 
losses in males and females?
9. Is there a substantial loss of intensities in the anterior wall of female patients and 
what is the cause of it?
10. What is the extent of scattered photons in the acquired images and does it contribute 
to the “distortion” in the images of the reconstructed left ventricle as well?
11. What are the differences in intensity losses experienced between male and female 
patients?
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12. Does the inferior wall experience the most substantial intensity losses and if so, what 
is the difference of the losses experienced between males and females?
13. What is the fractional intensity losses experienced in the different segments of the 
final left ventricular images?
This study will investigate these questions by using Monte Carlo simulations and the results 
will be analysed by using the means (of all the segments for all the anatomical parts) as a 
statistical model to quantify the results and to see how these results correlate to the 
published results. Chapter 5 will analyse how these effects are influenced by different 
orientations and positions of the heart within the thorax. Chapter 6 will investigate the effect 
of the corrections achieved by a transmission based attenuation correction technique 
combined with a resolution recovery algorithm and how these results compare to the 
intensity losses and variations predicted by the Monte Carlo simulations.
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4.2.1 Data Simulations and Analysis
The input data for the Monte Carlo simulation consisted of an attenuation map and an activity 
map for every simulation from the NCAT phantom.
Using the NCAT software an attenuation map of a normal patient was created for the whole 
thorax, referred to as the “whole thorax”, or “Everything”, map, displayed in figure 4.2 (a), an 
”air” map with no attenuation, as described in previous chapters, as well as an activity map, 
displayed in figure 4.2 (b). The purpose of these maps was to study the distortion of the 
uniformity in the resultant image of the left ventricle which will be presented in later 
paragraphs and so that questions 1-4 and 9-13 in section 4.1 could be answered.
To study the effect of the different anatomical parts on the overall amount of intensity losses 
experienced, additional attenuation maps were created by setting the attenuation coefficients 
to zero for all the anatomical parts in the thorax except for a single anatomical part. For 
example, assign a non-zero attenuation coefficient to the blood pool and set the coefficients 
for the rest of the anatomical parts in the thorax to zero, as displayed in figure 4.2(c). This in 
effect “removed” the remainder of tissue from the thorax and created a result with only the 
bloodpool creating attenuation. This was repeated for the following anatomical parts, 
myocardium, pericardium, skeleton, remainder and the lungs, which are displayed in figure 
4.2(d)-(h). Attenuation maps were also created for the remainder and skeleton combined 
(body), as well as the bloodpool, myocardium and pericardium combined (heart) and are 
displayed in figure 4.2(i)-(j). The same “air” map and activity map as described above were 
also used. All these attenuation maps were created for the same simulated patient. The 
purpose of these maps was to study the effect of the different anatomical parts so that 
questions 5-8 and 10 could be answered.
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These simulations were done for the 30 male and 30 female “patients” described in chapter 
3, each as a separate study. The reconstructed sinograms were analysed with the 9- 
segment model, as also described in chapter 3 and displayed again in figure 4.3.
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Figure 4-2: The individual body parts which acted as attenuation media, as well as “Everything", i.e. the whole 
thorax, which represents the attenuation map in patients, as well as the activity map.
where
B-ANT: Basal anterior, 
A-LAT: Apical lateral, 
B-SEP: Basal septal,
A-ANT: Apical anterior, 
B-INF: Basal inferior, 
A-SEP: Apical septal,
B-LAT: Basal lateral 
A-INF: Apical inferior 
APX: Apical
Figure 4-3: The 9-segment cardiac model which was used to analyse the data in this study.
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4.2.2 Evaluation Criteria
The effect of the different intensity losses was characterised using the following 2 criteria: (a) 
uniformity of the polar maps, (b) fractional absolute difference in intensities.
A. Uniformity of the Polar Map (PMU) Over the 9 Segments
When using polar maps to analyse the reconstructed images, intensity losses in these 
images manifest themselves as lack of uniformity in the polar maps. Each polar map was 
divided into 9 myocardial regions to create the 9 segment model, and the mean activity nr in 
each region was calculated. The maximum mmax of these 9 values was used to normalise all 
9 values using (m/rnmax)*10018°. The polar map uniformity (PMU) was calculated as follows 
for each segment:
PMU = (mmax -1^)/ rnmax*100 
where i represents a single segment.
This was expressed as a percentage. This should be 0% if there are no intensity losses 
because the activity is uniform in the LV wall in the phantom.
The PMU of the “Air” simulation (PMUair) was calculated for each segment and used as the 
reference. The PMU (PMUpart)for all the individual anatomical parts were also calculated for 
the different segments and the difference expressed as the Polar Map Uniformity Difference 
(PMUD), see figure 4.4:
PMUD = PMUair - PMUpart
In this study the whole thorax as attenuation medium is referred to as “Everything”, meaning 
it includes all the different individual anatomical parts. When referring to the different 
anatomical parts, “Everything” is treated in the same way.
The PMU of the “Air” simulation represents the values when no scatter or attenuation is 
present and any difference between this PMU and the PMU’s of the different anatomical 
parts represents the amount of non-uniformity introduced in that segment by these 
interactions. These non-uniformities will reflect themselves as “defects” when analysing the 
polar maps and therefore represent the artefacts, i.e. false positives as defects when 
analysing patient studies. Although this study does not relate PMUDs to clinically observed 
defects, the larger the PMUD, the more likely it is to be seen, and be a false positive.
A PMUD index was also defined as the mean of the PMUD’s of the 9 segments180:
PMUDI = mean(PMUD,)
where PMUD, defines the PMUD values for all the 9 segments. This value should again 
ideally be 0%.
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Mmax = 205.5
M j.iN F(part) =  1 4 7 .9
= 6 .6%
205.6
= 28%
Mmax= 206.4
(206.4 -  192.7) * 100
206.4
PMUD = PMUaif - PMUParl = 6.6%  - 28% = -21.4%
Figure 4-4: Images to illustrate the PMUD
B. Fraction Absolute Difference in Intensities
As indicated in the introduction, the mean of the intensities in each segment of the “Air” 
simulations are substantially higher than those for the whole thorax with attenuation. To 
study the effects of the artefacts introduced during the image acquisition process in more 
detail, the Fractional Index (FI) for each segment can be calculated:
FI = (Mean of intensities in segment)air/(Mean of intensities in segment)everything
The mean of all the FI’s in all the segments is defined as MFI:
4.2.3 Investigation of the Perfusion Losses in the Left Ventricle
When not Applying Any Corrections
To investigate and quantify the degree of non-uniformity of the perfusion in the reconstructed 
left ventricle (LV) a comparison has been made by using the Whole Thorax (“Everything”) as 
attenuation medium together with the “Air” simulation as reference. The PMUD of 
“Everything” as the attenuation medium was calculated for all the 9 segments.
If the whole thorax as attenuation medium does not alter the perfusion distribution in the 
original images as reflected in the polar maps of the simulated patient, the PMUD of each 
segment will be equal to zero. This was the null hypothesis.
MFI = mean(FI's of all 9 segments)
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The experimental hypothesis was that effects such as attenuation, scatter, the partial volume 
effect and the depth dependent collimator response can alter the intensity distribution in the 
final images by introducing non-uniformities. These can be interpreted as defects by a clinical 
reporter, and when interpreted as of clinical origin by such a reporter, could lead to the study 
reported as a false positive. If this hypothesis held true then the extent of these apparent 
defects were quantified and shown to be statistically significant in this study.
In this case the manipulations were done on the same simulated patient images and 
therefore the dependent means t-test was used to test the null hypothesis and it was a two- 
tailed test. If found that the null hypothesis does not hold true, i.e. the experimental 
hypothesis is valid, the effect size would be calculated and expressed as r-values to 
calculate the extent of non-uniformity in the final images of the left ventricle.
This hypothesis was used to see whether there are any defects introduced in the LV by the 
imaging process itself, and if found to be the case, to calculate the extent of these introduced 
defects. The next hypothesis will investigate any possible differences between the apical and 
basal parts in these introduced defects in the LV, what the extent of these differences may 
be.
4.2.4 Comparison Between the Basal and Apical Regions of the
Perfusion Distortion Found
When the photons travel from the patient to the imaging system some of them are attenuated 
(as described in 2.3) and this fact is reflected in the images as lower intensities as compared 
to what it would have been when no attenuation media is present. Therefore it can be 
concluded that the imaging system under estimates the real perfusion. As a result of the 
orientation of the heart, the basal parts of the left ventricle are further away from the imaging 
system than the apical parts and therefore subject to more attenuation medium. From this it 
can be concluded that the imaging system will underestimate the relative perfusion in the 
basal parts more than compared to the apical regions. Under estimation of the real perfusion 
is reflected as a positive PMUD value.
To quantify any perfusion uniformity difference found between the basal and apical parts of 
the left ventricle, a comparison has been made between the PMUDs of the basal and apical 
parts of each of the anterior (ANT), lateral (LAT), inferior (INF) and septal (SEP) regions of 
the reconstructed left ventricular images. Again the only attenuation medium was the Whole 
Thorax (“Everything”).
The null hypothesis was that there is no difference in the relative perfusion between the 
basal and apical parts of the LV and therefore no distortion caused in the LV as a result of 
the imaging process (introduced by effects such as attenuation, scatter, the partial volume
4.2 M ethods
effect and the depth dependent collimator response) and that any defects introduced are of 
the same extent in both the apical and basal parts and therefore the PMUDs should be zero.
If the null hypothesis did not hold true in a specific segment, the conclusion was made that 
there are substantial differences between the perfusion uniformities experienced between the 
apical and basal regions of a specific segment as illustrated in figure 4.5
NA A
Figure 4-5: Illustrating the differences in intensity losses between the basal and apical parts of the LV
These manipulations were done on the same simulated patient and therefore the dependent 
t-test was used to test the null hypothesis and it was a two-tailed test. If the hypothesis was 
true then the effect size was calculated. These effect sizes were used to specify the extent of 
the differences that contributed to the perfusion non-uniformity in the final images of the left 
ventricle.
This hypothesis tested to see whether the basal and apical parts experience a different level 
of intensity loss as a result of the imaging process, i.e. do the basal parts experience a 
bigger under estimation of the intensities as compared to the apical regions. The next 
hypothesis will test to see whether the apical parts not only experience a smaller loss in 
intensities but whether it actually experiences an over estimation of the intensities when no 
corrections are applied.
4.2.5 Investigating the Relative D istortion  in the Basal and A p ica l
Parts
From the previous section it can be concluded that the imaging system will underestimate the 
relative perfusion in the basal parts more compared to the underestimation in the apical 
regions. As stated earlier such an under estimation of the real perfusion will be reflected as a 
positive PMUD value. On the other hand, negative PMUD values will reflect an over 
estimation by the imaging system of the real perfusion in those segments, i.e. the intensity 
values in those parts of the images are higher than what it will be expected to be. This would 
be an unexpected, or unusual, and rarely considered result but this has been reported in the 
literature where the perfusion in SPECT images of the left ventricle were compared to those 
obtained by using PET 188, as well as in another Monte Carlo simulation study189. This will 
also contribute to the distortion effect on the relative perfusion in left ventricle and actually 
make it worse. The combined effect of the under estimation of the perfusion in the basal
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parts together with the over estimation in the apical parts will have a much bigger distortion 
effect than would have been the case if the under estimation of the real perfusion in the 
apical parts had simply been lower than that in the basal parts.
The null hypothesis was that that the apical parts of the LV do not experience an over 
estimation of the real intensities and therefore all the PMUD values would be positive. If any 
of these PMUD values were found to be negative then the null hypothesis was not true and 
the apical parts do experience an over estimation of the real intensities. Once again the 
PMUDs were calculated for the Whole thorax (“Everything”) as attenuation medium.
To determine which regions suffer the most from this an index, as described in 4.2.2, the 
PMDUI was calculated. Segments with a relative perfusion uniformity higher than this could 
be classified as experiencing a severe under estimation of their uniformity, which is a 
reflection of an under estimation of the perfusion in that region.
4.2.6 Investigation Into the C ontribution to This D is to rtion  by Each
A natom ical Part
The purpose of this part of the investigation was to determine how the different anatomical 
parts affected the observed perfusion distribution in the final reconstructed left ventricular 
images. By analysing the reconstructed images when only a specific anatomical part 
provided attenuation and scatter and comparing that to the “Air” simulation, the contribution 
of that part to each of the 9 segments could be calculated. The PMUD’s of each of the 
anatomical parts in all the 9 segments were determined. The PMUD’s of the heart 
(myocardium, pericardium and bloodpool together) and the Body (remainder and skeleton 
combined) were also calculated to see what the effect of these two parts as a combination is.
The effects of all the parts were also added together to give the whole thorax and the 
contribution of each part was expressed as a percentage of these summed value. This gives 
the relevant contribution of each part as a percentage and quantifies the contribution of each 
part.
4.2.7 Investigating the E ffect o f Scatter on the Perfusion
D istribution  in the Left Ventricle
It was also an experimental hypothesis that the main contributor to the over estimation of the 
perfusion of the apical regions, together with the under estimation of the real perfusion in the 
basal parts, resulting in the “distortion” in the final images, is from scattered photons. 
Attenuation leads to a reduction of the observed perfusion in a specific segment of the left 
ventricle while scattered photons from elsewhere can reduce the amount of observed 
perfusion loss estimated in that segment and this reduction in loss will be visible in the 
displayed images. This latter is undesirable as the scattered photons will have originated
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from outside that part of the left ventricle, this is also known as “in-scatter”. This can be 
reduced by narrowing the energy window during an acquisition but this will also limit the 
number of primary photons detected, therefore the same window width was used in this 
study as used in clinical practise. The hypothesis for this work is that this can potentially have 
serious consequences on the accuracy of quantitative analysis, and potential false positives 
and negatives, and that correction for attenuation only, and not scatter, will result in an over-
estimation of the observed perfusion.
To test the hypothesis that scatter plays a important role in the over estimation of the 
observed perfusion of the apical regions of images during a SPECT acquisition, 10 female 
patients were simulated again but in this case the primary and scattered photons were 
collected in separate sinograms so that the effect of the scattered photons could be 
analysed.
The percentage of the original photons that reached the target as primary and scattered 
photons were calculated for each of the 9 segments. For each of the 9 segments the scatter 
fraction was also calculated, i.e. the fraction of intensities (as compared to the total final 
intensities) in each segment which is due to scatter and expressed as a percentage.
To test the experimental hypothesis the percentage of the value of the means of the 
scattered photons in the apical regions were compared to the means of the scattered 
photons in the basal regions by using the dependent 2-tailed t-test. If the t-value, when 
comparing a specific apical region to a specific basal region, was significant, it was 
concluded that the scattered photons in that region contributes to the perfusion over 
estimation in that specific apical region. The same analysis was also performed on the 
primary photons. If the t-value is only significant for the scattered photons and not the 
primary photons the conclusion could be made that the over estimation is mainly due to the 
scattered photons but if it is also significant for the primary photons, it could only be 
concluded that the scattered photon partly contributes to the over estimation but there may 
be other contributing factors.
Fractional In tensity Losses in the Final Ventricular Images
The result of the mentioned permutations can result in up to 90% of the counts being lost and 
therefore substantially reduce the amount of counts in the final reconstructed left ventricular 
images. In this section the effect of this reduction was calculated as the FI value, as 
explained above, so that it can be used as a reference measurement in correction methods 
in later chapters.
4.3 Results
4.2.9 Investigating the D ifferences in Perfusion Losses
Experienced Between Males and Females
It is widely accepted that male and female patients do not display the same losses in 
intensities in the final reconstructed images as result of differences in anatomy190. The 
perception is that male patients experience more losses in the inferior part of the left 
ventricle, something that is often referred to as “diaphragm attenuation”191 but female 
patients experience more losses in the anterior parts of the left ventricle as a result of breast 
attenuation192. To investigate the actual differences in intensity losses experienced between 
male and female patients in the final left ventricular images, and what these differences are 
and how they affect each gender, a comparison has been made between the male and 
female simulated patients, especially in the region of the anterior wall which are influenced 
by breast attenuation in females.
To establish these differences, comparisons had been made between the PMUD’s of the 
Whole Thorax, the Heart and the Body as attenuation media and when comparing the basal 
and apical parts.
These comparisons have been quantified by using the 2-tailed independent samples t-test. 
These results were used to determine the differences in the polar map uniformities as a 
result of these parts.
The FI of the total intensity losses were also calculated and compared.
4.3 Results
4.3.1 Tests to Ensure That a Param etric M odel W ill be Valid
Box-plot methods and z-scores checked for outliers in the data. Levene’s tests confirmed the 
homogeneity of variance (homoscedasticity) and inspection also confirmed that they adhere 
to the principles of independence and interval data. Using the z-scores for skewness and 
kurtosis, as well as the Shapiro-Wilk test confirmed the normal distribution of the data.
4.3.2 The D istortion  in the Left Ventricle
The PMUDs calculated for all the male and female simulated patients for the 9 different 
segments when the whole thorax acts as attenuation medium are displayed in figure 4.5 and 
summarised in table 4.1 and 4.2. The thorax acts as an attenuation medium for every part of 
the left ventricle and therefore all the segments (representing the whole left ventricle) are 
expected to show a zero PMUD for the null hypothesis to be true. Should the PMUD’s not be 
zero than the experimental hypothesis holds true and a positive PMUD reflects an under
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estimation of the real perfusion and a negative PMUD reflects an over estimation of the real 
perfusion.
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Figure 4-5: The means (as displayed above each bar) of the PMUD’s as a result of the Whole Thorax together 
with the 95% confidence intervals for each of the 9 segments for the male and female simulated patients.
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Table 4-1: Summary of the PMUD values for both male and female simulated patients as a result of using the 
whole thorax as attenuation medium
1 PMUD as a Result cdF the W'hole Thorax
B-ANT A-ANT B-LAT A-LAT B-INF A-INF B-SEP A-SEP APX
10.3 -1.6 17.7 3.4 22.2 9.1 16.0 0.1 -7.0|
19.6 10.4 20.4 3.7 16.0 -1.1 19.0 0.3| -9.8|
Figure 4.5 shows a positive value for all the basal segments. On the other hand, only the 
apical-lateral and apical-inferior segment show a positive PMUD for the apical parts for the 
male simulated patients and these values are much lower than that of the basal parts. The 
apical-anterior and apex for the male simulated patients show a negative value and is very 
close to zero for the apical-septal segment. In the case of the female simulated patients the 
apical region also show a visible difference between the basal and apical parts with the 
apical-inferior and apex having negative values and the apical-septal segment once again 
have a value very close to zero. The calculated mean PMUD values are displayed in table 
4.1 with the t and p values displayed in table 4.2. The r-values are displayed in table 4.3 and 
the r-values that indicating a significant difference are displayed in red.
Table 4-2: Paired Samples t-test to determine the significance between the PMUD values
Paired Samples Test - PMUD when using Whole Thorax as Attenuation Medium
Male
Female
segment 
B_ANT 
A_ANT 
B_LAT 
A_LAT 
BJNF 
A INF
PMUD
APX
B_ANT
A_ANT
B_LAT
A_LAT
BJNF
A INF
Paired Differences 
Std. Std. Bror 95c 
Deviation PMUD F  be
APX
% Q of the PMUD
Lower Upper t df p (2-tailed)
9.1 11.5 17.3 29 .000
-2.9 -0.3 -2.6 29 .016
16.7 18.7 36.7 29 .000
2.6 4.1 8.7 29 .000
21.4 23.0 57.7 29 .000
8.0 10.1 18.2 29 .000
15.0 17.1 32.6 29 .000
i 0.0 0.2 1.3 29 .206
-7.8 -6.2 -17.1 29 .000
18.7 20.4 49.1 29 .000
9.7 11.2 27.2 29 .000
19.5 21.3 47.5 29 .000
3.0 4.5 9.7 29 .000
15.2 16.8 41.0 29 .000
-1.9 -0.4 -3.1 29 .005
18.1 19.8 46.3 29 .000
0.0 0.6 2.0 29 .050
i -10.8 -8.8 -19.8 29 .000
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Table 4-3: r-values to quantify the PMUD (Values in red indicate that it is significant)
r-values
B-ANT A-ANT B-LAT A-LAT B-INF A-INF B-SEP
Male (
Female
—
APX
17.3 -2.6 36.7 8.7 57.7 18.2 32.6 1.3
29 29 29 29 29 29 29 29
0.96 0.43 0.99 0.85 1.00 0.96 0.99 0.23
49.1 27.2 47.5 9.7 41.0 -3.1 46.3 2.0
29 29 29 29 29 29 29 29
0.99 0.98 0.99 0.87 0.99 0.50 0.99 0.36
-17.1
0.
-19.
4.3.3 Com parison Between the Basal and A p ica l Regions
The previous graphs indicate that there are substantial differences between the PMUD of the 
basal and apical parts for both male and female simulated patients. To quantify these 
differences the basal and apical parts of all the segments were compared and the PMUD’s 
when comparing these differences between the basal and apical regions for the male and 
female simulated patients are given in figure 4.6 and table 4.4 display the t and p values and 
table 4.5 the r-values.
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PMUD When Comparing the Basal and Apical Regions - Females
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Figure 4-6: The PMUD’s when comparing the difference between the basal and apical regions of the anterior, 
lateral, inferior and septal walls in the male and female simulated patients.
Table 4-4: 2-tailed dependent t-test to determine the equality of the means of the intensity losses differences 
between the basal and apical regions of the anterior, lateral, inferior and septal walls in male and female 
simulated patients
Paired SamplesTest - PMUD when using Whole Thorax as Attenuation Medium
Paired Differences
Male ? -
Female
C om paring
S e g n e n ts
1
PMUD j
lb ■ » ! '
a d . :
Deviation
a d . Brror 
PMUD
95% a  o f the PMUD 
Lower Upper t df
j P(2- ] 
tailed)
A_ANT- BANT I  "9 1 2.4 0.4 -10.0 -8.2 -21.1 29 .000
AJAT - BJAT
I "16‘6
2.1 0.4 -17.4 -15.8 -42.5 29 .000
AJNF-BJNF |  -17 2 1.7 0.3 -17.8 -16.5 -55.2 29 .000
AJSEP - BJ3EP N 187 2.1 0.4 -19.5 -17.9 -486 29 .000
APX- B_ANT I  -29.4 2.9 0.5 -30.4 -28.3 -55.2 29 .000
APX - BJAT |  -30.2 2.5 0.4 -31.1 -29.2 -67.4 29 .000
APX-BJNF 1 258 2.7 0.5 -26.8 -24.8 -52.4 29 .000
APX- B_SEP i  -288 2.8 0.5 -29.8 -27.7 -55.4 29 .000
A_ANT- B_ANT |  -11.9 2.1 0.4 -12.7 -11.1 -30.6 29 .000
A_LAT- B_LAT
1 143
2.4 0.4 -15.2 -13.4 -32.1 29 .000
AJNF-BJNF I  -13.2 1.9 0.4 -13.9 -12.4 -37.1 29 .000
AJSE> - BjSB3 |  -16.0 2.8 0.5 -17.0 -14.9 -31.6 29 .000
APX- B_ANT 1  173 4.4 0.8 -18.9 -15.7 -21.7 29 .000
APX - B_LAT II -247 3.2 0.6 -25.9 -23.5 -42.5 29 .000
APX-BJNF I  -292 2.2 0.4 -30.0 -28.4 -72.0 29 .000
APX - BSEP | |  -23.0 3.8 0.7 -24.5 -21.6 -32.9 29 .000
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Table 4-5: r-values to quantify the PMUD (Values in red indicate that it is significant)
Female
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0.97
30.6
29
0.98
-32.1
29
0.99
29
37.1
29
0.99
-48.6
29
0.99
-31.6
29
0.99
-55.2
29
1.00
-21.7
29
0.97
-67.4
29
1.00
-42.5
29
0.99
52.4
29
0.99
72.0
29
1.00
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0.
5i
i
w
4.3.4 Under Estimation of the Basal Regions and Over Estimation
of the Apical Regions of the Left Ventricle
As seen in the previous paragraphs the PMUD values do not always represent a positive 
value as in some cases these values are negative. When the photons travel from the patient 
to the imaging system some of them are attenuated and this fact is reflected in the images as 
lower intensities as compared to how it would have looked when no attenuation media are 
present. Therefore the imaging system under estimates the amount of counts coming from 
the patient. This fact is reflected as a positive PMUD value. An index, the PMDUI, was earlier 
defined to determine which segments are subject to the biggest perfusion under estimation. 
The PMUD’s when using the whole thorax as attenuation media in both the male and female 
simulated patients and the PMDUI to determine the under- and over-estimation of different 
regions are given in figure 4.7 and the results displayed in table 4.6
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Figure 4-7: The PMUD's when using the whole thorax as attenuation media in both the male and female 
simulated patients and the PMDUI to determine the under- and over-estimation of different regions.
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Table 4-6: The PMUDI’s for the male and female simulated patients. The values in red indicates negative 
PMUD’s and which indicates an over estimation in that segment and the ones in orange a PMUD higher than the 
index and therefore a severe under estimation
PWIUDI asa Result o f the W hole Thorax
B-ANT A-ANT B-LAT A-LAT B-INF A-INF B-SEP A-SB3
H -1.6 17.7 3.4 22.2 9.1 16.0 0.1
I 10.4 20.4 3.7 16.0 -1.1 19.0 0.3 -9.8
4.3.5 The Contribution of the Different Anatomical Parts to This
Distortion
Table 4.7 displays the PMUDs for all the parts while figure 4.8 displays the PMUDs when 
only the body is used as attenuation medium and figure 4.9 when only the heart is used as
attenuation medium. Figure 4.10 displays the PMUDs of the heart compared to those of the 
body. Figure 4.11 gives the percentage contribution to the intensity losses experienced in the 
final images as a result of the different anatomical parts for both genders. In the following
sections the following abbreviations are used: E-The whole thorax, L-Lungs, B-Bloodpool, M-
Myocardium, P-Pericardium, R-Remainder, S-Skeleton, BPM-Bloodpool & Pericardium &
Myocardium and RS-Remainder & Skeleton. B stands for the basal parts and A for the Apical
region where ANT-Anterior, LAT-Lateral, INF-Inferior, SEP-Septal and APX-Apical. The
PMUDs for the different anatomical parts for both male and female are given below.
A. The PMUD’s of the Individual Parts for the 9 Segments
Table 4-7: A summary of the PMUD’s in all the segments for all the anatomical parts for both the male and 
female simulated patients
PMUD for Each Anatomical Part for Each Segnent - Males
EPM
RS
B-ANT A-ANT B-LAT 1 A-LAT B-INF A-INF B-SEP A-SEP APX
10.3 -1.6 17.7 3.4 22.2 9.1 16.0 0.1 -7.0
4.4 1.4 4.9 3.2 3.6 22 0.7 0.0 0.0
0.5 0.4 3.8 0.0 7.6 21 9.6 0.0 2.8
-5.8 -4.1 -2.4 -3.8 6.5 25 6.3 0.2 -3.3
8.5 26 8.5 5.0 3.0 3.2 1.1 0.0 0.4
2.1 -4.3 1.7 -1.7 3.7 1.9 -1.4 0.4 -6.6
ZO 25 4.6 24 4.4 2.4 4.0 0.0 2.2
3.2 -0.2 10.0 3.4 16.1 8.0 14.2 0.0 0.2
3.2 -24 5.1 -1.3 7.9 3.0 2.2 0.1 -5.4
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PM UD for Each Anatomical Rart for Each Segnent - Females
B-ANT ArANT B-LAT ArLAT B-INF ArINF E3-SB3 ArSB3 APX
p X X X 'lB  19.6 10.4 20.4 3.7 16.0 -1.1 19.0 0.3! -9.8
J 5.2 21 5.5 3.7 4.0 2.2 0.8 0.0 0.4
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Figure 4-8: The means of the PMUD’s (as displayed above each bar) as a result of the body (remainder and 
skeleton) together with their 95% confidence intervals for each of the 9 segments for both genders.
C. The Contribution of the Heart
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PMUD - Heart vs Body - Female
Figure 4-10: The means of the PMUDs (as displayed above each bar) comparing the heart (myocardium, 
pericardium and bloodpool) and the body (remainder and skeleton) together with their 95% confidence intervals 
for each of the 9 segments for both genders.
D. The Contributions of the Individual Parts as a Percentage
This section displays the contribution of all the individual parts as percentages in figure 4-11, 
first for the males, then for the female simulated patients in all 9 segments. This is helpful in 
illustrating which anatomical parts are the main contributors to the intensity losses 
experienced as well as the differences between the two genders.
70
4.3 Results
%  Contribution of the Anatomical Parts - Male
B-ANT
o 
o
G
D
z
CL
L B M P R S
A-ANT
o 
o
G
Q.
L B M P R S
B-LAT
o 
o
D
D
z
Q.
L B M P R S
A-LAT B-INF A-INF
o 
o
G
Q.
o 
o
G
CL
o 
o
G
L B M P R S L B M P R S L B M P R S
B-SEP A-SEP APX
o 
o
G
z
CL
L B M P R S
Figure 4-11: The percentage contribution to the intensity losses experienced in the final images as a result of the 
different anatomical parts for both genders (the y-axis represent the % contribution).
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4.3.6 The Contribution of Scatter
The images in figure 4.12 display the result of the test of the hypothesis that scatter plays a 
substantial role in the non-uniformity of images during a SPECT acquisition. The figure 
displays the reconstructed images of the scattered, primary and non-attenuated images. 
Figure 4.13 displays the contribution to the intensity values when only the scattered photons 
are considered. This is for the nine segments as a percentage so that it is possible to deduce 
which segment experiences the most scatter. Table 4.8 compares the contribution of the 
scattered photons to the intensity value of the basal parts as compared to that of the apical 
parts so that a conclusion can be made that scatter contributes to the distortion observed.
Figure 4-12: Illustrating the effect of scatter, reconstructed images of only the scatter component (top row), 
reconstructed images of only the primary photons (middle row) and the non-attenuated reconstructed images 
(bottom row). Note that each image set is normalised to the maximum in that specific image set and that the 
maximum in the scatter reconstructed images is significant lower than the maximum in the other two sets.
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Figure 4-13: The scatter fraction (as a percentage) in the 9 segments as a result of scatter for the female 
simulated patients.
Table 4-8: Dependent sampled t-test to determine whether the mean of the percentage loss in apical parts are 
significant different from those in the basal parts for the scattered photons and primary photons as well as a 
comparison between the means of the scatter fractions of the basal and apical regions
Paired Samples Test -  Testing Equality of Means Between Apical and Basal -  Scattered
Pairl 
Pair2 
Pair 3 
Pair4 
Pairs 
Pair6 
Pair7 
Pair8
A ANT- B ANT
W  M  »■
A LAT- BLAT 
AJNF-BJNF 
A_SEP - B_SEP 
APX- BANT 
APX- BLAT 
APX- BJNF 
APX- B SB3
Mean
Paired Differences
95% Confide nee Interval 
Std. j: ad. t t  of the Difference
Deviation Mean T Lx>wer Upper df p (2-tailed)
73
4.3 Results
Paired Samples Test -  Testing Equality of Means Between Apical and Basal -  Primary
Paired Differences
Mean
ad. ad. Error
95%Confidence Interval of 
the Difference
t df
1
P (2-
Deviation Mean Lower Upper 21 tailed) |
Pairl AANT- BANT 7.19 0.74 0.23 6.66 7.72 30.85 9 .000
Pair2 ALAT- BLAT 6.44 0.56 0.18 6.04 6.84 36.36 9 .000
Pair3 AJN F-BJN F 4.67 0.49 0.15 4.32 5.02 30.14 9 .000
Pair4 A_SEP- B_SEP 11.06 1.19 0.38 10.21 11.91 29  44 9 .000
Pair5 APX- BANT 8.60 1.01 0.32 7.88 9.32 26.99 9 .000
Pair6 APX- BLAT 8 0 6 0.75 0.24 7.52 8 6 0 34.05 9 .000
Pair 7 APX- BJNF 8.80 0.83 0  26 8.20 9.40 33.37 9 .000
Pair8 APX- BJSEP 10.17 1.13 0 3 6 9.36 10.98 28 47 9 .000
Paired Samples Test -  Testing Equality of Means -  Scatter Fraction
Paired Differences
Mean
3d. ad. Error
95%Confidence Interval of 
the Difference
t J L df
p ( 2-  ;
Deviation Mean bower Upper Jailed);]
F i^r 1 A_ANT - B ANT ■  - 1 .65 2 .59 0 .82 - 3 .50 0 .2 0 - 2 .0 2 9 .074
Pair 2 AJAT- B_LAT
1  ' ° 37 2 .3 7 0 .7 5 - 2 .0 6 1.32 - 0 .4 9 9 633
Pair 3 A INF- B INF
M  M M
■  1 .95 2 .6 5 0 8 4 0 .0 6 3  84 2 .3 3 9 .045
Pair4 ASEP- B_SEP 1  - 5 .9 9 1.60 0.51 - 7 .1 4 - 4 .8 4 - 11 .82 9 .000
Pair 5 APX- B_ANT H  - 0 .84 4 .2 8 1.35 - 3 .9 0 2 .2 2 - 0 6 2 9 .550
Pair 6 APX - B LAT H  0 7 9 3 .3 0 1.04 - 1 .57 3 .15 0 .76 9 469
Pair 7 APX - BJNF R| 0  38 3 .62 1.14 - 2.21 2 .9 7 0 .33 9 .747
Pair 8 APX - B_SEP |  - 3 .52 3 .87 1.22 - 6 .2 8 - 0 .7 6 - 2 .8 8 9 018
4.3.7 Fractional intensity Loss in the Final Ventricular Images
In order to investigate the loss of intensity values in the final images the Fractional Index (FI) 
was introduced in 4.2.2 and 4.2.8. Figure 4.14 illustrates the loss of intensity values for the 
whole thorax as attenuation medium by displaying the FI for the 9 segments, first for the 
male simulated patients, then for the female simulated patients. The statistical results are 
displayed in table 4-9 so that a conclusion can be made whether there are any statistically 
significant differences.
4.3 Results
Figure 4-14: Fractional Index (FI) of the “Whole Thorax” as attenuation medium for the 9 segments.
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Table 4-9: Results of the 2-tailed independent t-test to determine the equality of the means of the fraction 
indexes for the male and female simulated patients
Independent Samples Test - Comparing Fractions- Male vs Female
t-test for Equal ity of M eans
95%Confidence Interval of
p(2- ! Mean 9d. &ror the Difference
1  •
t L .<?. tailed) Difference•  •  --- •  • •  *  •  A  A  •  -  -  *  •  ■ i  ■  /  -  •  •  ■  M l n  «  «  •  * Difference Lower Upper
B_ANT | -8.29 58 .000 -0.48 0.06 -0.60 -0.36
A_ANT 1 -4.46 58 .000 -0.19 0.04 -0.27 -0.10
B_LAT I 2.16 58 .035 0.11 0.05 0.01 0.21
A_LAT 1 4.95 58 .000 0.18 0.04 0.11 0.25
BJNF I 4.71 58 .000 0.30 0.06 0.17 0.42
AJNF I 9.13 58 .000 0.48 0.05 0.37 0.58
B_SEP 9 -5.35 58 .000 -0.36 0.07 -0.49 -0.23
ASEP 1 8.81 58 .000 0.38 0.04 0.29 0.47
APX | 1.72 57 .091 0.06 0.04 -0.01 0.14
4.3.8 Comparison Between the Simulated Male and Female
Patients
In order to establish any differences between the male and female simulated patients a 
comparison was made of the differences in the PMUD, first when the whole thorax was used 
as attenuation medium and displayed in figure 4.15, then with only the body (remainder) as 
attenuation medium and displayed in figure 4.16 and finally with the heart as the only 
attenuation medium as displayed in figure 4.17. The t-test values of these differences are 
summarised in table 4.10 so that a conclusion can be made whether the differences are 
statistically important. An important emphasis in this study is placed on the differences 
between the amount of intensity losses between the basal and apical parts. Figure 4.18 
displays a comparison between the male and female simulated patients of these differences 
and the statistical results are displayed in table 4.11 so that a conclusion can be made 
whether there are any statistically significant differences.
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Figure 4-15: The means of the PMUD’s of "Everything" for the Male and Female patient selection, presenting the 
differences between these two population groups (the y-axis represents the PMUD’s).
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PMU of Heart - Male vs Female
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Figure 4-16: The means of the PMUD's of the Heart for the Male and Female patient selection, presenting the 
differences between these two population groups (the y-axis represents the PMUD's).
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Table 4-10: Results of the 2-tailed independent t-test to determine the equality of the means of the PMUD’s as a 
result of the Whole Thorax, Heart and Body between the two genders. The values in red indicate that there is a 
significant difference between the two genders for that segment
Independent Samples Test - Comparing Everything - Male vs Female
t-test for Equality of Means
t df
p (2- ;i
tailed)
Mean
Difference
ad. BTor 
Difference
95% Conf i de nee 
Interval of the 
Difference 
Lower Upper
B_ANT 10.64 58 0.000 9.12 0.86 7.41 10.84
A_ANT -14.29 58 0.000 -11.15 0.78 -12.71 -9.59
BJAT -2.64 58 0.011 -1.88 0.71 -3.31 -0.45
A JA T 0.80 58 0.428 0.56 0.70 -0.84 1.95
BJNF 9.84 58 0.000 7.79 0.79 6.20 9.38
AJNF 13.09 58 0.000 11.73 0.90 9.94 13.53
B_SEP -2.73 58 0.008 -2.42 0.89 -4.19 -0.65
A_SEP 1.20 49.5 0.235 0.81 0.67 -0.54 2.16
APX 4.95 58 0.000 4.11 0.83 2.45 5.78
Independent Samples Test - Comparing Hearts - Male vs Female
t-test for Equality of Means
v  \  y .  f t . V  I I  1 1  | i  \  ‘  *  -  *  I  «  »  t  1  • »
95% Confidence
Interval of the
"  1  »  1  .  - 1 P (2- 1 Mean ad. B ror j Difference
t df tailed) Difference Difference Lower j ! Upper
B_ANT 2.80 58 0.007 1.96 0.70 0.56 3.36
A_ANT 2.53 58 0.014 1.14 0.45 0.24 2.04
B_LAT 2.98 58 0.004 1.65 0.55 0.54 2.76
A_LAT 2.04 33.4 0.049 2.90 1.42 0.01 5.78
BJNF -5.00 33.2 0.000 -8.50 1.70 -11.96 -5.04
AJNF -0.89 32.2 0.380 -1.24 1.39 -4.08 1.60
B_SEP -0.77 58 0.445 -0.57 0.75 -2.07 0.92
AjSB3 0.84 58 0.407 0.39 0.46 -0.54 1.31
APX -0.62 58 0.540 -0.29 0.47 -1.23 0.65
4.3 Results
1 Independent Samples Test - Comparing the Bodies- Male vs Female
1t-test for Equality of M eans
t df
P(2- Mean Std. Error
95%Confidence Interval of 
the Difference
tailed) Difference Difference Lower Upper |
B_ANT -27.04 57 .000 -12.65 0.47 -13.58 -11.71
A_ANT -22.10 53 .000 -12.54 0.57 -13.68 -11.40
B_LAT -9.02 58 .000 -5.57 0.62 -6.80 -4.33
A_LAT 0.35 58 .725 0.22 0.63 -1.04 1.49
BJNF 15.08 58 .000 7.51 0.50 6.51 8.50
AJNF 30.30 57 .000 11.61 0.38 10.84 12.37
B_SEP -11.62 58 .000 -5.89 0.51 -6.90 -4.88
A_Sff> -5.44 58 .000 -1.10 0.20 -1.50 -0.70
APX 9.77 53 .000 5.04 0.52 4.01 6.08
PMU Differences Between Basal and Apical - Male vs Female
ANT LAT
INF SEP
Figure 4-18: A comparison of the PMUD’s when comparing the basal and apical regions in both male and female 
simulated patients for the anterior, lateral, inferior and septal walls (the y-axis represents the PMUD’s).
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Table 4-9: Results of the 2-tailed independent t-test to determine the equality of the means of the PMUD’s 
when comparing the basal and apical regions of the anterior, lateral, inferior and septal walls for the male and 
female simulated patients
Independent Samples Test - Gbmparing Regions - Male vs Female
t-test for Equality of M eans
t df
R e - Mean Std. E rro r
)
95% Confidence 
Interval of the 
Difference
tailed) Difference Difference ^ . mi  0 .A r m  ^i-— U m V ^ „l ^ -_ Lower Upper
a n t 58 0.001 2.02 0.57 0.88 3.16
n  -4.19 58 0.000 -2.43 0.58 -3.60 -1.27
INF l l S p l 58 0.000 -4.46 0.69 -5.85 -3.07
-4 75 58 0.000 -3.24 0.68 -4.61 -1.88
4.4 Discussion and Conclusion
4.4.1 The Distortion in the Left Ventricle When Not Applying Any
Corrections
The results from figure 4.5 and table 4.1 to 4.3 clearly illustrate the substantial distortion of 
the left ventricle because of permutations such as attenuation, scatter, partial volume, etc. It 
shows that in most of the 9 regions represented by the 9 segment polar map there was an 
under estimation of the true intensities, but in some there was an over estimation. The only 
exception for both male and female simulated patients is the apical-septal region which has a 
PMUD very close to zero. Except for this region and the apical-anterior region in males and 
the apical-inferior region in females, the effect of the PMUD is very large with r-values very 
close to 1, which is the maximum value possible. This illustrates that for both male and 
female simulated patients there are distortions of the uniformity in 7 of the 9 segments.
The null hypothesis was only true in the apical-septal regions of both the male and female 
simulated patients and was rejected for the remainder of the regions.
The region which has the biggest loss of uniformity is the basal-inferior region in the male 
population with a value of 22.2%. This is in line with what was expected and reported in the 
literature and therefore confirms that the inferior wall is the region mostly affected by the 
permutations in men.
Female patients seem to experience a significant uniformity loss in the anterior wall as 
expected (19.6% in the basal-anterior) but the other walls, including the inferior wall, also 
experience a significant uniformity loss.
There is a substantial variation between patients, with some overlap with “normal”. Therefore 
a correction method which just applied a mean value will result in (different) false positives
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and negatives in some patients, and therefore only an individualised correction will cure all 
artefacts.
4.4.2 Comparison Between the Basal and Apical Regions of the
Non-Uniformities Experienced
In this case the null hypothesis was rejected for all the segments, for both genders. This 
means that the non-uniformities experienced in the polar maps are substantially different 
between the apical and basal regions and the effect size of these differences was also very 
substantial (all close to 1, some even 1). It can be safely concluded from this simulation 
study that for both male and female patients, the non-uniformity found between the basal and 
apical regions is very substantial.
4.4.3 The Relative Non-Uniformities in the Basal and Apical Parts
From figure 4.7 and table 4.6 it can be seen that in male patients the apical and apical- 
anterior regions are over estimated. For the female patients the over estimation was found in 
the apical and apical-inferior regions.
Large under estimations, which were statistically significant, were experienced in the basal- 
anterior, basal-lateral, basal-inferior, apical-inferior and basal-septal regions for the male 
patients. For the female patients the severe under estimations were detected in the basal- 
anterior, apical-anterior, basal-lateral, basal-inferior and basal-septal regions.
It can be seen that all the basal segments for both genders experienced a severe under 
estimation and also one apical region for each gender. Both genders experience an over 
estimation in the apical region but the second segment experiencing this is different.
4.4.4 The Contribution to This Distortion by Each Anatomical Part
By analysing the PMUDs values as a result of the heart as attenuation medium and 
comparing them to the values obtained for the body from figures 4.8 and 4.9 it can be seen 
that the heart contributed more to the loss in the basal-inferior segment than the body for the 
male population. The contribution to the uniformity loss in the basal-inferior wall (also the 
region which experienced the most substantial uniformity loss) is 1/3 for the body and 2/3s 
for the heart making the heart responsible for the most substantial uniformity loss in males. 
The same is true for the basal-lateral and basal-septal regions.
In females it seems that uniformity loss in the basal-inferior wall is almost entirely due to the 
heart. From figure 4.10 it is clear that the heart is the main contributor to the loss in uniformity 
for both male and female patients in all the regions except for the anterior wall in female 
patients.
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4.4.5 The Effect of Scatter on the Intensity Distribution in the Left
Ventricle
The effect of scatter in the female population can be seen from figure 4.13. The scatter 
contribution to the final images is between 24.5 and 28.6%. It can also be seen from table 
4.8 that for all the segments the scatter contribution is more substantial for the apical parts of 
the regions than the basal parts. This was also true for the primary photons. It can therefore 
be concluded that scatter does contribute to the over estimation in the apical regions but so 
does the primary photons. The conclusion from this is that although scatter contributes to the 
over estimation, it is not the only cause and the over estimation is a result of other factors as 
well.
4.4.6 Fractional Intensity Losses in the Final Ventricular Images
The fractional indexes for both gender indicates a substantial loss of counts as a result of the 
attenuation and scatter. The average fraction for the male population was 3.5 and for the 
female population it was also 3.4. This means that for both male and female the original 
intensities were 3 and a !4 times the intensities in the final images.
This substantial loss in intensities is a result of these permutations and can be used as a 
reference to review the performance of any clinical correction method under investigation.
4.4.7 Investigating the Differences in Intensity Losses Experienced
Between Males and Females
The simulations predicted that male patients will experience the most substantial intensity 
losses in the B-INF region and females in the B-ANT regions. It also suggests that females 
will experience substantial intensity losses in the other basal regions, including the B-INF 
segment. Both genders will experience an intensity gain in the apical regions. It also 
suggests that both genders experience a substantial loss of intensity in the B-INF segment 
as a result of the heart. Both genders also experience a substantial difference in the 
uniformity of the basal regions as compared to the apical regions. The fraction indexes 
suggest that both experience substantial intensity losses and the MFI values are actually the 
same.
4.4.8 Summary
This study illustrates that the inferior wall is the part mostly affected by scatter and 
attenuation with a PMUD of 22.2% in males and 16% in females. This study also 
demonstrates that inferior wall attenuation is just as prominent in females as in males. The 
main contributor to Inferior uniformity losses is the heart for both genders and it is a factor
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that cannot be predicted by the gender of the patient only and stresses the need for an 
accurate attenuation correction technique. Attenuation leads to an under estimation in the 
basal areas which could compromise volume calculations. Un-corrected images also lead to 
an over estimation of the apical regions which could mask patients with apical thinning. 
Although there are still debates about the clinical significance of apical thinning, the general 
consensus is that is has no clinical significance and therefore the clinical impact of the apical 
over estimation should be negligible. The reasons for this over estimation are still unclear 
and more work needs to be done to determine the reason for it. This study also confirms the 
substantial loss of intensities as a result of the mentioned problems which makes absolute 
quantification very difficult when not applying the appropriate corrections.
In this study effects such as apical over estimation, shortening of the basal parts of the left 
ventricle, substantial inferior wall intensity losses in females and the fact that up to 90% of 
the original intensities in the LV are lost in uncorrected images were highlighted. The fact that 
self-absorption in the heart is a very important factor leading to substantial intensity losses in 
the inferior wall have also been established in this study and this is the first time that this has 
been determined to the best knowledge of the author. Some of the findings in this chapter 
can be found in some references but emphasising them again here and combining them in 
one systematic study should make a substantial contribution to the field. Further the work 
provides a framework to test any correction. Another important contribution of this study is 
that it quantifies these effects, which has not always been the case in previous reports of the 
effects which have been studied. In particular, this study illustrates that the use of gender to 
decide whether intensity loss defects are real defects or not is not a reliable method, 
because of overlap of the range of results for male and female. This study also confirmed 
that scattered photons contribute to about 30% of the intensities in the energy window and 
confirms the need for scatter corrections.
The position and orientation of the heart within the thorax can vary substantially from person 
to person and this can make the intensity loss artefacts discussed in this chapter even more 
unpredictable. The influence of these variations on the intensity loss artefacts will be the 
subject of the next chapter.
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Chapter 5 - Attenuation 
Variations as a Result of 
Different Orientations and 
Positions of the Myocardium in
the Thorax
5.1 Introduction
In the previous chapter many little known effects as a result of the problems in image 
reconstruction in MPI were highlighted and quantified. The quantified values were 
established for the fixed configuration of the heart within the thorax in the Visible Human. The 
study recorded in this chapter attempts to extend these results by investigating the effect that 
different positions and orientation of the heart within the thorax have on the amount of 
intensity losses experienced in the LV There are substantial variations in the orientations 
and positions of the heart within the thorax in the general population.
The position and orientation of the myocardium within the thorax are defined by three 
rotational parameters and three translation parameters, i.e. xy-rotation (psi)(horizontal), zy- 
rotation (beta), xz-rotation (phi)(vertical), x-translation, y-translation and z-translation relative 
to the origin of a Cartesian coordinate system. Altering any of these parameters could 
potentially influence the extent and position of the attenuation of emitted photons from the 
radionuclide in the left ventricle. The exact values of these parameters, which define the 
orientation and position of the myocardium in the thorax, vary substantially from person to 
person. It is postulated that this can alter the extent and position of potential attenuation 
artefacts in the left ventricle. It has also been shown that females have a smaller rib cage 
size and a shorter diaphragm than males having the same height193. This results in a higher 
diaphragm dome in males. This position of the diaphragm dome results in a more horizontal 
orientation of the heart in males as compared to the orientation in females
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In the current routine use of MPI studies, probably the most important parameter of these six
parameters describing the orientation of the myocardium within the thorax, is the xz- rotation
(phi), as the image has to be rotated in this direction to ensure the correct alignment for the
accurate presentation of the patient’s images in clinical examinations. Incorrect alignment
results in lower reported sensitivity and specificity for the detection of perfusion defects194.
There can be substantial differences between patients; it has been reported195 that a
difference up to 57 between the minimum and maximum determined angles in a patient
population of 167 patients. Both these observations indicate that this is a very important 
parameter to study.
5.2 Methods
To investigate the effect of the different potential orientations (rotations) and positions of the 
heart within the thorax, six variation studies were performed. These included variations in the 
three different rotation parameters and variations in the three positional parameters. In each 
study, only one set of parameters was varied (by dividing it into 15 different values or 
variations, i.e. dividing the xz-orientation (phi) into 15 different angles) while the other five 
were kept constant, i.e. varying only the xz-orientation (phi) while keeping the xy- orientation 
(psi), zy-orientation (beta), x-position, y- position and z- position constant. The range in this 
study for each parameter is chosen to cover the normal patient range195,145. The reference 
values are the ones based on the Visible Human196,197 and are the dark cells in table 5.1
These potential variations were investigated by using 30 male patients who were selected as 
described in the previous chapter (section 4.8), and span the variation across the normal 
male patient range. For each of these male ‘patients’ the spatial parameters were divided in 
15 subsets as displayed in table 5.1 and illustrated in figure 5.1 (a)-(f).
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Table 5-1: The 15 variations for the 6 variation studies
[xzR otation  yxRotation  
phi (deg) psi (deg)
zy Rotation 
beta (deg)
x  Translation 
(m m )
y Translation 
(m m )
zTranslation
(m m )
-10 -31 -111 -14 -14 6
-12 -33 -108 -12 -12 8
-14 -35 -105 -10 -10 10
-16 -37 -102 -8 -8 12
-18 -39 -99 -6 -6 14
-20 -41 -96 -4 -4 16
-22 -43 -93 -2 -2 18
-24 -45 -90 0 0 20
-26 -47 -87 2 2 22
-28 -49 -84 4 4 24
-30 -51 -81 6 6 26
-32 -53 -78 8 8 28
-34 -55 -75 10 10 30
-36 -57 -72 12 12 32
-38 -59 -69 14 14 34
The following six images will illustrate the 3 translations and 3 translation which defines the 6 
variation studies.
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Figure 5-1: The 15 variations in each of the 6 variation studies (a) xz-rotation (phi), (b) xy-rotation (psi), (c) zy- 
rotation (beta), (d) x-translation, (e) y-translation and (f) z-translation.
5.2.1 Images Required for the Monte Carlo Simulations
Each of the patient studies was simulated as a 99rrTc SPECT study with the use of Monte 
Carlo simulations. The Monte Carlo simulation package used in this study (SIMSET) required 
an attenuation and activity index file that served as indexes into a translation table of 
attenuation coefficients and activity values for each of the patient studies being simulated. 
The NCAT program produced the activity and attenuation distributions as illustrated in figure 
5.2 (a) and (b). Because the SIMSET program required index files (each tissue type has a 
specific index value rather than an attenuation coefficient assigned to them. These index 
values are then used in a look-up table to obtain the required attenuation coefficients), rather 
than distribution files, an index file has been created from the tissue density values in figure 
5.2(b) as displayed in figure 5.2(c). An activity index file was also needed and the activity 
distribution shown in figure 5.2(a) also served as the index file. These files were created for 
each of the simulated patients. Each of the orientation variations (15) for every set (6), 
required a set of input files, i.e. a total of 90 for every simulated patient.
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Figure 5-2: The simulation input files generated with the NCAT program. The activity distribution and index file 
(a), the attenuation distribution (b) and the attenuation index file (c).
5.2 Methods
For each spatial variation two simulations were performed as described in chapter 3, 
paragraph 3.4. First the NCAT activity distribution was created and then an attenuation 
distribution of the thorax. After converting these distributions to index files they were used as 
input for the simulation. This was the first simulation or real life simulation. The simulation 
with no attenuation medium was repeated, as if the photons propagated in air (air 
simulation), illustrated in figure 5.3 (a) and (b).
(a) (b)
Figure 5-3: The simulation index input files generated with the NCAT program. The air simulation with the empty 
attenuation index file and the activity index file (a) and the real life simulation with the attenuation index file and 
the activity index file (b).
The output of the SIMSET simulation program provided a sinogram, therefore each set of 
simulations produced 2 sinograms. These sinograms were reconstructed as described in the 
section about reconstruction in the previous chapter (section 3.5) and analysed with the 
4DMSPECT program by using a 5-segment model.
This process was repeated for all six variation studies. This gave a total of 90 variations in 
each patient simulation. To ensure that the above mentioned statistical analysis could be 
applied to these studies, the whole process was repeated for all 30 patients, giving a total of 
2700 simulation sets, that is, 5400 individual simulations.
The hypothesis was that the intensity losses will change in either a linear or polynomial 
fashion. Therefore the intended statistical model to be used to determine the average
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intensity losses for the six variation studies was polynomial regression (which includes linear 
regression).
5.2.2 Statistical Analysis
To be able to apply the statistical models on the data the output of the 4DMSPECT program 
had to be manually transferred to a spreadsheet. This involves a substantial amount of 
manually entered data and therefore appropriate data validation checks were conducted 
using a box-plot method and z-scores.
The z-scores of the skewness and kurtosis, together with the Shapiro-Wilk test were 
performed to ensure that the data follow normal distributions and they were visually 
inspected to confirm independence and interval data. Levene’s test was used to test for 
homogeneity of variance.
After ensuring that the data is suitable for the application of a parametric test, regression 
analysis was performed and tested by using an independent t-test to see whether it is a valid 
statistical model. When regression was found to be a valid model, it was used to predict the 
outcome for unit changes in the variation under investigation. In the cases where it was not a 
valid statistical model, the mean was used and the assumption made that the outcome does 
not change for any changes in the predictor, i.e. the variation under investigation.
5.3 Results
After ensuring the integrity of the data by using the box-plot method and z-scores the data 
were analysed to ensure it adhered to the necessary four principles as described in section 
3.7.
After the completion of the above mentioned tests polynomial regression was done for all five 
segments and the total on every polar map obtained for every value of the independent 
variable, as described in section 3.6. There were six variation studies and each of these 
studies was a study with its own independent variable but the dependent variable was the 
calculated PMUDs in each of these studies The independent variables were the xz- 
orientation (phi), xy- orientation (psi), zy-orientation (beta), x-position, y- position and z- 
position and they were varied as depicted in table 5.1.
It was very clear from plotting the obtained PMUDs against each of the independent 
variables that a quadratic regression will not be a valid model and therefore only linear and 
cubic regressions were tested to see whether they are valid models. The outcome of the 
regression analysis are summarised in the tables and figures below.
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5.3.1 Results of the Linear Regression
In table 5.2 the calculated PMUDs for each segment were used as the dependent variables 
and the xz-orientation (phi), xy- orientation (psi), zy-orientation (beta), x-position, y- position 
and z- position each as the independent variables for linear regression as the proposed 
model. Table 5.3 summarises the segments for each of these six cases where the linear 
model is a valid model and the cases where the mean would be the correct model. The 
calculated coefficients of the linear regression model (again for all 6 the variation studies) are 
shown in table 5.4. In the cases where the mean is an acceptable model the slope reduces 
to zero as expected. Figure 5.4 displays the plots of the dependent variable against the 
independent variables.
Table 5-2: Model summary for the linear regression model
Phi Rsi ' M • , * k ( | ill*
Model Summary  ^B SB ■ MB B ■ Model Summary
R RSquare 'i
Std. Error of 
Adjusted R the 
Square Estimate : R/j RSquare
" * 1 • 1 1 1
Adjusted R 
Square
Std. Btot 
of the j 
Estimate
•* * • • • » ■ B* • !•
i 2 773  0.798 0637 0.636 2.215 ANT 0.520 0271 0.269 2.025
LAT B 0.637 0.636 2.215 LAT 0.719 0.517 0.516 1 873
INF B 0.384 0.383 1.917 INF 0.489 0.239 0.238 1.652
k T3]0 120 0.015 0012 1 867 I fT lS ] 0.331 0.110 0.108 1 940
0.233 0.054 0.052 2.816 IAPX 0.525 0 276 0.274 2.091
^ ^ [ 0 5 4 4 0296 0294 1.895 [ t o t 0.564 0319 0.317 1.757
Beta i y .  1 * 1  * I x-translation \* v;
Model Summary |j ■ Model Summary
Std. Btot of II Std. Error |
Adjusted R the Adjusted R j of the
R RSquare Square Estimate R RSquare Square j Estimate
0.531 0.282 0.280 2.259 ANT 0.571 0326 0.324 2.312
i a t  r a 0.725 0.724 2.242 I LAT 0699 0.489 0.488 2.276
INF B 0.513 0.512 2.031 INF 0462 0.214 0.212 1.770
k ^ J I  0.757 0.573 0572 2048 \ i  ;r; 0023 0001 -0.002 1 772
0.834 0696 0695 3.147 APX 0.211 0045 0.043 2851
T O T ® 0614 0.613 1.953 TOT 0.522 0272 0.270 1 926
y-translation 
Model Summa
R RSquare ji
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Square |
3d. Error of 
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Estimate |
ANT 0.692 0479 0478 2.183
LAT 0788 0621 0.620 1.935
INF 0 469 0.219 0.218 1.784
0035 0001 -0.001 1.877
APX 0 157 0025 0 022 2852
TOT 0.505 0255 0254 1.970
z-translation 
Model Summary
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I B u y  0 7 3 2
I - 1
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0.128 
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0163 
0448
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0016 0.014 1 951
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381 44 1 381.44 121 78 < 0001
1403 18 448 313
1784 62 449
0 72 1 072 023 .633
1406 74 448 3.14
1407 45 449
170 26 1 170 26 20 95 < 0001
3641 41 448 8 13
3811.67 449
621.30 1 621.30 167 42 < 0001
166250 448 371
2283 80 449
A PX
TOT
Ftegression
Regression
INF
Ftegression
ftesidual
Total
Ftegression
ota! 
Ftegession 
Ftesidual 
Total
Ftegression
Ftesidual
otal
y-translatlon
ANOVA
Sumof
Squares df
Mean 
Square j L l.  F
f ' • * * |
i 1 s \  1 1
p
1964 36 1 1964 36 41222 < 0001
2134 86 448 4.77
4099 23 449
1964 36 1 1964 36 41222 < 0001
2134 86 448 4.77
4099 23 449
401.17 1 401.17 125.99 < 0001
1426 49 448 3.18
1827 66 449
1.94 1 1 94 055 459
1578 68 448 3.52
1580 62 449
91.83 1 91 83 11.29 001
3643 66 448 8 13
3735 49 449
596 59 1 596 59 153 73 < 0001
1738 61 448 388
2335 19 449
A N T  ftesidual
Total
Ftegression 
LAT Ftesidual 
Total
Ftegession 
INF ftesidual 
Total
Ftegession
z-transiation 
OVA
Sumof Mean 'I
Squares df Square F 'i. iiiM
2268 14 1 2268.14 517.52 < 0001
1963 44 448 4.38
4231.58 449
1095 85 1 1095 85 318 46 < 0001
1541.64 448 3.44
2637 49 449
28 60 1 28 60 7.51 006
1705 63 448 381
1734 23 449
596 1 596 1.96 .163
1364 05 448 3.04
137001 449
7343 1 73.43 1229 001
2676 33 448 597
2749 76 449
288 38 1 288 38 112 67 < 0001
1146 67 448 256
1435 04 449
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Table 5-4: Coefficients for the linear regression model. For all non-significant values the p-value are shown in
red
LAT
INF
SEP
APX
TOT
slope
intercept
slope
intercept
slope
intercept
slope
intercept
slope
14 72 
65 07
0 70 20 70 
151 58
M l
HI
I I I
1
1
046 1104 
294 10 HI 1
002 633
I I I 1
021
052 12 94 
154 95
• ••
• ••
• ••
■ ■ ■ u p y-translation
Coefficients
m . •  A>LVV«i • * • v. t  b J  V i» iL ) i\ t. A r
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5.3 Resu lts
Linear Regression - Phi (XZ Rotation)
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5.3 Resu lts
Linear Regression - Psi (XY Rotation)
99
5.3 Resu lts
Linear Regression - Beta (ZY Rotation)
o  
o
D
Z
D .
30
15
0
-110 -100 -90 -80 -70
Angles (Degrees)
30
.o  
o
O
Z>
zCL
10
-10
-110 -100 -90 -80 -70
Angles (Degrees)
o  
o
zCL
40 INF
O 20
0
30
o  
o
D
D
zCL
10
-10
-110 -100 -90 -80 -70
Angles (Degrees)
-110 -100 -90 -80 -70
Angles (Degrees)
o  
o
D
D
zCL
APX 30 TOT
o  
o 15
D
Z
a. 0 R eg re ss io n  
9 5 %  C l 
9 5 %  PI
- 1 1 0  - 1 0 0
Angles (Degrees)
-110 -100 -90 -80 -70
Angles (Degrees)
1 0 0
P
M
U
D
(%
) 
P
M
U
D
(%
) 
P
M
U
D
(%
)
5.3 Resu lts
Linear Regression - X-Translation
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5.3 Resu lts
Linear Regression - Y-Translation
1 0 2
5.3 Results
Linear Regression - Z-Translation
Figure 5-4: Linear regression results showing the percentage intensity losses on the y-axis and indicating the 
95% confidence and prediction intervals.
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5.3.2 Results of the Cubic Regression
The next step was to perform cubic regression to see whether this leads to an improved 
statistical model over the linear regression to describe the data. This was again done on the 
five segments together with the total of the polar maps, as described in section 3.6 and 
repeated to complete it for all six variation studies. The outcome of the cubic regression 
analysis is summarised in the table 5.5 gives the model summaries, table 5.6 the ANOVA 
results and table 5.1 gives the polynomial coefficients. Figure 5.5 displays the plots of the 
dependent variable against the independent variables.
Table 5-5: Model summary for the cubic regression model
Phii • »*j * ' f '!?• # i '• 1 ■■
Model Summary 1
R
■ ■ ■ ■ ■ ■
■
Adjusted of the 
RSquare RSquare fetimate- — ..-t. —. -—- •. * -  • -  — --
ANT 0.886 0.784 0.783 2.360
LAT 0.816 0.666 0.664 2.127
INF 0.666 0.444 0.440 1.826
APX
TOT
ANT
LAT
INF
APX
TOT
ANT
LAT
INF
APX
Psi
Model Summary
Std. Error 
Adjusted of the
0.266 0.071 0.064
0.392 0.154 0.148
0.586 0.344 0.340
1.817
2.669
1.833
. r  ; RSquare RSquare
ANT 0.886 0.784 0.783
LAT 0.816 0.666 0.664
INF 0.666 0.444 0.440
SB3 0.266 0.071 0.064
APX 0.392 0.154 0.148
TOT 0.586 0.344 0.340
2.360
2.127
1.826
1.817
2.669
1.833
B eta
I
Model Summary
' m ■ « ■ ■ fc ^  ■ ■ ■ ■ ■ a ■ .  ■ m 1 ■ * —
9td. &ror
I Adjusted of the j
R RSquare RSquare Estimate
A \'m i
‘ w
x-tran sla tion  
Model Summary
/ . .A!
816
784
444
783
664
440
0.266 0.071 0.064
0.392 0.154
0.586 0.344
0.148
0.340
2.360
2.127
1.826
1.817
2.669
1.833
ANT
LAT
INF
y-translation S IS
APX
TOT
■
Model Summary
..... 9d .B ro r
Adjusted ! of the
R RSquare RSquare | Estimate
0.754
0.671
0.188
0.306
0.466
0.503
0.569
0.450
0.035
0094
0.217
0.253
0.566
0.447
0.029
0087
0.212
0.248
2.022
1.803
1.937
1.669
2.197
1.551
ANT
LAT
INF
APX
Std. Error
Adjusted of the 
RSquare RSquare Estimate
2.306
2.255
1.764
1.764 
2.621 
1.907
0.576 0.332 0.328
0.708 0.501 0.497
0.472 0.223 0.217
0.117 0.014 0.007
0.443 0.196 0.191
0.538 0.290 0.285
OUT"
R
z-translation
Model Summary
/ ,  , 11 194 1 ’ . ; .  . I C 1 1 I
Adjusted of the
R RSquare RSquare Estimate
0.712
0.799
0.479
0.172
0.469
0.516
0.508
0.638
0.230
0.030
0.220
0.266
504
635
0
0.023
0.215
0.261
2.127 
1.896 
1.777 
1 854 
2.556 
1.961
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Table 5-6: ANOVA results for the cubic regression model. The non-significant p-value is shown in red and 
therefore the significant p-values are those not marked in red.
Ph
Sim of
Square
• r,
LAT
Regession
ffesidual
Total
Regession
APX
TOT
Regression
Total
Recession
Residual
Total   
S ession
ffesidual
Total
9030 68 3 3010.23 540.31 < 0001
2484 79 446 5.57
1151547 449
4031.12 3 1343 71 297 05 < 0001
2017 50 446 4 52
6048 62 449
1187 74 3 395 91 118.70 < 0001
1487 56 446 334
2675 30 449
111.79 3 37 26 1128 < 0001
1472 99 446 3.30
158478 449
57826 3 192.75 27 06 < 0001
317716 446 7.12
3755 42 449
785 95 3 261.98 77.95 < 0001
1499 02 446 3.36
2284 97 449
•
Mean
Square
•  r .
 
fegesson
 
APX
TOT
Total
Ftegresaon
Ftesdual
Total
Regression
Residual
Total
9030 68 3 301023 540 31 < 0001
2484 79 446 5.57
1151547 449
4031.12 3 1343 71 297 05 < 0001
2017 50 446 4.52
6048 62 449
1187 74 3 395 91 11870
1487 56 446 3 34
  
2675 30 449
111.79 3 37 26 11 28  (Tffifl
147299 446 3.30
1584 78 449
57826 3 192 75 27 06 < 0001
317716 446 712
3755 42 449
785 95 3 261 98 77 95 < 0001
1499 02 446 3.36
2284 97 449
y-translation
t . r
R egession
APX
TOT
Recession
Total
Regession
Residual
Total
Recession
residual
Total
2407 31 3 80244 19618 < 0001
182426 446 409
4231.58 449
1187 83 3 395 94 121.82 000
1449 65 446 325
2637 49 449
61 07 3 20 36 5.43 (77jl
1673 15 446 3.75
1734 23 449
12816 3 42 72 1534 < 0001
1241.85 446 2 78
1370 01 449
597 49 3 199 16 41 27
2152 27 446 483
2749 76 449
362 69 3 120 90 50 28 < 0001
107235 446 2.40
1435 04 449
Regession 
ANT Residual
AFX
TOT
ANT
ANT
LAT
INF
APX
TOT
E g re s s io n
• : r .
Ftecreasion
Total
R egess ion
Residual
Total
Regression
Residual
Total
Regession
Residual
Total• **•- •• — » ^ . 
Regression
(Egression
Regression 
TOT Residual 
otal
Sum of
9030.68 
2484 79 
1151547
3
446
449
3010.23
5.57
540 31 < 0001
4031.12
3
1343 71 297 05 < 0001
201750 446 4.52
6048 62 449
1187.74 3 39591 118 70 < 0001
1487 56 446 3 34
267530 449
111.79 3 37 26 11 28 < 0001
1472 99 446 3.30
1584 78 449
578 26 3 192.75 27 06 < 0001
317716 446 712
375542 449
785 95 3 261.98 77.95 < 0001
1499 02 446 3.36
2284 97 449
ANOVA
SUm of
Squares df
INF
Total
Regression
Resdual
Total
Regression
1180 54 3 39351 73.97 < 0001
237268 446 5.32
3553 22 449
2273.39 3 757 80 14903 < 0001
2267 89 446 5.08
4541 28 449
397.10 3 132.37 42 55 < 0001
1387 52 446 3.11
1784 62 449
19 22 3 6.41 2.06 .105
138823 446 3.11
1407 45 449
748 55 3 249 52 36 33 < 0001
3063 12 446 6.87
3811.67 449
66121 3 22040 60 58 < 0001
1622 59 446 3.64
2283 80 449
z-translation
ANOVA '■ '•••■ .‘P j - • •
' rn.mm
Egression
Residual
Total
Regesson
Residual
Total
Regession
Residual
Total*— • m — — • - — # .
Regession
Total
Rege9sion
Residual
Total
Regession
Residual
Total
Sumof
Squares df
Mean
Square L  F
1 i
2080 63 3 693 54 153.23 < .0001
2018 60 446 4.53
4099 23 449
2823 00 3 941.00 261 86 < 0001
1602.70 446 3.59
4425 70 449
420 00 3 140 00 44 36 < 0001
1407 66 446 316
1827 66 449
46 80 3 15 60 4 54 004
1533 82 446 344
1580 62 449
82242 3 274 14 41 97 < 0001
2913 07 446 6.53
373549 449
62078 3 20693 53 83 < 0001
1714 41 446 384
2335 19 449
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Table 5-7: Coefficients for the cubic regression model. The non-significant p-value is shown in red and 
therefore the significant p-values are those not marked in red.
PSi
Coefficients
Unstandardized Standardized 
Coefficients Coefficients
b3
b2
b1
bo
b3
b2
b1
bo
b3
b2
bo
b3
b2
bo
b3
b2
b1
bo
b3
b2
b1
bo
B a d .  Bror Beta t P
-1 567 0 368 -2676 - 4.258 <  0001
-0 095 0016 -7928 -5861 <  0001
-0 001 i IXU.I -4 463 -5 976 <  0001 
.0714624 2 555 1 810
- 1.731 0 332 -4 080 - 5.221 <  0001
-0 093 0015 - 10.624 - 6.317 <  0001
-0 001 0000 - 5.857 -6 308 <  0001
8053 2.302 3499 001
- 0.817 0 285 -2 894 -2 868 004
-0038 0013 - 6.527 -3 006 .003
-0 001 0000 -4 353 -3631 <  0001
17 039 1.977 8621 <  0001
-1 426 0.283 -6 568 -5034 <  0001
-0 063 0.013 -14052 -5 005 <  0001
-0 001 0000 - 7,501 -4 839 <  0001
2961 1 967 1 505 .133
-3 064 0416 -9 165 -7 364 <  0001
-0 133 0018 -19411 -7247 <  0001
-0 002 0000 -10 681 -7222 <  0001
-24 155 2 889 -8 362 <  0001
- 1.351 0286 - 5.181 - 4.727 <  0001
-0 069 0013 -12892 -5 466 <  0001
-0 001 0 000 - 7.310 -5 613 <  0001
6 800 1 984 3427 001
bo
b3
b2
x-transiation
Coefficients
Unstandardized
Coefficients
B  a
Sandardized
Coefficients
0206 
-0 003 
0 000 
7.329
0.288 
-0 005 
0000 
16628
0064 
-0 002 
0 000 
24 649
- 0.045 
-0 001 
0 000 
12 739
0 172 
-0016 
-0 001 
-0 793
0.126 
-0 004 
0 000 
14 404
0 032 
0 002 
0 000 
0 164
0 031 
0 002 
0000 
0.160
0 024 
0 001 
0 000 
0 125
0 024 
0 001 
0 000 
0 125
0 036 
0 002 
0 000 
0 186
0 633 
0075 
0 067
0 782 
■0 102 
•0 090
0278 
•0 050 
0 201
-0221 
-0 048 
0 265
6 438 
- 1.932 
-0 684 
44 767
< 0001 
.054 
.494 
< 0001
9203 
-3 042 
-1 063 
103 889
< 0001 
002 
.289 
< 0001
2617 
-1 202 
1.895 
196 893
-1 852 
-1 010 
2219 
101 734
0 509 
-0 368 
0 324
0 026 
0 001 
0 000 
0 135
0 482 
- 0.131 
0 043
4 723 
-8 670 
-3 006 
-4 265
4 752 
-3 284 
0 427 
106 393
009
.230
.059
H I 1
0065 
0.313 
0027 
< 0001
• ••
< 0001 
<
003 
< 0001
< 0001 
001 
.669 
< 0001
1 0 6
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ANT
LAT
INF
TOT
b3 
b2 
b1 
bo 
b3 
b2 
b1 
bo 
b3 
b2 
b1 
bo 
b3 
b2 
b1
b3I
b2
b3
b2
b1
bo
y-transiation
Coefficients
Unstandardized Standardized 
Coefficients Coefficients
B Std. Error Beta
mu
m i
0.030
0.002
0.000
0.156
0.974 12.333 < .0001
-0.149 -4.788 < .0001
-0.263 -3.332 .001
55.911 < .0001
0.951 10.668 < .0001
-0.133 -3.781 < .0001
-0.334 -3.742 < .0001
122.302 < .0001
0.148 1.250 .212
-0.069 -1.482 .139
-0.300 -2.542 .011
169.967 < .0001
0.234 2.042 0.042
-0.290 -6.430 < .0001
-0.183 -1.595 o .m
  
105.274 < .0001
0.211 1.980 .048
-0.436 -10.410 < .0001
-0.051 -0 483 .629
-9.985 < .0001
0.731 7.028 < .0001
-0.193 -4.709 < .0001
-0.307 -2.955 .003
125.174 < .0001
TOT
b1
bo
b3
b2
b1
bo
z-translation
Coefficients
Unstandardized Standardized
Coefficients Goeffidents
B ad. Error Beta t p
0.234 0.029 0.671 7948 < .0001
-0.008 0.002 -0.168 -5.061 < .0001
0.000 0.000 0.023 0.275 .783
7.558 0.151 50.056 < .0001
0.262 0.026 0.722 9.971 < .0001
-0.006 0.001 -0.127 -4.462 < .0001
0.000 0.000 0.072 0.995 .320
16.419 0.135 122.033 < .0001
0.058 0.025 0.247 2.339 .020
-0.001 -0.036 -0.868 .3 8 6
0.000 0.000 0.241 2.283 .023
24.566 0.126 194.822 < .0001
-0.062 0.026 -0.286 -2.412 0.016
-0.003 0.001 -0.097 -2.090 0.037
0.001 0.000 0.349 2.946 0.003
12.977 0.132 98.591 < .0001
0.200 0.035 0.599 5.638 < .0001
-0.017 0.002 -0.400 -9.558 < .0001
-0.001 0.000 -0.481 -4.527 < .0001
-0.828 0.181 -4.566 < .0001
.1 1 3 .027 .430 4 .1 7 0 < .0001
-.0 0 3 001 -.0 9 6 - 2 .3 7 8 .018
.000 .000 .082 .799 .425
1 4 .3 2 5 .1 3 9 102 .944 < .0001
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Cubic Regression - Phi (XZ Rotation)
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5.3 Results
Cubic Regression - Psi (XY Rotation)
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5.3 Results
Cubic Regression - Beta (ZY Rotations)
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Cubic Regression - X-Translation
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5.3 Results
Cubic regression - Y-Translation
ANT
15
5
-5
-10 0 10
y-Translation (mm)
12
-10 0 10
y-Translation (mm)
APX
10
0
-10
-10 0 10
y-Translation (mm)
LAT
O 
O'Q 15
Z
CL
0
-10 0 10
y-Translation (mm)
SEP
p 
o
Q
Dza.
15
0
-10 0 10
y-Translation (mm)
TOT
O 
O
D
D
zQ.
15
0
Regression 
9 5 %  Cl 
95%  PI
-10 0 10
y-Translation (mm)
112
P
M
U
D
(%
) 
P
M
U
D
(%
) 
P
M
U
D
(%
)
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Cubic Regression - Z-Translation
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Figure 5-5: Cubic regression results showing the percentage intensity losses on the y-axis and indicating the 
95% confidence and prediction intervals.
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5.3.3 Comparison Between the Linear and Cubic Regression
To determine whether the cubic model would be an improved model over the linear model a 
comparison between the models were made by comparing the mean standard errors in table 
5.8 and comparing the R Square values in table 5.9. The comparison between the F and t 
values is displayed in table 5.10.
Table 5-8: Comparison of the mean standard error between the linear and cubic regressions. The non-
significant p-value is shown in red and therefore the significant p-values are those not marked in red.
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5 . 3  R e s u l t s
Table 5-9: C om parison o f m odels o f the linear regression aga inst tha t o f the cubic regressions. W hen the R 
Squares are com pared, the best (h ighest) va lues are shown in green
Phi
Comparing Models
Part Source R Square Square
Adjusted R the 
Square Estimate
2.215
0 798 
0816
0620
0666
0.120
0266
0.637
0.666
0.384
0.444
0.233
0.392
TOT
Line 
Oi
0.544
0-586
0.015
0071
0 054 
0.154
0.636
0664V/ .  V A A f
0.383
0.440
0.064
0.052
0.148
1867
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Table 5-10: F and t values and their significance
Statistics and their significance - Linear Recession
LAT INF APX TOT
Phi ■
t (slope)
Psi
F
t (slope)
Beta F
t (slope)
x-trans F
t (slope)
y-trans F
t (slope)
statistic ■ H statistic P statistic P
* '  ■
statistic P statistic P statistic P
35823 < 0001 215.81 < 0001 4542 < 0001 1.94 0.187
0.187
3.52 0.083 35.28 < 0001
1893 < 0001 1469 < 0001 -6.74 < 0001 1.39 -1.88 0.083 5.94 < 0001
166.4234 < 0001 479.8287 < 0001 140986 < 0001 55.16 < 0001 170.8328 209.43 < 0001
1290 < 0001 21.90 < 0001 11.87 < 0001 7.43 < 0001 13.07 < 0001 14.47
175.7442 < 0001 1180.491 < 0001 471.77 < 0001 602.1024 1023 935 711.3595 < 0001
-13.26 < 0001 -34.36 < 0001 -21.72 -24 54 < 0001 -32.00 < 0001 -26.67 < 0001
216.6435 < 0001 428.673 121.784 < oooil 0228 0.633 20.947 < 0001 167424 < 0001
14.72 20.70 < 0001 11.04 0. 0.48 4.58 < 0001 1294 < 0001
4122211 < 0001 4122211 < 0001 125.9891 < 0001 0 550054 0.452 11.29138 0.001 153.7272
20.30 < 0001 2709 < 0001 11 22 < 0001 0.74 0.459 3.36 0.001 12.40 < 0001
517 5236 < 0001 318455 < 0001 7.51074 0 .
i
1 95659 0.163
0.163
1229254 0.001 112.669
2275 < 0001 17.85 < 0001 -274 0 . 1.40 3.51 0.001 10.61 < 0001
•  ;
—  "  ■ ■ — ■ -  ■■ »
Statistics and 1:heir significance -  Cubic R
INF SB3
CoI
<  »■ «  ^ ■ • • •  — «
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ANT LAT APX
f .  1 . 
» TOT
statistic P statistic P statistic P statistic P statistic statistic P 1
Phi F 54031 < 0001 29705 < 0001 118.70 < 0001 11.28 27.06 77.95 < 0001
Psi F 60.82 < 0001 186.64 < 0001 55.26 < 0001 20.13 < 0001 56.83 < 0001 80.7
Beta F 75.11 <0001 590 17 < 0001 229 72 < 0001 245.69 485 8 < 0001 317.19
x-trans F 73.97 149.03 < 0001 4255 < 0001 2.06 0.105 36.33 < 0001 60.58 < 0001
y-trans F 196.18 < 0001 12182 0000 5.43 0.001 15.34 < 0001 41.27 < 0001 50.28 < 0001
z-trans F 153.23 < 0001 26186 < 0001 44.36 < 0001 4.54 0 004 41.97 53.83 < 0001
5.3.4 Final Outcome o f the Analysis
After deciding that the linear model is a valid model and sections 5.4.1 and 5.4.2 suggested
that this will be the most suitable model to use, the difference in the percentage intensity loss
to be expected as a result of a unit change in the independent value was calculated and are
displayed in table 5.11 and the minimum and maximum values in the percentage intensity
losses for the ranges used in the studies, are displayed in table 5.12.
Table 5-11: Percentage intensity losses at the reference orientation of the Visible Human and the percentage 
unit intensity losses when deviating from it when using the linear regression model
Percentage Count
ANT LAT INF
Beta
9.1
0.51
13.9
0.14
9.0
-0.11
16.5
0.34
x-trans
y-trans
z-trans
0.19
7.1
0.24
8.1
0.22
13.7
-0.28
16.5
0.26
15.7
0.29
23.5 13.8
-0.17 0.03
27.7 15.3
0.11 0.08
22.0 13.2
-0.16 -0.18
25.0 12.9
0.11 0.01
24.6 12.8
0.11 0.01
22.9 121
-0.03 0.01
SEP 81 APX m TOT
-1.7
-0.08
0.15
-3.5
-0.37
-
0.07
-1.3
0.05
- 1.2
0.05
13.3
-0.19
14.5
0.14
13.7
0.09
* Valuesfor the orientation of the 'Visible Human' 
%UCL- Percentage Unit Count Loss
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Table 5-12: The maximum intensity losses found for the variation ranges used in this study
M ini mum and Maximum values*
Phi
Rsi
Beta
x-t rans
y-trans
z-trans
bot
top
range
bot B
top
range
bot
top
range
bot
top
range
-111
-
ANT
10.5
7.2
3.3
9.3
4.3 
4.9
9.5
2.6 
6.9
2.6
7.4
LAT
9.6 
17.3
7.6
17.9
24.1
6.3
18.1
8.3
9.7
19.3
12.5
6.8
19.3
11.3 
8.0
17.0
12.2
4.8
INF
27.9
21.8
6.1
24.8
27.9 
3.0
13.6
15.7 
2.1
APX
Values for the range of angles used in this study.
0.2
-4.8
5.0
- 0.6
4.0
4.6
0.3
2.1
2.4
-3.2
-4.2
0.9
-4.5
-3.9
0.6
-3.9
-6.3
2.3
TOT
. 
14.3 
2.5
15. 
19.5 
4.1
16.6
10.1
13.
11.1
2.6
5.4 Discussion and Conclusion
5.4.1 Deciding Which Model to Use
For all six of the variation studies linear and cubic regressions have been done. These 
results are summarised in tables 5.2 to 5.4 for the linear regression analysis and tables 5.5 to 
5.7 for the cubic regression analysis providing the goodness of fit statistics. Figures 5.4 and 
5.5 contain the graphical presentation of these analysis including 95% prediction and 
confidence intervals as graphical presentations.
These graphical presentations together with the numerical results of tables 5.8 to 5.10 should 
be analysed to determine the appropriate statistical model to use in the six variation studies. 
Section 3.7.1 discussed the different techniques to be used in deciding the choice of an 
appropriate model and an important aspect of that discussion is the fact that the model 
should be simple and easy to interpret. The simplicity of the model will be improved if the 
same model, either linear or cubic, are used for all the segments in a specific variation study. 
Using the same model for all the segments of all six variation studies will maximise the 
simplicity but this can only be done if a single model is suitable for all of them. Taking these
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arguments into consideration a model can be used even if it is less appropriate than another 
model according to the results but the results also show that it is still a valid model.
5.4.2 Variation Studies
Both the graphical analysis and the numerical analysis confirm that both the linear and cubic 
regression models are valid statistical models for all the segments in all the variation except 
for those marked in red in table 5.10. For these segments the mean will be the most 
appropriate statistical model, indicating that the amount of intensity losses is not influenced 
by variations in the specific variation parameter.
Based on the graphical analysis and the numerical analysis in table 5.9 the cubic regression 
is the best presentation of most of the data but in all the cases, except those exceptions 
marked in red in table 5.10, the linear model is also a valid model. To make the outcome of 
the analysis as simple as possible to implement and for it to be useful the choice of the linear 
regression as a statistical model will be the most appropriate for the six variation studies.
By applying these models one can see that changes in most parameters will lead to a 
comparable change in non-uniformity. Changes in the phi angle have the biggest effect on 
the anterior wall but none on the septal and very little on the septum. Therefore there can be 
potentially substantial differences in the anterior segment between patients which may result 
in “defects” being reported in the final study. It is already known that this is an area affected 
mostly by breast attenuation in females (reflected in the changes in the body size) but this 
study shows the orientation of the heart can influence this phenomenon substantially. In 
addition the anterior wall is also one of the most visible parameters in the display on the final 
reconstructed images. Changes in other parameters also have an effect in most segments 
but it seems that none of the translation variations have much affect on the uniformity in the 
apex and septum. The z-translations also have little effect on changes in the inferior wall 
which is a very interesting observation. It is widely accepted that the inferior wall is affected 
substantially by the tissue underneath the diaphragm pushing upwards. The z-translation is 
the parameter influencing the relative position of these tissues the most. Table 5.11 gives the 
values of the Visible Human and the studies’ estimate of changes due to patient variability.
5.4.3 Summary
^ ______ ___ ______________________________________________ ___ _  _
Table 5.11 summarises the percentage intensity loss for each segment for the orientations 
and positions of the heart of the Visible Human as well as the percentage intensity loss to be 
expected for a unit change in the variation (1 degree or 1 mm), assuming a linear regression 
model. Although these unit changes can be used to predict the amount of intensity loss in a 
specific segment when a specific variation between a patient study and that of the Visible 
Human is known. The table at present will be of limited use because only one variation is
118
5.4 Discussion and Conclusion
modelled and the 5 other variations must be those of the Visible Human. For example, if the 
phi angle difference between the patient and the Visible Human is 10°, meaning the patient’s 
phi orientation is -30 , as opposed to -20° for the Visible Human, one can expect a 
percentage intensity loss of 4.1% (9.1% - 5%) for the patient in the anterior segment. This 
will only be a valid argument if the psi angle, beta angle, x-trans, y-trans and z-trans of the 
patient is the same as that of the Visible Human. The statistical models in this study do not 
make provision for situations where two or more of the orientation differs from the Visible 
Human but a number of parameters show only limited variation. Therefore it could be 
possible that changes in several parameters might result in a linear combination of the 
effects of each parameter change. The main benefit from this study is that it provides an 
insight into the level of variation one can expect in a specific segment when a specific 
parameter changes. These models also demonstrate the complexity of intensity losses 
caused in different segments of the left ventricle when analysing the intensity distribution in it 
and the absolute necessity of techniques to compensate for these permutations. Further 
study with the model used here would evaluate the effect of variation of groups of the 
parameters, but, as the study has demonstrated the need for correction techniques at this 
stage, the further study is of only academic value.
To emphasise this it will be worthwhile to remember what was mentioned earlier, changes of 
up to 57° have been reported between patients for the vertical orientation (phi), which, from 
this analysis, indicates a difference of up to 28.5% (0.51% difference in intensities for every 
1° change) in the percentage intensity loss in the anterior segment. This difference in 
intensity loss will exist even if the patients under comparisons are of the same gender, the 
same weight, height, chest size, etc., meaning exactly the same anatomy with the only 
difference the vertical orientation of the heart in the thorax. This means that two patients with 
exactly the same anatomy with the only difference between them the orientation of the heart, 
can present two completely different final image sets, one could potentially be classified as 
normal and the other as abnormal, if no corrections are applied.
Table 5.12 gives the range of intensity losses for the minimum and maximum values of the 
different values used in this study for the angles and translations. However, precise ranges of 
all of the anatomical variations in the general population are not known, except for the phi 
angle as mentioned previously. A best estimate for the other 5 parameters has been used 
but further work to establish the normal range in humans is required to confirm this, and 
therefore further refinement of the minimum and maximum values of intensity losses is 
worthwhile.
The previous chapter investigated the changes in the segments of the left ventricle because 
of differences between genders and studied which part of the thorax is mostly responsible for 
the loss of uniformities in the polar maps and it was clear that the heart itself is a very
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important factor in the loss on polar map uniformities, as was illustrated in section 4.3.5. In 
this chapter the changes in intensity losses because of different orientations and positions of 
the heart were investigated. Such intensity losses will manifest themselves as polar map 
uniformity losses. This again emphasises the complexity of intensity losses caused in the 
final reconstructed images of the left ventricle, without detailed knowledge of the anatomy of 
the individual patient. The range of the intensity losses in different individuals indicates that 
an individual, rather than a population average correction, is essential. Currently 
transmission based attenuation correction methods are commercially available as well as 
corrections for the other permutations leading to these intensity losses, i.e. partial volume, 
scatter, etc. but it was demonstrated in chapter 2 that they suffer from important drawbacks 
and lack universal acceptance. This chapter, together with the previous one, highlighted the 
range of intensity losses and their impact on the final reconstructed images of the left 
ventricle. Armed with this knowledge one can investigate the effectiveness of the mentioned 
commercially available systems. The next chapter will investigate how a specific 
commercially available system is actually performing in correcting for these intensity losses.
Chapter 6 - Determination of 
the Extent of Attenuation 
Correction in Patients by 
Using a Commercially 
Available Correction Solution
6.1 Introduction
As described in detail in chapter 2 the full clinical potential of Myocardial Perfusion Imaging 
(MPI) has not been realised because of numerous factors producing artefacts that degrade 
image quality and result in misinterpretation of the results198. Photon attenuation, scatter 
radiation, partial-volume errors, and other perturbations compromise the accuracy obtainable 
with MPI49.
The application of depth-dependent resolution recovery, attenuation correction using external 
source devices, and scatter correction has been developed for Nuclear Medicine Imaging in 
general, and it has been suggested that these techniques will also improve the specificity for 
MPI and an improvement in its specificity and substantial advances had been made in 
implementing these solutions.
Attenuation correction, and transmission based methods in particular, still lack wide spread 
implementation and some of the reasons for this lack of acceptance are that it seems to 
introduce additional artefacts, and add cost and complexity. The results of the studies in 
Chapters 3 to 5 illustrate the importance of attenuation correction and the risk of not 
implementing it. Although transmission based attenuation correction is viewed with a great 
deal of scepticism, it is currently commercially available on most gamma camera systems. It 
is often combined with correction methods for both depth-dependent collimator blurring and 
scatter. In this chapter a study to evaluate such a commercially available solution which uses 
transmission scanning, scatter correction and depth-dependent resolution recovery is 
described. The study attempted to determine the level of Improvement achieved with such a
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method compared to the total intensity losses estimated in the phantom studies in chapter 4 
despite the reservation about using transmission scanning131. This will be important because 
the implementation of these available systems could be used to substantially improve the 
outcome of MPI. However, this needs to be carefully evaluated, as such systems could 
introduce alternative artefacts. The closeness of the correction of this commercial system to 
the ideal will determine whether the system should be implemented despite its other
drawbacks, or whether the lengthy development of alternative emission-based methods is 
worthwhile.
The clinical attenuation compensation techniques currently available commercially 
i99.2oo.2oi,202,203^  use attenuation maps reconstructed from data obtained in transmission scans.
Siemens introduced a 3D OSEM reconstruction algorithm utilising Transmission Attenuation 
Correction, Scatter Compensation as well as 3D Resolution Recovery and 3D Collimator and 
Detector Response Correction202. Because Transmission based attenuation corrections are 
not universally accepted, it was decided to determine the improvement achieved by this 
specific implementation of a Transmission Based Attenuation correction technique together 
with a Resolution Recovery Implementation (TBAR) and to compare the intensity gains 
achieved by the commercial system to the losses predicted by the Monte Carlo simulations in 
Chapter 4.
The questions which this study will attempt to answer are:
1. What is the intensity gain in each of the 9 segment model when using TBAR?
2. What is the difference in the intensity gain between male and female patients?
3. How does the amount of intensity gain obtained by using TBAR in male and female 
patients compare to the losses predicted by the Monte Carlo simulations?
4. Is there a intensity reduction in the apical parts of the left ventricle in the attenuation 
correction images as compared to the non-attenuation images?
5. What is the total intensity gain experienced in the different segment of the final left 
ventricular images?
6. Did the basal parts of the left ventricle experience a bigger intensity gain than the 
apical regions?
7. Did the inferior wall experience the most gain and if so, is that true for both male and 
female patients?
8. Did the anterior wall in female patients experience a significant intensity gain?
9. How does the overall amount of intensities gained by using TBAR compare to the 
losses predicted by the Monte Carlo simulations?
This study will investigate these questions by studying the specific implementation using 
scanning line sources of Gd-153 with parallel-hole collimators which is available on the 
Siemens c.cam system known as c.clear and the images reconstructed with Flash 3D, the 
resolution recovery implementation discussed in paragraph 2.3.5. The effectiveness of this
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implementation was evaluated using the same analysis as described in chapters 4 and 5 
using Monte Carlo simulations, and compared to the results of those simulations.
6.2 Methods
6.2.1 Patient Selection and Analysis
The purpose of this study was to estimate the level of the effectiveness of the above 
mentioned commercial system in correcting for the intensity losses in MPI quantified in the 
previous analyses in this project. This was done by comparing intensity gains in patient 
studies against the intensity losses predicted by the Monte Carlo simulations in chapter 4. 
There were some limitations in the current study relating to the availability and interpretation 
of patient data. Only patients who were judged to have normal MPI scans by standard clinical 
reporting were included. The study also included patients x and y where the clinician had 
identified defects which he decided had no clinical relevance, and were artefacts of the 
imaging process. This analysis therefore represents a preliminary study which should be 
extended in future using more data and abnormal scans, where the confirmation of defects 
can be established as artefacts, or otherwise, in a research study which includes a “gold 
standard” test such as angiography.
Twenty-one male patients (mean age ±SD was 66.6 ± 8.3) and nineteen female patients 
(mean age ±SD was 59.4 ± 12.6) were analysed. These patients were imaged on a c-cam 
system in the incline position with the arms placed above their heads. The gamma camera 
system uses a dual head configuration with the two heads at a 90° angle. Data were 
acquired in a 128x128 matrix with a pixel size of 0.48 x 0.48 cm.
Simultaneous transmission/emission scanning was performed. Emission data was acquired 
with a 15% energy window centred at 140 keV. These patients had been referred for 
standard clinical studies with ethical approval that the resulting data could be used in this 
study. Further acquisition parameters were 2.813° per step, 90° each head and 15 seconds 
per projection starting at the LAO and ending in the RPO position. Transaxial images of 128 
x 128 pixels were reconstructed using 8 iterations with 4 subsets of OSEM which included 
resolution recovery. The Convolution Kernel used was: 3DOSEM, 8i, 4s\Btw, 0.40, 5, which 
indicates a 3D implementation of OSEM, 8 iterations with 4 subsets and the reconstruction 
filter was a Butterworth filter with order 5 and cut-off of 0.4.
The choice of the 20 % energy window for the Monte Carlo simulations was based upon the 
examples provided by the authors of the simulation package and was also the window used 
in the verification simulations, and subsequently all the Monte Carlo simulations. However,
modern gamma cameras now use a 15% energy window and the nature of the project was 
such that patient settings could not be altered.
6.2 Methods
From reangulated tomographic images, polar maps of regional myocardial tracer uptake 
were generated using the commercial package (4DMSPECT developed at the University of 
Michigan). From non-corrected and attenuation-corrected images, average tracer uptake was 
measured in 9 polar map segments (B-ANT: Basal anterior, A-ANT: Apical anterior, B-LAT: 
Basal lateral, A-LAT: Apical lateral, B-INF: Basal inferior, A-INF: Apical inferior, B-SEP: Basal 
septal, A-SEP: Apical septal, APX: Apical) and the percentage gain in each segment 
calculated.
6.2.2 Analysing the “Distortion” on the Left Ventricle
For both the male and female patients, the PMUD, PMUDI and the FI were calculated as 
described in chapter 5. These results were used to establish the effects on each of the 9 
polar map regions as described in chapter 5.
6.2.3 Comparing the Basal and Apical Portions for Both Genders
To investigate and quantify the “distortion” of the uniformity of the intensity distribution in the 
reconstructed left ventricle the PMUD for all the 9 segments was calculated and compared.
If the null hypothesis, that the whole thorax as attenuation medium does not correct for the 
position and intensity distribution in the patient, is true the PMUD of each segment will be 
equal to zero.
The experimental hypothesis was that effects such as attenuation, scatter and the partial 
volume effect do alter the position and intensity distribution in the final image, which lead to 
the original “distortion” existing in the final images, and that correcting for these effects leads 
to a significant difference between the means of the segments when they were compared 
and the values of the PMUD’s will not be equal to zero.
In this case the manipulations were done on the same patient images and therefore the 
dependent means t-test was used to test the null hypothesis and it was a two-tailed test. If 
found that the null hypothesis does not hold true, i.e. the experimental hypothesis is valid, the 
effect size was calculated and expressed as r-values to calculate the extent of “distortion” in 
the final images of the left ventricle.
6.2.4 Comparing the Results of the Male Patients Against Those of
the Female Patients
Using the PMUD and FI a comparison was done between the male and female studies to 
see which region are the most influenced by these permutations, described in chapter 2, for 
the two genders and how they differ, especially the inferior wall for both and the anterior wall
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for females. The difference between the basal and apical regions was also determined. The 
amount of intensity gained was also compared by using the FI.
6.2.5 Comparing the Results of the Patients Against Those
Predicted by the Monte Carlo Simulations
The means of the PMUD and FI for the male and female patients were compared against the 
PMUD and FI of the Monte Carlo simulated male and female patients by using the 
independent samples t-test. A comparison has also been made between the MFI’s, i.e. the 
mean of the values of the 9 segments, to establish the intensities gained by implementing 
TBAR.
6.3 Results
6.3.1 Tests to Ensure that a Parametric Model Will be Valid for the
Attenuation Corrected Patient Studies on the Commercial 
System
Box-plot methods and z-scores assured the integrity of the data. Levene’s tests confirmed 
the homogeneity of variance (homoscedasticity) and inspection also confirmed that they 
adhere to the principles of independence and interval data. Using the z-scores for skewness 
and kurtosis, as well as the Shapiro-Wilk test confirmed the normal distribution of the data.
6.3.2 The “Distortion” in the Left Ventricle in the Attenuation
Corrected Patient Studies
Figure 6.1 illustrates the PMUD values obtained for the 9 segment model for both the male 
and female patients when using transmission attenuation correction and table 6.1 displays 
the mean and 95% confidence intervals for these PMUDs.
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Figure 6-1. PMUD of the 9 segments of male and female patients as a result of transmission attenuation 
corrections using Gd-153 line sources.
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Table 6-1: Summary of the means of the PMUD values for both male and female patients as well as the 
PMUDI
The Mean and 95% Q  for M eans of the PM UD
B-ANT A-AN T B-LAT A-LAT B-INF A-INF B-SE3 A-SEP APX PMUDI
7.9 1.9 20 -1.6 16.3 145 3.0 00 -0.5
Male Lower Bound 56 -Q5 -20 -50 125 125 0.1 -3.3 -46
Upper Bound 1Q2 4.2 60 1.8 202 16.6 5.9 3.3 3.6
Mean 52 48 29 -25 125 6.3 2.9 1.5 -22 3.5
Female Lower Bound 1.9 1.8 -1.2 -4.1 9.5 40 0.4 -05 -5.0
Upper Bound 8.6 77 71 -08 15.5 8.6 5.5 3.6 o.d
6.3.3 Comparing the Basal Against the Apical Regions of the
Attenuation Corrected Patient Studies
The comparison between the PMUD values for the basal and apical parts of the left ventricle 
is displayed in figure 6.2 below, for both genders and the results of the dependent t-test 
summarised in table 6.2. The calculated r-values are represented in table 6.3.
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Figure 6-2: The PMUD’s when comparing the difference between the basal and apical regions of the anterior, 
lateral, inferior and septal walls in the male and female patients.
Table 6-2: Comparing the PMUD’s between the apical and basal parts
Male
Paired Sam ples Test - PM UD - Comparing Basal vs Apical
Paired Differenoes
95% Confide nee Interval of 
3 d . a d . Error the PMUD
PMUD Deviation PMUD Lower Upper t
Female
A A N T - B A N T  
AJLAT- BLAT  
A JN F- BJNF 
A_se>- BSEP 
APX- B A N T  
APX- BLAT 
APX- BJNF 
APX- B_SBP 
A A N T - B A N T  
A LAT- B LAT 
A JN F- BJNF 
A_SB3 - B_SB3 
APX- BANT  
APX- BLAT 
APX- BJNF 
APX- B SEP
04 
-3.61 
-1.79 
-2.98 
-8.40 
-2.47 
-16.81 
-3.47 
-0.46 
-5.43 
-6.15 
-1.41 
-7.40 
-5.14 
-14.67 
-5.14
4.63 
5.69 
8.07 
5.55 
10.78 
14.36 
14.02 
10.66 
4.88 
7.35 
7.02 
5.66 
10.19 
12.64 
9 64 
9.01
1.01
1.24
1.76
1.21
2.35
3.13
3.06
2.33 
1.12 
1.69 
1.61 
1.30
2.34 
2.90 
2.21
2.07
-8.15
- 6.20
-5.46
-5.50
-13.31
-9.00
-23.19
-8.32
-2.81
-8.97|
-9.54
-4.14
-12.31
-11.231
-19.32
-9.48
-3.93 
- 1.02 
1 88 
-0.45 
-3.49 
4.07 
-10.43 
1.39 
1.89 
-1.89 
-2.77 
1.32 
-2.49 
0.96 
- 10.02 
-0.80
-5.98
-2.91
- 1.02
-2.46
-3.57
-0.79
-5.50
-1.49
-0.41
-3.22
-382
-1.09
-3.17
-1.77
-6.63
-2.49
df
20
20
20
20
20
20
20
20
18
18
18
18
18
18
18
18
P(2-
tailed)
.000
.009
.322
.023
.002
.440
.000
.152
.687
.005
.001
.292
.005
093
.000
023
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Table 6-3: The r-values when comparing the PMUD's between the apical and basal parts
Male ■:u v.M 'l •
A_ANT-
B_ANT
AJA*
B1A1
-5.98
20
i
“ 4
. 4
Female  
0.80
IF- A_SB3- ,
IF BSBP I• i 7 4
0.48 17
6.3.4 Under Estimation of the Basal Regions and Over Estimation
of the Apical Regions of the Left Ventricle of the Attenuation 
Corrected Images on the Commercial System
To establish whether the intensity values in the basal parts of the left ventricle are 
underestimated and those in the apical regions been overestimated by the commercial 
system, the PMUD values displayed in figure 6.1 were used and the PMUDI added to the 
graphs so that a conclusion can be made. These results for the two genders are displayed in 
figure 6.3 and summarised in table 6.4.
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Figure 6-3: Showing the PMUDI values to determine the amount of under estimation in the basal regions.
Table 6-4: PMUD and PMUDI values to determine the amount of under estimation in the basal regions and 
over estimation in the apical regions
L---- -—  - . __ PMUD and PMUDI Values
B-ANT A-ANT B-LAT A-LAT B-INF A -IN F B-SB5 A-SEP APX l| PMUDI
M ale | 7.9 1.9 2 0  -1.6 16.3 14.5 3.0 -o .a 4.8
Female | 5.2 4.7 2 9  -2 5  125  6.3 3 0 1.5 -2 2| 3.5
6.3.5 Fraction Intensity Losses in the Final Ventricular Images of
the Attenuation Corrected Patient Studies on the Commercial 
System
To establish the amount of intensity gain as a result of the corrections done the fractional 
indexes were calculated for both the male and female patients and are displayed in figure 
6.4. These results will be used in section 6.3 to determine how these corrections compared 
to the amount of losses predicted by the Monte Carlo simulations.
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6.3.6 Comparing Attenuation Corrected Male Against Female
Patients on the Commercial System
To assess how the commercial correction method’s results differ between male and female 
patients a comparison was made between the PMUDs of the 9 segments for both the male 
and female patients. These results are displayed in figure 6.5 and summarised in table 6.5. 
The differences between the fractional images will also be used for this analysis and 
displayed in figure 6.6 and summarised in table 6.6. To determine how the effects of the 
corrections differ in the corrections obtained for the basal and apical parts the PMUD values 
for the 2 genders calculated are displayed in figure 6.7.
Table 6-5: Comparing the uniformity gains (PMUD) between the two genders in the 9 segments
Independent Samples Test - Comparing PMUD - Male vs Female
t-test for Equality of Means
V ,  '  | M \  I
df
R e -
I
Mean Sd. Bror
95%Confidence Interval of 
the Difference
t . j v .  .
- - - - - - - - - - - - - - - - - - - - - - - - - - -  - - - - - - - - - J
tailed) Difference j Difference Lower Upper
B_ANT 33 .173 2.70 1.94 -1.25 6.65
AANT p i  1 35 .116 -2.88 1.79 -6.51 0.75
BLAT I B ^ I 38 .726 -0.97 2.75 -6.53 4.59
A_LAT l ^ ^ g j t l 29 .642 0.85 1.81 -2.85 4.55J 37 .108 3.84 2.33 -0.88 8.57
37 .000 8.21 1.47 5.22 11.19
B__SEP 38 .988 0.03 1.86 -3.75 3.80
A_SB3 W M i i 33 .411 -1.54 1.85 -5.29 2.22
0  o. 7i| 35 .480 1.70 2.38 -3.13 6.53
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Figure 6-5: Comparison of percentage intensity gain in the 9 segments between male and female patients as a 
result of transmission attenuation corrections using Gd-153 line sources (in each graph the y-axis represents the 
% intensities gained from the attenuation correction).
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Figure 6-6: Comparing the FI’s of the male population to the female population.
Table 6-6: Comparing the FI’s of the male population to the female population
Independent Samples Test - Comparing R - M ale vs Female
t-te s t fo r Equality o f M eans
t d f p (2-ta iled )
M ean !; 9td. Error
95% Confidence Interval o f the
Difference
Difference D ifference Lower U pper
B A N T 36 .781 0.06 0.20 -0.35 0 4 7
A_ANT | K r c | | 33 .535 -0.13 0.21 -0.56 0.29
B L A T  H H Q I 34 .669 -0.08 0.19 -0.46 0.30
A L A T  « K @ p 38 .896 0.03 0.20 -0.38 0.43
i f i 35 .140 0.30 0.20 -0.10 0.70
A JN F 38 .068 0.42 0.22 -0.03 087
-0 43 34 .667 -0.08 0.18 -0.44 0.28
-0.40 38 .688 -0.08 0.20 -0.48 0.32
E 3 H  0.26 36 .796 0.06 0.24 -0.42 0.54
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PMUD Patients vs MC- Females
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Figure 6-7: Comparing the PMUD’s when comparing the difference obtained after attenuation correction for the 
basal and apical regions of the male population against that of the female population.
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6.3.7 Comparing the Results of the Attenuation Corrected Patients
on the Commercial System Against Those Predicted by the 
Monte Carlo Simulations
Similar to the comparisons made and displayed in the previous paragraph by comparing the 
results of the 2 genders, each gender was compared to the Monte Carlo simulations. The 
result of comparing the PMUD values are displayed in figure 6.8 and summarised in table 6.7 
for the male patients and table 6.8 for the female patients. The results of comparing the 
fractional indexes are displayed in figure 6.9 and summarised in table 6.9. Lastly the means 
of the fractional indexes (as described in section 4.2.2) were compared and the result 
summarised in tables 6.10 and 6.1.
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Figure 6-8 a:A comparison between the uniformities gained by using TBAR to the uniformity losses predicted by 
the Monte Carlo simulations -  Male patients.
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PMUD Patients vs MC- Females
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Figure 6-9 b: A comparison between the uniformities gained by using TBAR to the uniformity losses predicted
by the Monte Carlo simulations -  Female patients.
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Table 6-7: The mean and 95% confidence intervals for the percentage intensity gain in the 9 segments for the 
male patients
I independent Samples Test - Comparing PM UD - Female vs M C
! .',. t-test for Equality of Means
95% Confidence Interval of the 
p(2- Mean ad. Bror Difference
t df tailed) Dfference Difference Lower Upper
B_ANT 10.59 47 .000 14.35 1.35 11.62 17.07
A_ANT 4.72 47 .000 5.69 1.20 3.26 8.11
B_LAT 10.57 47 .000 17.42 1.65 14.11 20.74
AJAT 7.91 47 .000 6.22 0.79 4.64 7.81
BJNF 2.90 47 .006 3.57 1.23 1.09 6.04
AJNF -7.61 47 .000 -7.44 0.98 -9.41 -5.47
B\_S B > 14.56 47 .000 16.03 1.10 13.82 18.24
A_SE P -1.56 47 .124 -1.25 0.80 -2.87 0.36
APX -6.15 47 .000 -7.60 1.24 -10.09 -5.12
Table 6-8: 2-tailed paired t-tests to compare the means of the attenuation gain in each of the 9 segments 
against each other in the male population
Independent Samples Test - Comparing PMUD - Male vsM C
t-test for Equality of Means
95% Confidence Interval of the 
p(2- Mean ad.Bror Difference
t df tailed) Difference Difference Lower Upper
B_ANT 2.05 49 .046 2.39 1.16 0.05 4.73
A_ANT -2.91 49 .005 -3.50 1.20 -5.92 -1.09
B_LAT 9.25 49 .000 15.71 1.70 12.30 19.12
A_LAT 3.47 49 .001 4.98 1.44 2.09 7.87
BJNF 3.67 49 .001 5.89 1.60 2.67 9.11
AJNF -5.38 49 .000 -5.47 1.02 -7.51 -3.43
BjSEP 10.01 49 .000 13.07 1.31 10.44 15.69
A_SBP 0.05 49 .961 0.06 1.30 -2.55 2.68
AFX -3.82 49 .000 -6.50 1.70 -9.92 -3.08
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FI Female vs MC
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Figure 6-10: A comparison between the intensity gained by using TBAR to the intensity losses predicted by the 
Monte Carlo simulations.
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Table 6-9: A comparison between the intensity gained by using TBAR to the intensity losses predicted by the 
Monte Carlo simulations
Independent Samples Test - Comparing R - Male vsM C
t-test for Equality of Means
R e-
tailed)
Mean
Difference
Std. Error 
Difference
95% Confidence Interval of the
Difference 
Lower Upper
B_ANT
A_ANT
E3LAT
AJAT
BJNF
A INF
APX
-1.78
-3.17
2.50
-1.24
-1.15
-4.17
2.16
-2.41
-3.63
49
49
49
49
49
49
49
49
49
.082
.003
.016
.220
.254
.000
.036
.020
.001
.26 
.48 
0.34 
-0.18 
-0.17 
-0.69 
0.30 
-0.33 
-0.59
5 
5 
0.14 
0.15 
0.15 
0.16 
0.14 
0.14 
0.16
.55 
.79 
0.07 
-0.48 
-0.47 
-1.02 
0.02 
-0.61 
-0.92
0.03
-0.18
0.61
0.11
0.13
-0.36
0.57
-0.06
-0.26
Independent Samples Test -Comparing R - Female vsM C
t-test for Equality of M eans
; 1 . .  * - ~ 0  . V . ; . .  j . 95% Confidence Interval of the
J  r |  1 * '  9J  1 • • ; P(2- Mean Std. Bror Difference
i df tailed) Difference Difference Lower Upper
B_ANT
A_ANT
B_LAT
AJLAT
BJNF
A INF
APX
2.62
-4.54
1.62
-4.53
-1.67
-7.69
6.07
-8.58
-5.13
47
47
47
47
47
47
47
.000
.102
.000
.000
.000
.000
.28 
.43 
0.15 
0.34 
0.17 
0.74 
0.58 
0.79 
0.59
0.09
0.09
0.07
0.10
0.10
0.10
0.09
0.12
.06 
.62 
-0.04 
-0.49 
-0.37 
-0.94 
0.39 
-0.98 
-0.83
.49 
.24 
0.34 
-0.19 
0.03 
-0.55 
0.77 
-0.61 
-0.36
Table 6-10: Summary of the MFI values of the patients and the Monte Carlo simulations
TBAR
Male
Female
3.5 3.8
3.5 3.7
Table 6-11: Comparing the MFI between the genders and the Monte Carlo simulations
Independent Samples Test - MR Between Patients and MC
t-test for Equality of Means
MR_M 
MR_F 
MR 
MR
1.60
273
1.35
0.28
49
47
56
32
Mean
Difference
0.22
0.23
0.06
0.05
Std. Bror 
Difference
i
.14
.08 
0 04 
0.19
95% Confidence Interval of the
Difference
Lower Upper
.50
.40
.03
.33
0.15
0.43
142
6.4 Discussion and Conclusion
6.4 Discussion and Conclusion
6.4.1 Attenuation Correction in Attenuation Corrected Male
Patients on the Commercial System
For the male patients using the commercial system the most significant attenuation gains 
were in the basal-anterior, basal-inferior and the apical-inferior regions. Of these, the most 
significant segment was the basal-inferior, the difference of the mean of this attenuation in 
this segment is significantly greater than that obtained in other segments as indicated in table 
6.3. This is in line with other published results182.
The mean of the attenuation gain in many of the apical segments is very small and in some 
segments even negative (apical and apical-lateral and in the apical-septal segment it is 
0.5%). The results for the average of the patients has a range that encompasses 0, but 
some individual patients (for the 21 male patients, 11 in the apex and 9 in the apical-septal 
and apical-anterior and 8 in the apical-lateral segments were negative) clearly have a 
negative value but none of them experienced a negative attenuation gain in the basal-inferior 
region.
6.4.2 Attenuation Correction in Female Patients on the Commercial
System
For the female patients the mean of the basal-inferior wall attenuation correction is 
substantially higher for the basal-anterior and the apical-anterior sections as well as the 
apical-anterior wall attenuation compensation, making this segment the one to benefit the 
most from the attenuation correction and it illustrates the benefits of applying transmission 
based attenuation correction, scatter correction and resolution recovery.
The mean of the attenuation gain in some of the apical segments is also very small and in 
some segments also even negative (apical and apical-lateral). In all these segments the 95% 
intervals do include 0 and therefore one cannot conclude that the gain in these segments will 
also be negative but in a substantial number of the patients it is actually negative (for the 19 
female patients, 9 in the apex and 11 in the apical-lateral segments were negative). Again 
none of them experienced a negative attenuation gain in the basal-inferior region.
6.4.3 Comparing the Correction in Male to That in Female Patients
on the Commercial System
In both the male and female patients studies the segment which gained the most by the 
attenuation correction was the basal-inferior region. From table 6.5 it can be concluded that 
the means of the basal-inferior and apical-inferior regions differ substantially between the
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male and female patients but in the remainder of the segments there are no significant 
differences between the means of the two genders.
The conclusion is that both genders experienced the most attenuation gain in the basal- 
inferior region which is greater in the male population than the female population and this 
difference can be most likely be attributed to anatomical differences. In the remainder of the 
regions the two genders experienced the same amount of gain (or loss), even in the two 
anterior regions. This again illustrates the benefits of these correction techniques.
6.4.4 Comparing the Attenuation Correction Obtained in Patients
on the Commercial System Against the Attenuation Losses 
Predicted by the Monte Carlo Simulations
A. Significant Inferior Wall Attenuation
The most prominent attenuation correction is in the basal-inferior region for both males and 
females (a mean of 22.1 for males and 16.7 for females as a percentage). The second most 
significant correction in males is the apical-inferior wall. For the female patients the second 
most significant is both the apical-inferior and basal-anterior regions. These results are in line 
with the predictions from the Monte Carlo Simulations made in chapter 4 that the inferior wall 
is the most significant affected by attenuation and that the second most significant regions is 
the anterior regions in females.
B. The Effect of the Heart Itself as Attenuation Medium
The Monte Carlo simulations in chapter 4 predict that the heart is a very important contributor 
to the attenuation experienced in the inferior wall. The female heart is generally smaller204 
than that of males and this could be the reason for the difference in the female patients in the 
inferior regions being lower than in males.
C. Under Estimation of the Basal Regions of the Left Ventricle
As shown in Chapter 4 these regions are subject to the greatest intensity losses in the 
uncorrected images. It is appropriate, therefore, that the TBAR system makes the greatest 
corrections here and as illustrated by the FI values figure 6.9 (values of 3.6 for the male 
patients and 4.0 for the TBAR method in the B-LAT segment, etc.) the TBAR method makes 
a complete correction for the intensity losses experience by the simulated scans.
D. The Overestimation and “Correction” of the Apical Region
Monte Carlo simulations made in chapter 4 predict that non-attenuated Myocardial Perfusion 
images experienced an overestimation of the intensity in the apical regions and this 
observation was also reported in the literature182 where the uncorrected intensities were 
compared against those determined in a PET study which served as the reference.
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In the patient studies many of the patients experience a negative gain in many of the apical 
regions when attenuation correction was applied to these regions. This is a well-known fact 
and the subject of many studies205,206 207 and is often described as “an apparent apical defect 
caused by attenuation correction”. Traditionally, it has been assumed that attenuation 
correction will always either keep the observed intensity in a region constant or increase the 
observed intensity. Hence, the reduction of the intensity in the apical region when such 
corrections were made was assumed to be an error of the method, introducing an artefact. 
As a result of the simulations in chapter 4 it is clear that the reduction in observed intensity is 
due to the loss of intensity as a result of the partial-volume effect, non-uniform attenuation, 
depth-dependent detector response, scatter and statistical noise as described in chapter 4 
and therefore the reduction in intensities is appropriate and has a valid cause. This is not well 
known and the general acceptance of this can be difficult to achieve, but this is the third 
study where this has been established. However it is the first study to demonstrate that the 
amount of intensities over estimated by the non-corrected images is equal to the intensity 
reduction achieved by the correction method.
E. The Intensities Gained by Implementation of TBAR
As shown in chapter 2 the intensity losses in the uncorrected image can be as high as 90% 
and this will result in substantial intensity losses in the final images displayed. The Mean 
Fractional Index (MFI), defined in section 4.2.2., is a measurement of the intensities gained 
when using a correction method or the intensity losses as a result of the shortcoming of 
imaging methodology. The MFI’s has been calculated for both the male and female 
simulated patients in chapter 4 and this provide a quantitative measurement for the intensity 
losses as a result of the simulated Myocardial Perfusion Scans. These values are displayed 
in table 6.10 together with the values calculated for the patient studies using the TBAR 
method illustrating that this method restores all the intensity losses experience by the 
simulated scans. These findings illustrates that the commercial system with transmission 
based attenuation correction, together with scatter and attenuation correction, corrects for all 
the intensity losses experienced.
F. Summary
The Monte Carlo simulations used in this study are the gold standard against which the 
TBAR method has been evaluated. These simulations provide the values in the areas where 
intensity losses would be anticipated in patient studies. The patient studies experienced most 
of the predictions from the Monte Carlo simulations, one of the most obvious ones is the fact 
that the inferior wall experiences the most attenuation during a patient acquisition and also 
that the inferior wall’s attenuation in females is often more severe than that of the anterior 
wall. The patient studies also confirm that the basal parts of the left ventricle experience
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more attenuation which leads to a smaller left ventricular cavity observed. It seems that 
attenuation correction corrects for the over estimation of the apical parts, meaning that not 
only an increase in areas where losses are experienced, but also a decrease in areas where 
there are an over estimation. These results illustrate the importance of attenuation correction 
and that it is hugely beneficial and should be used routinely in clinical studies. The results of 
this study also suggest that by implementing attenuation correction in combination with 
resolution recovery and scatter correction leads to substantial improvements in the intensity 
losses experienced with Myocardial Perfusion Scans, bringing us much closer to the original 
goal of absolute quantification. Unfortunately there are still drawbacks as a result of the use 
of hardware such as line sources or an added CT scanner which has the disadvantage of 
added, patient dose, scan time and cost. Therefore, the approach used in the TBAR method 
provides a substantial advance to correct for all the permutations in MPI (attenuation, scatter 
and depth dependent resolution problems). Unfortunately the technique still has the 
substantial disadvantages of additional patient dose, additional scanning time and increased 
cost, added to that of the resistance to the general acceptance of transmission attenuation 
correction.
The results of this chapter seem to verify that a substantial advance has been made with the 
introduction of the commercially available solutions, even with the use of transmission 
scanning. The introduction of an acceptable emission based attenuation correction, whicn 
can be combined with the correction for the collimator depth-dependent blurring and 
correction for scatter, will be another substantial step, especially if it can break down the 
resistance of using attenuation correction on a routine basis. The next chapter discusses the 
introduction of two such emission based attenuation correction techniques which were also 
discussed in paragraph 2.4.5.
It is also recommended that this study be extended to overcome the limitations of the patient 
selection discussed in paragraph 6.2.1. Although this can lead to a slightly different outcome 
of the results obtained here, one can expected it not to differ enough to alter most of the 
conclusion that has been made in this chapter.
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Chapter 7 - The Proposed 
Methods of Inferred & Derived
Anatomy for Attenuation 
Correction in the Thorax
7.1 Introduction
The need for an accurate attenuation correction technique has been established in the 
previous studies in chapters 4 and 5 but chapter 2 confirmed the problems and lack of 
universal acceptance of current methods that rely on transmission based correction. Chapter 
6 investigated a commercially available method for correcting for attenuation, scatter and 
depth-dependent collimator blurring by using transmission based correction and therefore 
also demonstrated the advantages of using these correction techniques. In this study it was 
established that the commercially available TBAR method corrects for all the intensity losses 
experienced by the simulated patient studies and that it also corrected the distortion 
experience by the LV, i.e. under estimation of the basal areas and over estimation of the 
apical areas. The advantages of this method are clear but it still suffers some serious 
shortcomings, as discussed, and also lack universal acceptance, therefore this study will 
introduce two new emission based correction techniques which could be suitable for 
accurate individual attenuation correction without the drawbacks it poses, i.e. additional 
radiation dose, increased cost and time, of transmission based methods.
As suggested in chapter 2 although the thorax is far less homogeneous than the brain it may 
be feasible to extend the method of inferred anatomy to provide non-uniform attenuation 
correction in the thorax to make emission based attenuation correction a reality.
To achieve this image registration must be used to devise the patient specific attenuation 
map. This involves the creation of a source and target object. The target object, relating to 
the patient, contains the size, shape and orientation required and the source object must be 
changed to conform to that of the target image.
The source object in this instance is an attenuation map created from the NCAT phantom. 
Figure 7.1(a) shows a typical slice created from the NCAT phantom with the different
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attenuation coefficients, but it is not suited to be registered to the image data as it shows all 
the structures seen in a CT image which are not seen in an MPI image. The critical feature of 
the source object is the image of the left ventricle, which can be extracted from the structural 
source object, along with the body outline, to give a “functional” source object. Therefore a 
functional image of the NCAT phantom needs to be created, i.e. the creation of an activity 
object by simulating the injection of a radioactive tracer into the attenuation object. This is an 
image set with a uniform background value and a higher uniform activity in the left ventricle, 
Figure 7.1(b) shows the same slice as in Figure 7.1(a) with only this activity instead of 
attenuation coefficients. The target object is the activity object created out of the patient data 
from the MPI image consisting of a uniform body outline and the left ventricle as shown in 
Figure 7.1(c).
(a) (b) (c)
Figure 7-1: A typical slice from the attenuation object created out of the NCAT phantom (a), the functional 
image of this slice (b) and a slice from the target object created from the patient data (c).
The source object is a pre-defined set of images which can be used in every patient study. 
These were originally created from the NCAT phantom. The target image must be created 
from the patient data in each individual study. The body outline and left ventricle needs to be 
determined for the specific patient and both are then given a constant activity value to create 
the functional images which will serve as the target images. The creation of the objects 
shown above will be discussed in more detail in section 7.2 and 7.3.
In a normal image registration process two sets of objects are used, the source object and
the target object. In this study three sets of objects are used. The first is the functional target
object, a typical slice as shown in Figure 7.1(c), that will be created out of the patient data.
The rest are two source objects, i.e. the attenuation source object (Figure 7.1(a) shows a
typical slice) and functional source object (Figure 7.1(b) shows again a typical slice), both
created from the NCAT phantom. A corrected version of the attenuation source object, which
matches both the patient’s outline and their heart shape, Figure 7.1(a), is the desired
outcome, but the functional source object, Figure 7.1(b) will be used to determine the
registration parameters that describe the difference between the attenuation source object
and the patient data. The registration parameters will be determined from the corrected
“functional” source object and then used to alter the attenuation source object to produce the 
desired outcome.
7.2 Creation of the Source Object
7.2 Creation of the Source Object
The source objects are pre-defined sets of attenuation maps and “functional” images created 
from the NCAT phantom as displayed in figure 7.2.
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Figure 7-2: The provided NCAT attenuation map (a) and functional map (b) which need to be modified to 
adhere to the spatial representation of the patient under investigation.
These data sets consist of a fixed number of slices that must be reduced (or increased) to 
coincide with the same number of slices in the patient study that will be used in the final 
reconstruction. Therefore the number of relevant slices in the patient data needs to be 
determined as described below in “Determination of the patient data slices”. The x and y 
dimensions of the source objects and the target object will match but the z dimension, that 
represents the number of slices, must be changed in the attenuation source object and the 
functional source object by the use of polynomial warping to add or subtract slices. This 
provides the final attenuation source object and functional source object.
7.3 Creation of the Target Object
A well-defined outline of the body is necessary for the registration of the source object to the 
target object and the steps outlined below are applied to every slice in the patient data set. 
This technique is known as segmentation which refers to the process of partitioning a digital 
image into multiple segments (sets of pixels). The goal of segmentation is to simplify and/or 
change the representation of an image into something that is more meaningful and easier to
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analyse . Image segmentation is typically used to locate objects and boundaries (lines, 
curves, etc.) in images. More precisely, image segmentation is the process of assigning a
label to every pixel in an image such that pixels with the same label share certain visual 
characteristics.
The target object consists of the body outline and the segmentation of the left ventricle 
derived from the acquired patient data.
To obtain the body and the left ventricle outlines, an initial reconstruction of the patient data 
must be done. To minimize the background data (see Figure 7.3), an iterative reconstruction 
using the Maximum Likelihood Expectation Maximisation reconstruction algorithm209 is used 
instead of filtered backprojection (fbp). This provides the input data for the segmentation 
steps described below.
0
(b)
Figure 7-3: The same patient data set reconstructed by using filtered backprojection (fbp) (a) and the Maximum 
Likelihood Expectation Maximisation (MLEM) reconstruction method (b) showing the reduced background 
produced by the iterative reconstruction method in (b).
7.3.1 Segmentation of the Body Outline
Segmentation of the body outline is achieved by first using clustering, followed by 
thresholding, erosion and the application of an automatic masking algorithm. This method 
has been presented at a scientific meeting by the author210,211, having been developed in the 
early stages of this project, and the software necessary to implement it has been developed 
by the author by using the Interactive Data Language (IDL)212 and the algorithm will be 
described below.
Binary images of the original images are created with the use of clustering so that the body 
outline could be established. Clustering213,214 is the classification of objects into different 
groups, or more precisely, the partitioning of a data set into subsets (clusters), so that the 
data in each subset (ideally) shares some common trait. These results are shown as a single 
slice in Figure 7.4(a). These images contain a substantial amount of background noise that 
lead to a poorly defined outline of the body.
Thresholding213 (also called masking) is used to isolate features within an image, which are 
above, below, or equal to a specified pixel value. The value (known as the threshold level) 
determines how masking occurs. By experimentally choosing an appropriate threshold level,
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setting all the image values below this threshold to zero and creating another binary image, 
the amount of background can be substantially reduced from the original image, leaving the 
body outline with still some background clusters. Using an empirically determined threshold 
value will achieve this. Although this leads to an improvement of the body outline, 
unfortunately this body outline is still not well defined as shown in Figure 7.4(b).
The remaining background values that do not contribute to the body outline can be further 
reduced by the use of erosion213. Erosion reduces the size of objects in relation to their 
background by using a structuring element. This operation is commonly known as “shrink” or 
“reduce”. It can be used to remove islands smaller than the structuring element. Over each 
pixel of the image, the origin of the structuring element is overlaid. If each nonzero element 
of the structuring element is contained in the image, the output pixel is set to one. Letting A (8) 
B represent the erosion of an image A by structuring element B, erosion can be defined as:
C = A®B x
where (A)_b represents the translation of A by b. The structuring element B can be visualized 
as a probe that slides across image A, testing the spatial nature of A at each point. If B 
translated by i,j can be contained in A (by placing the origin of B at i,j), then i,j belongs to the 
erosion of A by B. The basic erosion morphological operation is then applied to get rid cf 
most of the background clusters as shown in Figure 7.4(c).
The remaining clusters can be removed by applying an elliptical mask215 to the image. It uses 
a “mass density" method, in which each pixel has a "weight" that can be used to determine 
the centre of mass and mass distribution of a region of interest (ROI). Although the masking 
algorithm can be applied straight away without the thresholding and erosion steps, it can be 
seen from figure 7.4 that the application of these steps will lead to a more accurate 
determination of the centre of mass and therefore a more accurate elliptical fit by removing 
the “noise” around the image. The ellipse is fitted to this mass distribution. Next the mass 
distribution tensor is calculated for these pixels and the tensor is used to calculate the 
eigenvalues and eigenvectors. The eigenvalues give the semi-major and semi-minor axes of 
the ellipse we are trying to find. The major and minor axes give the ellipse. The orientation of 
the ellipse is found from the first eigenvector. The orientation is calculated in degrees 
counter-clockwise from the x-axis. The points that make up the ellipse itself are now 
calculated. These points are now used to define a ROI that describes the outline of the 
patient. All points outside of this ROI are set equal to zero. This gives a well-defined body 
outline that can be used in the registration algorithm by removing the “spikes” from the body 
outline as shown in Figure 7.4(d).
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Figure 7-4: The originally binary image (a), the binary image of the body outline after applying thresholding (b), 
the body outline after erosion (c) and the outline after masking (d).
Applying these steps to all the relevant slices of the patient data provides the body outline, 
shown in Figure 7.5(b), of the functional target object and together with the left ventricle 
clusters determined in the part described below, provides the functional target object for the 
registration.
(b)
Figure 7-5: Segmentation of the body outline. The images after the initial reconstruction of a patient dataset (a) 
and the body outline of the same data set after application of the body outline segmentation steps (b).
7.3.2 Segmentation of the Left Ventricle
The second part of the registration requires a well defined outline of the left ventricle only. It 
is therefore necessary to create a binary image of the patient slices that contains only the left 
ventricle. A variable threshold together with cluster size and position discrimination and 
quadranting is used to achieve this. The method described in this section is similar to a
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published method194 and the software necessary to implement it has again been developed 
by the author by using the Interactive Data Language (IDL) and the algorithm will be 
described below.
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Figure 7-6: Automatic segmentation of left ventricular myocardium. The initial threshold used in the 
clusterification process is based on the maximal intensity activity in the upper half of the transaxial image volume, 
i.e., the area that should contain at least part of the heart if the study has been correctly reconstructed and 
reoriented. When present, hepatic activity is generally confined to the lower left quadrant of the short-axis image 
volume, while splenic or intestinal activity is likely to appear in the lower right quadrant.
The maximal voxel intensity value Cmax in the upper right quadrant of the images set (128 x 
128 x L (L < 128)) transaxial image volume is calculated; if the study has been correctly 
acquired and reconstructed, that regional maximum is likely to correspond to the myocardium 
as illustrated in figure 7.6. The entire transaxial volume is then thresholded to 50% of Cmax. 
The volume is now binarised and the binary clusters in the volume determined. Each cluster, 
or set of connected voxels, is identified. When all clusters have been determined, those 
physiologically too small (<50 ml) to represent the LV myocardium are eliminated. If only one 
cluster remains and its volume is smaller than 250 ml, the cluster is assumed to correctly 
identify the LV myocardium. If two or more clusters remain (suggesting that thresholding 
was successful in separating the LV from other “hot” structures), the one closest to the center 
of the upper right quadrant of the transaxial image volume is chosen. In either case, if the 
candidate LV cluster's volume is greater than 250 ml (suggesting that spurious hepatic, 
splenic or intestinal activity is still “connected” to that in the LV), “erosion” of the cluster is 
performed by raising the threshold in 5% steps from the original value of Cmax/2, until the 
cluster is broken into two or more pieces. The two larger subclusters are selected and 
assigned to the liver and the LV myocardium (again, based on likely location considerations) 
and this will eliminate splenic and/or intestinal activity by setting those clusters to zero. 
Then, dilation of the clusters containing the liver and LV is performed by iteratively adding 1- 
voxel wide layers of voxels, therefore increasing the number of voxels, checking every voxel 
in each layer to ensure that its addition will not reconnect the clusters. This dilation is 
continued until the original 0 ^ /2  threshold is reached and this results in producing a cluster
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containing the correct size of the LV. The binary cluster representing the LV is used as a 
mask in the subsequent phases of the algorithm.
Figure 7.7(a) shows all the reconstructed slices of a typical patient data set and Figure 7.7(b) 
is the final segmentation of the left ventricle from the patient data. This data will be used to 
determine which slices of the initial reconstruction are relevant so that the attenuation source 
object and functional source object can be determined and be used in the final 
reconstruction.
(a)
(b)
Figure 7-7: Segmentation of the left ventricle. The images after the initial reconstruction of a patient dataset (a) 
and the left ventricle of the same data set after application of the left ventricle segmentation steps (b).
This whole process has been developed step by step to ensure proper working by testing the 
steps manually. It was then automated but the final implementation does provide image sets 
for quality assurance which could be adjusted manually, if necessary, as illustrated by figure 
7.8.
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Figure 7-8: Quality control of the segmentation process. LV cluster’s volume of 250 ml can be adjusted should 
the segmentation not be satisfactory and the clustering process repeated.
7.3.3 Determination of the Patient Data Slices
The predefined NCAT attenuation map and functional images consist of a fixed number of 
slices but the actual number of slices required varies for each individual patient and therefore 
this number needs to be adjusted for each individual patient. Therefore the actual number of 
slices needs to be determined so that the predefined NCAT attenuation map and functional 
images could be adjusted to provide the correct number of slices. The number of slices of the 
original NCAT data required for each patient is determined from the segmented LV images 
together with the body outline.
In a patient study the data is acquired over the whole field of view, i.e. the full 128x128 or 
64x64 matrix. Reconstruction is done by the selection of only the relevant part of the 
acquired data and these required slices are often manually chosen and therefore can include 
unnecessary slices. It is therefore necessary to determine which of these slices used in the 
reconstruction are relevant. This relevant number of slices is then used to adjust the number 
of slices of the supplied NCAT data.
After the segmentation of both the body outline and the left ventricle they are combined into a 
single data set as shown in Figure 7.9(a) to decide which of these slices to use. The first step 
is to determine the first non-zero LV slice as displayed in Figure 7.9(a). The first relevant 
slice is the slice one lower than this first non-zero LV slice as displayed in Figure 7.9(b). The 
next step is to determine the last non-zero LV slice as displayed in Figure 7.9(a) and the last 
relevant slice will be the next slice after this non-zero LV slice as displayed in Figure 7.9(b). 
This then establishes the relevant slices which are used to determine the slices for the 
attenuation correction reconstruction of the patient data. The original NCAT data are now
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also resampled so that the number of slices is the same as those of the patient data set in 
the attenuation source object and the functional source object.
This step has to be introduced to ensure the correct function of the algorithm and the 
software necessary to implement this method. It has again been developed by the author by 
using the Interactive Data Language (IDL).
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Figure 7-9: Segmentation of the complete patient data set. The body outline segmentation together with the left 
ventricle segmentation indicating the first and last non-zero LV slices (a) and the same data set after the selection 
of the relevant slices (b).
7.4 Registration of the Source Object to the Relevant Target Object
Registration returns an image array with a specified geometric correction applied. In this 
study images are warped using control (tie) points such that locations (x„ y) on the source 
object which are shifted to locations (Xo, y0) on the target object. The registration algorithm 
used in this section has not previously been introduced to the best knowledge of the author 
and this is the first implementation of this algorithm and once again the software necessary 
to implement it has again been developed by the author by using the Interactive Data 
Language (IDL). This method was easy and straight forward to implement and provided the 
registration results without any lengthy delays. Commercially available registration programs,
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i.e. AIR216, were used originally but it proved too cumbersome and ensuring that the whole 
attenuation correction process will be an automated process, required the incorporation of 
this program into the existing attenuation source code, something that would be both time 
consuming and difficult to achieve.
The registration process in this study was implemented as a two step process which is fully 
automated. The whole process starts with the automated selection of the slices of the 
patient data, as is done in any routine processing of MPI studies and shown in figure 7.10, to 
do the initial iterative reconstruction as described in the beginning of paragraph 7.3. The 
functional objects containing the correct number of slices are then obtained automatically as 
described above. The functional source object is then registered to the functional target 
object and the results displayed in a quality control image set which allows manual 
adjustment and repeated registration should that be deemed necessary.
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Figure 7-10: Selection (between the 2 white lines) of the slices for the initial reconstruction.
— ---------------------------------  ---------------------------------------------------------
The first stage of the registration process is the main part in which the body outlines of the 
functional source object are matched to the body outlines of the functional target object. This 
result is used to provide an attenuation map consisting of the lung, bone and remainder of 
the body as attenuation objects as well as an initial position for the heart object. The same 
spatial transformations are applied to the segmented LV which forms part of the original 
functional image (source image). This LV functional source object is then matched to the LV 
functional target object to produce the final heart attenuation object. Only the LV is used to 
determine the registration parameters of the whole heart because the LV is the only part 
which can be segmented in a patient study as it is the only part of the heart taking up the 
radio-pharmaceutical in the vast majority of cases. The position of the LV in the functional
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image is used to adjust the position of the heart in the structural image to produce the final 
attenuation map. This could potentially lead to the formation of small “gaps” in the 
attenuation map which are filled by the lungs as explained in the remainder of this section.
The registration is done for every slice separately and is therefore a 2-D registration process. 
The tie points of the first part in both the source and target objects are determined by fitting 
an ellipse to the source object (body outline of the NCAT phantom) providing (Xj, y t) and to 
the target object (body outline of the patient) providing (Xo, y0). Performing a fit of the ellipse 
as described earlier does this.
The data locations (Xo, yQ) define an irregular grid, which is then triangulated by using a 
Delaunay triangulation217 of this planar set of points. Delaunay triangulations are very useful 
for the interpolation, analysis, and visual display of irregularly gridded data.
The surfaces defined by (Xo, y0, x.) and (x<>, y0> yi) are interpolated to obtain the locations in 
the input image of each pixel in the output image. These surface values are then interpolated 
to a regular grid to provide the output image, i.e. shifting the points at locations (x„ y,) to (Xo, 
y0). Since Delaunay triangulations have the property that the circumcircle of any triangle in 
the triangulation contains no other vertices in its interior, interpolated values are only 
computed from nearby points. Linear or smooth quintic polynomial interpolation can be used.
This registration process is performed on the functional source object and the result is used 
to create an initial attenuation map as explained above.
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Figure 7-6: The original and final source objects of the first part of the registration. The body outline before (a) 
and after (b) registration. The attenuation map before (c) and after (d) registration.
The second part of the registration uses the initial LV functional source object and the 
segmented LV of the patient data as the target object. The differences in the position 
between these two sets of objects are then used to determine the left ventricle registration 
parameters. These registration parameters are then used to “fine tune” the heart attenuation 
object to produce the final heart attenuation object. The size, shape and initial orientation of 
the source heart object have been determined in the first part of the registration process and 
only the orientation of the heart is now adjusted by “fine tuning” it. The “fine tuning” of the 
heart consists of the determination of the top and right side of the left ventricle segmentation. 
The heart attenuation object is then moved up/down and/or left/right to coincide with the 
segmented left ventricle. The attenuation map’s final construction consists of first determining 
the body outline of the map; this is then filled with the attenuation coefficient correlating to 
that of the lungs. The skeleton, muscle, soft tissue and other organs are then added to make 
up the complete thorax before the final heart object is added.
This heart object together with the lung, bone and remainder of the body attenuation objects 
provide the final attenuation maps. These maps will act as input into an iterative MLEM 
reconstruction algorithm to get the attenuation corrected images.
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Figure 7-7: Quality control of the registration process. Adjusting the Intensity and Contrast allow the verification 
of the registration of the left ventricle (a) as well as the body (b).
7.5 Testing of the segmentation and Registration
The testing of the algorithm was done in a step by step fashion. First each segmentation step 
was tested manually on images without any extra-cardiac activity and defects (referred to as 
normal uptake images) to ensure that it is working properly. The steps were then combined 
in an automated algorithm and again tested on normal uptake images without any extra-
cardiac activity. Only after ensuring its proper working on these images, was it tried out on 
normal patient studies (no apparent defects) but will contain extra-cardiac activity. Different 
scenarios were identified, i.e. studies with very hot gall bladders, liver, spleen and gut 
uptake. These tested studies include those where it was very difficult to distinguish between 
LV and extra-cardiac activity. The final step was to include abnormal studies with enlarged 
LV’s and severe perfusion defects which included extra-cardiac activity.
7.5 Testing of the segmentation and Registration
To date, the segmentation and registration algorithm has been tested on 60 patients as 
detailed in table 7.1 and a number of images from some of the more difficult cases are 
displayed below in figures 7.13 to 7.16.
Table 7-1: Results of the segmentation and registration
The registration process was verified with the use of a fusion display. The original 
reconstructed images were overlaid over the determined attenuation map. The contrast and 
intensity of the original reconstructed images can be adjusted to aid in the verification as
displayed in figure 7.11. This process forms part of the final algorithm to ensure quality 
control during the process.
7.5.1 Patient with a Hot Gall Bladder
Hot gall bladders can cause serious problems during segmentation and therefore it is
important that the algorithm can handle these cases effectively. Figure 7.13 illustrates such a
case and illustrates that the algorithm successfully segmented the images that has lead to a 
successful image registration.
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(f) Fusion images to verify registration of the body
(g) Final attenuation map
Figure 7"8: The images obtained for a patient with an extremely hot gall bladder, (a) Raw images illustrating the 
masking effect of this situation, (b) The original reconstructed images (c) The body and LV segmented images 
(d) Images illustrating the removal of all the non-LV pixels (e) Overlay of this images over the final attenuation 
map illustrating the successful outcome of the registration parts and (f) The final attenuation map.
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7.5.2 Patient with Substantial Gut Uptake
Gut uptake is one of the most important obstacles in the successful segmentation of the 
images and considerable effort has been taken when writing the algorithm to ensure that it 
can handle these cases successfully. Figure 7.14 illustrates such a case and illustrates once 
again that the algorithm successfully segmented the images that has lead to a successful 
image registration.
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Significant Gut Uptake
(a) Raw Images
(b) Initial Reconstructed Images
(c) Functional Images
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(f) Fusion images to verify aligment of Left Ventricle
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Figure 7-9: Set of images from a patient with substantial gut uptake.
7.5.3 Patient with Substantial Liver Uptake
Another important obstacle to obtain successful segmentation is liver uptake and therefore 
the algorithm should be able to handle these cases as well to once again ensure successful 
segmentation. Figure 7.15 illustrates a case with severe liver uptake and illustrates that the 
algorithm successfully segmented these images once again that has lead to a successful 
image registration.
(a) Substantial Liver Uptake
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(c) Initial Reconstructed Images
(d) Clustering of the Left Ventricle
167
7.5 Testing of the segmentation and Registration
(e) Segmented Left Ventricle images
(f) Fusion images to verify aligment of Left Ventricle
(g) Fusion images to verify registration of the body
(h) Final attenuation map 
Figure 7-10: Set of images from a patient with substantial liver uptake
168
7.5 Testing of the segmentation and Registration
7.5.4 Patient with Substantial Intensity Loss in the Inferior Wall
The algorithm must be able to detect the whole left ventricle and this can be complicated
when there is a substantial (or even absence) of intensity values in a part on the left
ventricle. Figure 7.16 illustrates a case where there is a substantial loss of intensity values in
the inferior wall but the algorithm also passed this obstacle to obtain a successful image 
registration.
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(c) Clustering of the Left Ventricle
(d) Segmented Left Ventricle images
(e) Fusion images to verify aligment of Left Ventricle
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Figure 7-11: Set o f images from a patient with substantial intensity loss in the inferior wall
7.5.5 Cardiomyopathy with Very Severe Defects
The above mentioned intensity losses can be further complicated in cases with 
cardiomyopathy and in these cases there is often a part which has no intensity values. Figure 
7.17 illustrates the successful segmentation and consequently image registration.
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7.6 The method of derived anatomy
Another attractive method of emission based attenuation correction is to use a derived NCAT 
attenuation map. This differs from the previous method, which starts with an existing 
attenuation map which was spatially altered to relate to a specific patient, by a method which 
does not make use of an existing attenuation map and the map is created from first principles 
for each patient. The NCAT phantom software uses a parameter file as input which defines 
the parameters of the “patient" to be created by the software. Should it be feasible to derive 
the required parameters from the patient data a patient specific attenuation map can be 
created from the parameter file alone which can be used in the reconstruction process.
The automated segmentation used in the method of inferred anatomy can be extended to 
derive the required parameters and it includes both the segmentation of the LV and body 
outline used in the method of inferred anatomy. In this method an additional step is required, 
which is extracting of the mid-myocardial surface (this is similar to a published method194 218 
but there are some small differences in the method discussed here, especially the fitting of 
the ellipsoid) and included in the automated algorithm. In this algorithm no use will be made 
of image registration and the initial reconstruction will again be used to obtain the images to 
be used in the segmentation and mid-myocardial surface extraction to determine the values 
necessary for the NCAT input parameter file. The determination of the mid-myocardial 
surface closely resembles the method as described in the literature but its output has never 
been used before to determine the values of the input NCAT parameter file.
7.6.1 Mid-Myocardial Surface Extraction and Fit
The center of mass (COM) of the three-dimensional binary mask segmenting the LV 
myocardium is chosen as the origin of the sampling coordinate system. If segmentation of 
the LV was successful, the COM will be located within the LV cavity, even in the presence of 
large perfusion defects. Radial count profiles originating from the COM are generated to 
achieve three-dimensional, spherical sampling of the product of the binary mask and the 
transaxial image volume. The locus of the profiles first maxima identifies the maximal count 
myocardial surface, which is an acceptable proxy for the mid-myocardial surface. Sampling is 
every 10° longitudinally (18 total) and every 10° latitudinally (36 total), resulting in 684 count 
profiles. It should be noted that a variable, potentially large number of these profiles are 
uniformly zero. In fact, both the basal portion of the myocardium at the valve plane and all 
perfusion defects will correspond to “holes” in the mask, for which no maxima are returned.
A fit of the mid-myocardial surface to a quadratic surface is performed by using the moments
and the quadratic form of the ellipsoid equation219 and the long axis of the quadratic surface 
is considered an initial estimate of the long axis of the LV.
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The surface extraction process is then repeated using a new origin for the sampling
coordinate system, determined as the projection of the original COM onto the estimate of the
long axis. This approach seeks to obviate errors in mid-myocardial surface extraction,
especially in cases where the original COM is close to the wall due to extensive perfusion
defects. The process is iterated until the long-axis angular variation is less than 0.5°, which 
generally requires two to three iterations.
We now have an estimate of the mid-myocardial surface, plus the ellipsoid that best fits it. 
This image of the myocardial surface may contain some "perfusion holes” ie defects caused 
by disease, artefact, the basal part, etc. These "perfusion holes” needs to be filled by an 
automated method to get the best fitted estimate of the shape, size and orientation of the LV. 
To incorporate perfusion data from under perfused areas into the fit (fill the holes), a set of 
myocardial likelihood profiles” (24 latitudinally, 32 longitudinally) is generated by extracting 
count profiles normal of the ellipsoid from the unmasked and non thresholded image and 
convolving them with a feature detector consisting of the double derivative of a Gaussian 
with a s.d. a = 10 mm. The s.d. value of 10mm was chosen based on expected feature size 
and camera resolution and observed LV myocardial count profiles, which are seen to 
approximate Gaussians with standard deviations of approximately 10 mm. The number of 
samples was chosen so that a sampling frequency of approximately 5 mm from count profile 
to count profile at the myocardium would result for a typical LV geometry (75mm from apex 
to base, 50mm from superior to inferior wall). The local maxima of these profiles are 
extracted (there is generally at least one local maximum per profile). The final mid myocardial 
surface is then defined as that set of surface points, one per profile. An ellipsoid is finally 
fitted to this myocardial surface and the resulting long axis returned as that of the LV.
The method of Mid-Myocardial Surface Extraction and Fit described here, as well as the
segmentation of the LV, form part of commercially available packages such as the
quantitative gated SPECT (QGS)/quantitative perfusion SPECT (QPS) program220221, which
is routinely used in nuclear cardiology examinations. Therefore no source code or programs
are available and the desired part of the commercially available programs cannot be used on
its own to do the segmentation and fitting and therefore the method was developed for this 
project by using the Interactive Data Language (IDL)212.
7.6.2 Testing the Mid-Myocardial Surface Extraction and Fit
The segmentation of the LV has been extensively tested for the method of inferred anatomy 
and it has been founded to be very robust in dealing with even difficult cases, see section 
7.5. This segmentation forms the first stage of the method of derived anatomy, and will 
perform in a similar manner. The method of derived anatomy then uses the mid-Myocardial 
Surface Extraction and Fit. This part was successfully tested on ideal images (simulated
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image set with no attenuation medium) as illustrated in figure 7.18 and 7.19 but further 
testing is necessary on normal and abnormal patient data.
Figure 7-13: The fit (mesh) fitted to the extracted data points of the mid-myocardial surface.
Figure 7-14: Determination of the angles required by the NCAT parameter file
7.7 Conclusion
This study demonstrates the successful creation of an inferred attenuation map of the thorax. 
It illustrates that it is possible to segment the thorax to obtain the body and only the left 
ventricle so that the input images for the registration process can be obtained. It also 
illustrates the successful registration so that the final attenuation map can be obtained. It
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handled difficult cases such as hot gall bladders, spurious hepatic, splenic or intestinal 
activity, even those where it is difficult to distinguish between extra-cardiac and LV activity as 
well as studies which contained perfusion “holes". The segmentation was successful in all 
the tested cases and the registration was successful in all but 2 of the 60 cases, giving a 
success rate of 97% which compared favourably with the success rate of commercially 
available programs such as the quantitative gated SPECT (QGS)/quantitative perfusion 
SPECT (QPS) which had a segmentation success rate of 98.7%220 when tested. It is 
worthwhile noting that the patient studies which failed the registration in this study were 
patients with severely dilated myocardia with very severe defects, cases in which the benefits 
of attenuation correction would not be necessary to establish the clinical interpretation of the 
scan. Therefore the segmentation and registration should be suitable for use in the clinical 
environment as part of the inferred anatomy method of attenuation correction.
It is also worthwhile to note that the only manual part of the attenuation correction process is 
the loading of the patient study which is then displayed as depicted in figure 7.10 for the 
manual selection of the slices. The remainder of the process, i.e. initial reconstruction, 
segmentation, image registration, determination of the final attenuation map and the 
attenuation corrected reconstruction are executed automatically to produce the attenuation 
corrected images.
Another worthwhile point is the fact that the initial reconstruction serves a dual purpose. It is 
always good practice to display both corrected and uncorrected images when interpreting the 
reconstructed images. Although the initial reconstruction is necessary for the determination 
of the attenuation map, it also provides the uncorrected images and is therefore an essential 
but not an additional step.
The successful extraction of the mid-myocardial surface has also been demonstrated in an 
ideal situation. The successful extraction of the surface, together with the LV segmentation, 
makes the determination of values for the NCAT parameter file possible so that a patient 
specific attenuation map can be obtained. The extraction method does need additional 
testing and development, if necessary, to ensure it will be suitable to handle more difficult 
cases and that it can be used in the method of derived anatomy.
7.8 Future Work
The method of inferred anatomy has been tested successfully on a wide range of patient 
data illustrating that it could be useful as an attenuation correction method to improve the 
outcome of patient studies but the method needs to be verified against a standard, either 
transmission attenuation maps or coronary angiography as a gold standard, to verify its 
suitability in a clinical environment. The method of derived anatomy needs some more 
development and testing before it will also have to be tested against a gold standard to verify
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its suitability in a clinical environment. This testing can be performed by using the previous 
Monte Carlo simulated data with the associated attenuation maps that has been used to 
generate the required attenuation in the simulations and to compare the attenuation 
correction results to the simulations without the attenuation medium. The next step will be to 
use patient data that has been acquired with attenuation maps and where these maps have 
been used to correct for attenuation. By replacing these attenuation maps with the inferred 
and/or derived maps, the reconstruction can be repeated and the two sets of reconstruction 
data compared. This testing will be part of follow-up studies and not be part of the thesis.
The segmentation part as well as the registration could be further improved. Note that the
segmentation forms part of both of the two proposed methods. The areas where it could be 
improved are>
1. the detection of lung areas in both male and females and
2. the breasts in females.
Currently the body outline of females does include the breast areas but it is more an
“averaging” than the exact detection of the size and shape as a result of the detection of the
body outline and using the breast as part of the body instead of explicitly deriving the
parameters of the breasts, i.e. angles, tilt, etc. to define these parameters in the NCAT 
parameter file.
The lungs areas cannot be established from the current reconstruction of the emission data.
The lung/body ratio does vary between patients and the exact outline of the lungs could be
used to determine the size of the rib long and short axis. The importance of using the exact
rib cage dimensions together with the body dimensions instead of an approximation (as is
currently the case) when the body outline is known is not clear at the moment. This could be 
established with a Monte Carlo simulation study.
The possibility of improved segmentation should be investigated with the use of MAP-EM 
reconstruction methods. MAP stands for maximum a posteriori by incorporating a priori 
knowledge into the reconstruction algorithm. This means that one uses existing knowledge to 
guide the reconstruction process for a more robust and reliable solution. This prior or existing 
knowledge are often referred to as priors. Examples of such prior knowledge are knowledge 
about the range of the attenuation coefficients, the anatomical outline of the patient, etc. The 
reconstruction problem can be formulated as a Bayesian model222. In a Bayesian model the 
posterior distribution is obtained from the likelihood and prior distribution. The prior 
representing the knowledge of the spatial distribution of the source can be modelled as a 
Gibbs distribution and the likelihood can be modelled as a Poisson distribution223.
Such an implementation has been proposed139 where the a priori knowledge about absolute 
attenuation values was implemented as a bi- or trimodal probability distribution. The
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attenuation map can be expected to be locally smooth and the local smoothing prior is 
implemented using a 2-D Gibbs distribution.
The initial reconstruction can then be performed by using the MAP algorithm with priors 
containing the range of attenuation coefficients and a Gibbs distribution to obtain images 
which will make improved segmentation possible so that segmentation of the lungs and 
breasts could be a possibility.
The image registration algorithm can also be extended to a fully 3-D algorithm to take into
consideration the spatial relationship between slices. This will have an impact only on the 
method of inferred anatomy.
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Chapter 8 - Conclusions and
Further Work
8.1 Conclusions
The main purpose of this project was to investigate the current limitations of MPI so that the 
areas which will benefit most from improving could be identified. Identification of these areas 
led to investigations into the reason why they still pose problems. By doing so it has been 
possible to identify and investigate future improvements.
Chapter 2 illustrated in detail the extensive work that has been done to improve the usability 
and accuracy of Myocardial Perfusion Imaging (MPI) over the years. From this analysis the 
main factors that degrade the image quality and the quantitative accuracy of emission 
tomography reconstructions were identified as:
► Attenuation of the photons travelling toward the detector,
► The detection of scattered as well as primary photons,
► Depth-dependent collimator response correction (frequency-distance principle),
► The finite spatial resolution of the imaging systems or partial-volume effect.
There are other problems associated with the degrading of image quality in MPI such as
patient movement, breathing, etc. but this project concentrated on the limitations introduced 
by the imaging and processing equipment itself.
These limitations are reflected in the measurement of the sensitivity and specificity of the
imaging technique. Many solutions for these limitations have been suggested over the years
but it seems that the implementation of generally accepted methods has been escalated
recently, especially for MPI techniques. This is especially true with the recent introduction of
depth-dependent resolution recovery and scatter techniques as well as new camera
architecture designs. The potential improvement of the sensitivity and specificity of MPI with
these improvements has not been widely reported yet but one can expect that it might be 
realised soon.
It seems that the one single issue still causing debates and discussions is attenuation 
correction. It is a very intensively studied topic but despite this fact it still lacks universal 
clinical implementation. The conclusion of the author for the reasons for this is three-fold.
The first is that some people involved in the use of MPI do not appreciate the complexity and 
often unpredictable nature of the defects caused by attenuation. This leads to an almost
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cavalier approach that attenuation defects are always very simple to identify and that these 
defects are also always predictable and that can be allowed for by an experienced reporter of 
MPI studies. Although it is true that experienced reporters are able to distinguish between 
many defects caused by attenuation as compared to true defects, the uncertainty caused by 
doubt does exist and there are cases where it is not possible to distinguish between an 
artefact and an abnormality and some of these aspects have been highlighted in this study 
and are the subject of the next couple of paragraphs.
The real contributions of the individual anatomical parts in the thorax are not well known and 
especially the effect of the heart itself. The PMUD values in table 4.7 demonstrates clearly 
that the attenuation caused by self-absorption in males is actually greater than the 
attenuation caused by the soft tissue and skeleton combined, and in females the contribution 
of the heart is similar to the attenuation caused by the combination of the soft tissue and 
skeleton. The impact of this self-absorption of the heart has been demonstrated for the first 
time in this study and this was further extended in chapter 5 which illustrated that the position 
of the defect is more unpredictable as a result of their dependence on the position and 
orientation of the heart. It has been clearly shown that the attenuation caused by the self-
absorption of the heart can be significant. As the orientation and position of the left ventricle 
in a specific patient is unknown to the interpreter of the study, it is impossible for any
reporter, no matter how knowledgeable or experienced, to “mentally” correct for any defects 
caused by the self-absorption of the heart.
Section 4.3.4, especially figure 4.6 and table 4.6 illustrated that the attenuation not only
causes defects, but also distorts the left ventricle by under estimating the basal parts and
over estimating the apical parts. Although this effect has been reported previously in the
literature, the extend of this effect is not that well known. This effect has been properly
highlighted in this study and this is also something that “mental” correction will not succeed in
correcting. This distortion will also have an effect on quantitative analysis such as ejection 
fraction calculations.
Another aspect that seems to attract little attention, although there is evidence for it in the
literature, is the fact that inferior wall attenuation defects are also a wide spread problem in
female patients, not just male patients, as illustrated in figure 4.9. The reason for this fact is
the self-absorption on the heart, as discussed earlier. This study demonstrated clearly for the
first time that the heart can cause significant inferior wall attenuation defects in female
patients. The results in this study show its importance, and need to be highlighted to a wider
audience in a published paper. Seeing that it is mainly caused by the heart, “mental” 
correction will again fail.
From this discussion it is very clear that even experienced reporters simply cannot correct 
“mentally” for a significant number of attenuation defects. It is not just a problem identifying
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the relevant defects, because the consequences of anatomical variations can also lead to a
significant number of patients been misdiagnosed by experienced reporters with such an
approach. For less experienced reporters the pitfalls are even bigger and this project has
illustrated that the effect of attenuation can be very subtle and seemingly unpredictable and
thus could result in incorrect reporting, and therefore inappropriate patient treatment and 
management.
The second reason is that the introduction of transmission based methods can lead to 
artefacts which are difficult to identify and which can alter the outcome of the study. These 
include truncation of the transmission images, mis-registration, cross-talk between the 
emission and transmission data and the introduction of artefacts, especially in the apical 
region. This has lead to many debates about the usefulness of the technique and also to the 
lack of its clinical implementation. This project, together with many other studies published in 
the literature, found that the implementation of transmission correction techniques, does 
improve the usefulness of MPI, despite its drawbacks. Careful analysis of the images will 
prevent or identify truncation problems and many of the commercial available transmission 
correction systems seem to have developed techniques to overcome, or at least, minimise 
cross-talk and mis-registration problems. A proper image quality assurance implementation 
as part of the routine analysis of the MPI data, will identify the existence of truncation and 
mis-registration cases and therefore will minimise or even eliminate these problems. 
Therefore the only real objective to the implementation of transmission base attenuation 
correction, where available, is the apparent introduction of additional apical “defects”. It has 
been illustrated in the literature that in the non-attenuation corrected image, there is often an 
over estimation of the apical region, which make these images even less reliable for 
interpretation. These findings are not that well known and need to be brought to the attention 
of a much wider audience. The significance of this effect has also been confirmed in this 
study (in chapter 4) and should be highlighted to a wider audience in a published paper.
However, this study went even further and demonstrated in chapter 6 that the use of 
transmission attenuation correction (together with depth-dependent resolution recovery and 
scatter correction) corrects this effect and does not necessarily introduce any other defects. 
This is a very important result and the first time that it has been reported. The realisation that 
these apical defects actually exist in the patient study as real defects and are not a 
creation of attenuation correction, could be extremely helpful in breaking down some of the 
resistance towards transmission attenuation correction. Therefore the proper implementation 
of image quality assurance protocols and the knowledge that transmission attenuation 
correction is not introducing these “apparent” defects will counteract any arguments for not 
implementing it, now that it is available and possible to obtain the equipment to implement it.
The third reason is the cost, unavailability and the possibility that it cannot be implemented
on all systems, as well as the complexity of the technique and the additional burden of longer
scanning time and increased patient dose. Many institutions in the world can simply not
afford to obtain transmission attenuation correction capability. Furthermore, the new breed of
specialised cardiac cameras is making the implementation of transmission attenuation
correction almost impossible on such systems. The benefits of implementing transmission
attenuation have been clearly demonstrated in this study, especially in chapter 6. By using
transmission attenuation correction together with depth dependent resolution recovery and
scatter correction leads to the elimination of many of the inherent system problems in MPI.
Therefore it is concluded that where it be possible to implement transmission attenuation
correction, then this should be done as the patient benefits obtained far outweigh the
additional burden of additional scanning time and dose. The aspect of cost, availability and
implementability, however, do remain serious issues that will prevent the implementation of
attenuation correction techniques in many institutions and systems. To overcome this, the
novel approaches of chapter 7 can be developed further so that transmission attenuation can
be replaced by emission attenuation correction. Additionally, figure 4.14 illustrated the effect
caused by scatter in the distortion in the left ventricle and although these results are not new
they confirm the existing knowledge about the contribution of scatter. Chapter 4 also
reconfirmed the fact that almost 90% of the counts in the MPI studies are lost as the result of
the different degrading factors, leaving only a small amount of counts left to use for
interpretation and analysis. As only a very small amount of the injected tracer actually
reaches the left ventricle (about 2%), the 90% loss of counts does have a significant impact
on the final outcome of the study. This leads to increased patient doses and therefore every
attempt should be made to minimise these count losses. If this is achieved then it should be
possible to reduce the amount of injected tracer, and hence reduce patient dose. It has been
illustrated in chapter 6 that the combination of transmission attenuation correction, scatter
correction and depth dependent resolution recovery leads to the recovery of most of the
counts in the left ventricle. This leads to the possibility of reducing the injected activity given
to the patient. Although transmission scanning increases the radiation dose to the patient,
the recovery of counts and subsequently reduction in injected activity, can go a long way to
offset this. This is the subject of a number of studies in the literature and an active field of
investigation. In addition the introduction of an emission-based attenuation correction method
will achieve the reduction of injected activity without the increase dose of transmission 
scanning.
This study illustrated that the correct and individual implementation of attenuation correction 
can be potentially very beneficial and will overcome the problems associated with the 
technique. It furthermore illustrated that a generic patient-average system is not capable of 
providing the appropriate attenuation correction.
8.2 Future Work
8.2 Future Work
The effect of the range of recent introductions, both software and camera developments, on 
the improvement of the sensitivity and specificity of MPI is something to anticipate and 
hopefully relevant studies will be forthcoming in the near future. The execution of such 
studies will rely on the availability of the recent introductions.
Another aspect which will need attention is the extension of the recent software 
developments to be applicable with the new camera configurations and designs. Although 
some of these camera developments will limit the need for some of the corrections reported 
here, it will not completely remove the need. The patient will always cause attenuation and 
scatter within the body with a significant impact on the acquired images.
The one conclusion which urgently needs to be reached is the introduction of method(s) for 
attenuation correction which will be universally accepted and which is also easy and
relatively cheap to implement. Such techniques have been introduced in this project and it is 
work which will be continued by the author.
Although MPI has come a long way and significant advancements have been made, should 
the stage been reached where universally accepted attenuation correction methods are 
available together with the other techniques and improvements discussed, it will really lead to 
a significant advance in the usefulness of Myocardial Perfusion Imaging, and therefore 
improved patient diagnosis, treatment and subsequent improved health.
Appendix A -  Source Code 
used for the Reconstruction of
the Simulated Studies
;+
; NAME:
; Nlkul_proj
J
; PURPOSE:
; Compute projection or backprojection using coefficients pre-computed 
; by Nlkulcoeff.
; CATEGORY:
Reconstruction
CALLING SEQUENCE:
NIkul_proj, image, sinogram, projnum, prcf
; INPUTS:
; IMAGE the reconstruction image. When keyword BACKPROJECT is 
backprojection is ADDED to this image.
set, the
SINOGRAM: When keyword BACKPROJECT is zero or not
receives the projection values.
set, the sinogram
PROJNUM: the number of the current projection (row number
sinogram).
PRCF: pointer obtained from NIkul coeff.
; KEYWORD PARAMETERS:
when set, a backprojection from SINOGRAM into IMAGE is
computed. When not set or zero, a projection from IMAGE into 
SINOGRAM is comouted
; OUTPUTS:
The output is IMAGE or SINOGRAM, depending on the keyword BACKPROJECT
; COMMON BLOCKS:
NC_lib_common required finding the reconstruction library
; PROCEDURE:
Calls a module from the reconstruction library
; MODIFICATION HISTORY:
Written by: Johan Nuyts, 10 april 1996
pro NIkul_pro;j, image, sinogram, projnum, prcf, backproject=backproject, $
maxim=maxim
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common NC_lib_common 
projnum = fix(projnum) 
if keyword_set(maxim) then $
dummy = call_external(NC_recon, 'NIkul_projmaxim•, image, sinogram,$ 
projnum, prcf) $
else if keyword_set(backproject) $
then dummy = call_external(NC_recon, 'NIkul_bproj ', image, sinogram,$
projnum, prcf) $
else dummy = call_external(NC_recon, 'NIkul_proj ', image, sinogram, projnum,
prcf)
end
+
NAME:
NIkul free
PURPOSE:
Deallocate memory allocated by NIkul
CATEGORY:
Reconstruction
CALLING SEQUENCE:
NIkul_free, pcoeff
INPUTS:
PCOEFF the pointer to the memory allocated by the external c-code, 
and returned by NIkul_coeff.
PCOEFF is set to zero.
COMMON BLOCKS:
NC_lib_common: requi to find the reconstruction library
RESTRICTIONS:
Calling the routine with an invalid pointer will cause a core dump 
Calling with a pointer equal to zero will cause an error message.
PROCEDURE:
Calls the deallocation routine in the reconstruction c-
MODIFICATION HISTORY:
Written by: Johan Nuyts, 10 apr 1996
********************************************************** + + jm ^ ^ A + ^ ^ ^  + + ^  + +
pro NIkul free, prcf
common NC lib common
if n_elements(prcf) 
print, 'NIkul free
0 then begin 
pointer does not
endif
if prcf eq 0 then begin
print, "NIkul_free: pointer is already 0" 
return
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prcf = call_external(NC_recon, 'NIkul_free', prcf)
end
+
NAME:
NIkul coeff
PURPOSE:
Pre-computation of the linear interpolation coefficients 
projection and backprojection.
CATEGORY:
Reconstruction
CALLING SEQUENCE:
pcoeff = NIkul_coeff(nrdet, nrproj, startangle=S, deltaangle=D, $
radius=R, coroffset=C, arc_radius = arc radius)
INPUTS:
NRDET: Number of detectors (or number of columns in the sinogram)
Number of projections (or number
KEYWORD PARAMETERS:
STARTANGLE: projection angle in radians of first sinogram row
Zero means projection along y-axis (and upward). 
Default: zero.
DELTAANGLE: offset in radians to next projection angle
Positive is clockwise.
Default: NRPROJ / !pi
RADIUS: Radius of the field 
If very large or set 
computed for the en 
the computation will
of view in pixels, 
to -1, the (back)projection will be 
reconstruction image. Otherwise, 
be limited to pixels within the
circle.
Warning: in iterative reconstruction, artifacts will occur 
when reconstructing a truncated field of view. RADIUS should 
be larger than for the largest enclosed circle.
Default: -1
COROFFSET Center of rotation offset. When not set, ignored.
When set to a single value, the same center of rotation 
offset is used for all angles.
When set to an array of length NRPROJ, a different center 
rotation offset is used for every angle.
of
ARC RADIUS Radius of the PET-system in pixels (convert if known in 
cm and sinogram pixels known) . Ignored if set to zero or 
set. If specified, an arc-correction is included in the 
computations of the interpolation coefficients.
not
OUTPUTS:
PCOEFF: a long int, which contains a pointer that can
NIkul_proj and NIkul free.
be used by
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COMMON BLOCKS:
Uses NC_lib_common to find the reconstruction library
SIDE EFFECTS:
A structure of 
memory cannot 
C-modules. Keep 
gets lost.
a few Mb will be allocated by the C-procedure. This
accessed by IDL, it is intended to be reused by other 
the value of PCOEFF unchanged, otherwise that memory
PROCEDURE:
Calls a routine from the C reconstruction library, which computes
s and stores them in newly allocated memory, which can 
accessed by other modules from the same library.
IDL cannot access that memory.
Use NIkul_free to deallocate the memory.
the
be
MODIFICATION HISTORY:
Written by: Johan Nuy ts, 10 apr 1996
added: ProjCoeffArray >
************************************* ********************************************
function NIkul coeff , nrdet, nrproj, startangle = startangle, $ 
deltaangle = deltaangle, radius = radius, $ 
coroffset = coroffset, arc radius= arc radius
common NC lib common
0
if
then startangle = 0.0
0 then deltaangle = !pi /
0 then radius = -1.0
then arc radius = 0.00
0
n_elements(startangle) 
n_elements(deltaangle) 
n_elements(radius) 
n_elements(arc_radius) 
n_elements(coroffset) 
then cor = fltarr(nrproj) $ 
else if n_elements(coroffset) eq
then cor = fltarr(nrproj) + float(coroffset[0]) $ 
else if n_elements(coroffset) eq nrproj $ 
then cor = float(coroffset) $ 
else begin
nrproj
1 $
print, "NIkul_coeff 
return, 0
size of coroffset incorrect!"
endelse
nrdet = 
nrproj = 
startangle = 
deltaangle = 
radius = 
arc radius =
(nrdet) 
fix(nrproj) 
float(startangle) 
float(deltaangle) 
float(radius) 
float(arc radius)
prcf = call_external(NC_recon, •NIkul_coeff3 •, nrdet, nrproj, startangle, $
deltaangle, radius, cor, arc radius)
return, prcf
end
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; * * * * * * * * * * * * * * * * *  t * * * * * * * * * * * * * * * * * * * * * * * ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
; +
; NAME:
; NIkul spectproj
; PURPOSE:
Compute projection or backprojection using coefficients pre-computed 
by NIkul coeff.
; CATEGORY:
Reconstruction
CALLING SEQUENCE:
NIkul_spectproj, image, sinogram, attenimg, projnum, prcf
; INPUTS:
IMAGE: the reconstruction image. When keyword BACKPROJECT is
backprojection is ADDED to this image.
set, the
SINOGRAM: When keyword BACKPROJECT is zero or not
receives the projection values.
set, the sinogram
ATTENIMG: Attenuation image. Pixel values contain linear attenuation
coefficient per pixel.
PROJNUM: the number of the current projection (row number in the
sinogram).
PRCF: pointer obtained from NIkul coeff.
/ KEYWORD PARAMETERS:
; BACKPROJECT: when set, a backprojection 
; computed. When not set
> SINOGRAM is computed.
from SINOGRAM into IMAGE is 
or zero, a projection from IMAGE into
; OUTPUTS:
/ The output is IMAGE or SINOGRAM, depending on the keyword BACKPROJECT
; COMMON BLOCKS:
NC_lib_common, required finding the reconstruction library.
; PROCEDURE:
; Calls a module from the reconstruction library.
i
; MODIFICATION HISTORY:
; Written by: Johan Nuyts, 10 april 1996
/
; * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^  
pro NIkul_spectproj, image, sinogram, attenimg, projnum, prcf, $
backproject=backproj ect
common NC_lib_common 
n_elements(image) le 1 then image = attenimg * 0
projnum = (projnum)
if keyword_set(backproject) $
then dummy = call_external(NC_recon, •NIkul_abproj-, image, sinogram, $
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attenimg, projnum, prcf) $
else dummy = call_external(NC_recon, 'NIkul_aproj•, image, sinogram, $
attenimg, projnum, prcf)
NAME :
NIsino subset
PURPOSE:
Generates an index, defining a subset of projections from a sinogram.
The ML-EM algorithm (or any other iterative algorithm) can then be 
applied to the subset only, to decrease the processing time.
The algorithm generates consecutive subsets, in such a way that
1) after number_of_subset calls, all projections have been included 
in exactly one subset
2) Each subset is a) as different (in projection angle) as possible from 
the all previous subset and
b) as different as possible from the previous subset.
The idea of accelerating the reconstruction with subsets is due 
to MH Hudson and RS Larkin, "Accelerated image reconstruction 
using ordered subsets of projection data", IEEE Trans Med Imaging,
1994; 13: 601-609.
CALLING SEQUENCE:
subset — NIsino_subset, nrsubsets, nrangles, subsetnum, subsetmask, previous
INPUTS:
NRSUBSETS
The number of subsets to be generated. This number must not be larger 
than the total number of projection. There is no other restriction.
If the remainder of nrangles diveded by nrsubsets is nonzero, the 
number of projections per subset will vary. As far as I know, this 
has no noticable effect on the convergence.
NRANGLES
The number of DronectionR nr nrmonf i An anrtl
SUBSETNUM 
Supply ; 
NIsino_: 
NIsino :
and reset
a variable which is equal to zero in the first call, 
subset will then initialize the variables SUBSETMASK 
subset will increment subsetnum after each subsequent 
et it to zero when all projections are processed.
and PREVIOUS 
call,
SUBSETMASK
Variable for internal use, used to remember which subsets have been
processed. Do not modify it between calls to NIsino subset.
Passing internal variables to the caller is preferred to a common block,
so that, if ever required, two or more iterative schemes can be executed 
in an interleaved way.
PREVIOUS
Internal variable, used to remember which subset was processed most 
recently. Do not modify.
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KEYWORD PARAMETERS: 
none
OUTPUTS:
SUBSET:
An array of indices defining the subset. This array can be used by 
NIproj to restrict the scope of its calculations.
COMMON BLOCKS: 
none
SIDE EFFECTS: 
none
PROCEDURE:
See comments in the source.
MODIFICATION HISTORY:
Written by: Johan Nuyts, K.U.Leuven, Belgium
aug-1995
; ************************************** ************************************ *******
function n i sino_subset, nrsubsets, nrangles, subsetnum, subsetmask, previous
; Check whether parameters are meaningful
•  M M  M  _  m m  M  ^
/ —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  ____ ________
if nrsubsets gt nrangles then begin
print, NIsino_subset: nrsubsets must not be larger than nrangles!' + $
string(7b) 
return, -1 
endif
;--  New start. First subset contains first projection.
;--  Initialize the mask.
if subsetnum eq 0 then begin
subset = indgen(ceil(float(nrangles) / nrsubsets)) * nrsubsets 
subsetmask = indgen(nrsubsets) * 0 
subsetmask[0] = 1 
previous = 0
;--  subsetmask:
;--  - subsetmask index represent first projection of the subset.
_ For processed subsets, mask is set to 1, the others are zero.
;--  Algorithm:
; Extend the subsetmask with last element in front and first at the end 
'• reflect cyclic nature of the projections.
; Scan from left to right and right to left, and calculate for every
; element in the mask the distance to the closest subset that was already
;--  processed.
; Find the subsetmask elements with maximum distance: one of these must be 
;--  processed now.
; From these, select the one with maximum distance to the previously 
;--  processed subset (stored in PREVIOUS).
•  *mm m m  m b  m m  _
/  —  —  —  —  —  —  —  —  —  —  —  —  —    —
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endif else begin
nlen = n_elements(subsetmask)-1
subsetmask = [subsetmask[nlen], subsetmask, subsetmask[0]] 
newlen = nlen + 2
leftdistar = intarr(newlen+1) 
rightdistar = intarr(newlen+1) 
leftdist = 1000 
rightdist = 1000 
for i = 0, newlen do begin 
if subsetmask[i] eq 1 $ 
then leftdist = 0 $
else leftdist = leftdist + 1
leftdistar[i] = leftdist
j = newlen - i 
if subsetmask[j] eq 1 $ 
then rightdist = 0 $
else rightdist = rightdist + 1
rightdistar[j] = rightdist 
endfor
distar = leftdistar < rightdistar 
distar = distar[1:newlen-1] 
subsetmask = subsetmask[1:newlen-1]
firstproj = where(distar eq max(distar))
compare = abs(firstproj - previous) < (nrsubsets - abs(firstproj - previous))
firstproj = firstproj(where(compare eq max(compare)))
firstproj = firstproj[0] 
subsetmask[firstproj] = 1
subset = indgen(ceil(float(nrangles) / nrsubsets)) * nrsubsets + firstproj 
previous = firstproj
f ---  —  —  —  —  ~  —  ~  —  — ____________________________ ____  -
' Make sure the subset is not too long. This step reduces the calculation
, of the subset to a call to indgen with sufficiently large parameter
• _ v  v  m m  mmm m m * m  _  —  - _
/  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —    M ~ _ _    —  ____ M M M M .    _ _ _ _ _    _
subset = subset(where(subset le (nrangles-1))) 
subsetnum = subsetnum + 1
if subsetnum ge nrsubsets then subsetnum = 0 
return, subset
PURPOSE:
Calculate a projection of a reconstruction image into a sinogram, or 
calculate a backprojection from the sinogram into the reconstruction
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; image.
; The operation can be restricted to a subset of projections.
%
f
CALLING SEQUENCE:
NIproj, image, sinogram, firstangle, deltangle
INPUTS:
IMAGE
The reconstruction image.
Must be provided in the case of projection.
In the case of backprojection, it is created if it does not exist.
The image must be two or three dimensional. The third dimension is 
regarded as perpendicular to the reconstruction plane.
SINOGRAM
The sinogram image.
Must be provided in the case of backprojection.
In the case of projection, it is created if it does not exist.
If both sinogram and image are provided, they must have the same number 
of dimensions.
FIRSTANGLE
Angle in radians corresponding to the first projection. Set it to 
zero if the first projection is vertical.
Default: 0.
Ignored when PCOEFF is non-zero.
DELTAANGLE
Angle between two consecutive projections in radians.
Ignored when PCOEFF is non-zero.
OPTIONAL INPUTS:
NRANGLES
Provide it if the sinogram to be calculated is not yet allocated.
If it is calculated, the number of angles equals the number of rows 
(second coordinate) in the sinogram.
Ignored when PCOEFF is non-zero.
KEYWORD PARAMETERS:
SUBSET
Set it to an array containing the indices of the projections that must 
be involved in the calculations.
Default: all projections.
BILINEAR
If set, bilinear interpolation is applied.
Otherwise, nearest neighbor interpolation is applied.
See RIEMANN.
Ignored when PCOEFF is non-zero (uses always bilinear interpolation). 
CENTER
Set this to the center of the projection image. Different from RIEMANN,
the default is (number_of_projection_pixels - 1 .0) / 2.0.
(See RIEMANN).
Ignored when PCOEFF is non-zero.
COR
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Position of the center of rotation in 
Default = [nr_columns - 1., nr_rows - 
the default provided by RIEMANN.
(See RIEMANN).
Ignored when PCOEFF is non-zero.
the image.
1) / 2. This from
D
Sampling distance. See RIEMANN 
Ignored when PCOEFF is non-zero.
BACKPROJECT
If set, a backprojection is applied. 
If not, a projection is applied.
See RIEMANN
NEW
, the output image is cleared before storing the result of 
projection or backprojection. Otherwise, the result is added to the 
contents of the output image.
PCOEFF
If the keyword is 
computed with the 
If the keyword is 
(back)projections 
c-
not set or equal to zero, (back)projections 
RIEMANN command.
set to the result of a call to NIkul_coeff, 
are computed by calling a routine from the
the
SPECTATTEN
If this keyword is not set or equal to zero, no attenuation is 
assumed. (For PET-type attenuation, the non-attenuated projections 
be multiplied with the attenuation along each projection line to 
produced attenuated projections.)
For spect-type attenuation, the attenuation must be included in 
the projection calculations. For SPECT-type attenuation, set 
SPECTATTEN to an image containing the linear attenuation 
coefficients per pixel. In this case, the keyword PCOEFF must 
be set as well, since RIEMANN cannot compute attenuated 
projections.
can
OUTPUTS:
IMAGE or SINOGRAM is updated, depending on the value of the BACKPROJECTION 
keyword.
COMMON BLOCKS
none
SIDE EFFECTS
none
PROCEDURE:
RIEMANN
MODIFICATION HISTORY:
Written by: Johan Nuyts/ K.U.Leuven, Belgium
aug-1995
*****************************+**+
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  +  +  +  ^ # ^ ^  +  1t +  +  +
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pro Nlproj, image, sinogram, firstangle, deltaangle, nrangles, $
bilinear = bilinear, center = center, cor = cor, d = d, $ 
backproject = backproject, subset = subset, new=new, $ 
pcoeff = pcoeff, spectatten=spectatten, maxim=maxim
common NIkul_common, nrriemann, nrkulproj
%  _  m,- _
f  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  _  —  —  —
;-- Default values
f  — —  —  —  —  —  “  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  _  —
if n_elements(firstangle) eq 0 then firstangle = 0 
if not keyword_set(bilinear) then bilinear = 0 
if n_elements(d) eq 0 then d = 1
if not keyword_set(backproject) then backproject = 0 
if n_elements(pcoeff) eq 0 then begin
if keyword_set(maxim) then begin
print, 'Nlproj: maximum intensity projection requires pcoeff' 
return
endif
endif
if n_elements(pcoeff) eq 0 and n_elements(spectatten) gt 1 then begin
image = -1
print, 'Nlproj: if SPECTATTEN is set, PCOEFF must be set as well!' 
return
endif
if n_elements(nrriemann) eq 0 then nrriemann = OL 
if n_elements(nrkulproj) eq 0 then nrkulproj = OL
--  Allocate a sinogram if it does not exist already
The size is that of the largest projection in the image 
--  (See IDL-help for RIEMANN)
if n_elements(sinogram) le 1 then begin
if backproject then begin 
image = 0
print, 'Nlproj: no sinogram given' + string(7b)
return
endif
imsize = size(image) 
nrdet = imsize[1] / d
if imsize[0] It 3 then sinogram = fltarr(nrdet, nrangles) $
else sinogram = fltarr(nrdet, nrangles, imsize[3])
endif
;--  Allocate an image if it does not exist.
; The size is such that its largest projection will fit
;--  in the sinogram matrix.
• ._ M  M  M  —  ^ ^ . _ _ __ _
f  —  —  —  —    —  —  —  —  —  —  —  —  —  —  _  —    _ _ _ _ _ _ _ _
if n_elements(image) le 1 then begin
if not backproject then begin
sinogram = 0
print, 'Nlproj: no image given' + string(7b)
return
endif
sinosize = size(sinogram) 
nrcols = sinosize[1] * d
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sinosize[0] It 3 then image =
else image = fits
endif
fltarr(nrcols, nrcols) $
•r(nrcols, nrcols, sinosize[3])
--  Clear the images requested
keyword_set(new) then $
if backproject then image = image * 0.0 else sinogram = sinogram * 0.0
- Calculate the centers of the image.
The defaults used by RIEMANN are not the ones we want to use: 
-- RIEMANN uses nrni x«=»l .=?/? wo want- \ /o
sinosize = si
lmgsize = size
ze(sinogram) 
e(image)
sinosize[0] It 3 then nplanes = 1 else nplanes = sinosize(3)
if n_elements(center) eq 0 then center 
if n_elements(cor) eq 0 then cor
0.5 * (sinosize[l] - 1.0) 
0.5 * (imgsize[1:2] - 1.0)
Calculate nrangles. If the caller supplies both the sinogram and the 
- number of anales . chp>ck whot-hor- t-hio -i c ov-
sinosize = size(sinogram)
if n_elements(nrangles) eq 0 then nrangles = 
if nrangles ne sinosize[2] then begin
if nrangles gt 1 and sinosize[0] gt 1 
print, 'NIproj : sinogram size and nrai 
return
sinosize[2]
then begin
gles not identical + string(7b)
if n_elements(subset) eq 0 then subset = indgen(nrangles)
if n_elements(deltaangle) eq 0 then deltaangle = !pi/float(nrangles)
for plane = 0, nplanes-1 do begin
3D projection: copy the sinogram, because riemann may wish to
--  add to its contents, and cannot add directly to
--  sinogram[*,*,plane].
C°PY also image, otherwise an implicit copy is forced for every
subset. Afterwards, the tmpsino is put back in the original
sinogram in the case of projection, and the tmpimg in the case of 
--  backprojection.
in the case of backprojection, the newly calculated values are 
-- divided by the number of oroiect-.i nns
tmpsino = sinogram[*,*,plane] 
tmpimg = image[*,*,plane] 
if n_elements(spectatten) gt 1 then tmpatten = spectatten[*,*,plane]
tmpsize = size(tmpsino) 
if tmpsize[0] eq 1
/overwrite)
then tmpsino = reform(tmpsino, tmpsize(1], 1,
196
Appendix A -  Source Code used for the Reconstruction of the Simulated Studies
centerl = center[0]
if n_elements(pcoeff) eq 0 then begin
for j = 0, n_elements(subset)-1 do begin
i = subset[j]
riemann, tmpsino, tmpimg, firstangle 
row = i, backproject = backproject,
$
d = d, cor = cor, center = center 
nrriemann = nrriemann + 1
+ i * deltaangle, $ 
bilinear = bilinear,
endif else begin
for j = 0, n_elements(subset)-1 do begin
i = subset[j]
if n_elements(spectatten) le 1 $
then Nlkul_proj, tmpimg, tmpsino, i, pcoeff,
backproject=backproject, maxim=maxim $
else NIkul_spectproj, tmpimg, tmpsino, tmpatten,
i, pcoeff, backproject=backproject 
nrkulproj = nrkulproj + 1
endfor 
se
if backproject eq 0 then sinogram[*,*,plane] = tmpsino $
else image[*,*,plane] = tmpimg / n_elements(subset)
end
************************************* 
+
NAME :
NImlosem
********************************************
PURPOSE:
Maximum Likelihood expectation maximisation (Shepp, Vardi, IEEE TMI 
MI-1:113-122 and Lange, Carson, J Comput Assist Tomog, 1984, 8:306 
The procedure also implements Ordered Subsets (Hudson, Larkin, IEEE 
1994;13:601-609).
CALLING SEQUENCE:
recon = NImlosem(sinogram)
INPUTS:
SINOGRAM: the sinogram. First coordinate is the pixel in th
second coordinate points to the projection angle.
KEYWORD PARAMETERS:
RECON
The initial image. If not provided, a homogenous image is used.
Supply the previous reconstruction if you want to continue iterating 
on the same image.
NRITER
Number of iterations. For multi 
one ML-EM-iteration per subset.
NRSUBSETS
number of subsets. Any number 
livider of the number of Droie
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Wa-LL not have the same amount of projections.
See Hudson and Larkin - paper.
For multiple subsets, the calculation of the likelihood
and is always lower than the true value. See the LIKELI 
Default: 1.
ONLYSUBSET
If set, only the subset with the number ONLYSUBS 
ML~computation. When not set, the ML-computation 
all subsets.
SHOWSUB
When set, shows the reconstruction after each sub-iteration in the 
current display window.
SHOWFINAL
When set, show 
display window
LIKELIHOOD i
A value proportional the log-likelihood (See Shepp and Vardi-paper) is 
calculated for each iteration. In fact, the variable part of the 
log-likelihood is calculated, and divided by the maximum attainable 
value (reached when calculated projection is identical to the 
measurement). The log-likelihood should increase but never reach 1, 
except maybe for simulations.
If the keyword is omitted, the likelihood is not calculated.
If the keyword is set to a non-existing variable, that variable is 
set to an array with consecutive likelihoods.
If the keyword is set to an array, the new array is appended.
For multiple subsets, only an approximate value is calculated, using
only the new reprojections of the current subset, together with the
older (and actually obsolete) reprojections of the previously processed
subsets. As a result, the approximate value is always lower than the 
true value.
If multiple subsets are used in a second call to NImlosem, it is 
recommended that you would provide the previously obtained CALCSINO.
If you don't, the procedure cannot use the reprojections of the 
previous iteration, resulting in strong underestimations of the 
likelihood. This does not influence the final reconstruction image.
CALCSINO
Calculated sinogram. If keyword is set but the image does not exist, 
it is created. If it exists, it is reused. In subsequent calls to 
NImlosem for the same image, the procedure needs the previously 
calculated sinogram for the calculation of the likelihood, if multiple 
subsets are used. The sinogram is calculated anyway, so no time is 
saved by not providing it.
STARTANGLE
Angle corresponding to the projection (in radians). Default: 0
DELTAANGLE
Angle between two consecutive projections (in radians) 
Default: pi / number of angles
ATTENUATION
An image of the same as sino, containing the attenuation factors
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tor tne ECAT 931 PET, this the inverse (p 
which contains the attenuation correction
PCOEFF
If the keyword is not set or equal to 
computed with the RIEMANN command.
If the keyword is set to the result o 
(back)projections are computed bv cal
(back)projections
±n every iteration, the backprojected ratio of measurement and 
prediction must be divided by the sum of detection probabilities. 
This sum equals 1 of no PET- or SPECT-attenuation is specified.
If there is attenuation, the sum of detection probabilities is 
computed by backprojecting the a sinogram with all pixels set to 1 
If backatten does not exist or is set to a single value, this 
backprojection is computed. If backatten is set, it is reused
OUTPUTS: 
RECON
COMMON BLOCKS:
Calls NIimage, which reads the lookup table block
SIDE EFFECTS:
Displays an image in the current display window, if the keyword 
SHOWSUB or SHOWFINAL is set.
RESTRICTIONS:
The projections are calculated using the RIEMANN function, which expec 
that the projection array contains more pixels than the dimension of 
the reconstruction image. This routine uses the same number of columns 
for the projection as for the reconstruction image, apparently without 
adverse effects.
PROCEDURE:
Calls NIsino_subset to define the sinogram subsets, and NIml for 
the actual ML-EM calculations.
EXAMPLE:
See batchfile Nlexample ml.pro
MODIFICATION HISTORY:
Johan Nuyts, K.U.Leuven, Belgium 
aug-1995
Written by:
********************************************************************************* 
function NImlosem, sinogram, nrsubsets = nrsubsets, recon = recon, $
nriter = nriter, showsub = showsub, showfinal = showfinal, $
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likelihood, calcsino = calcsino, 
startangle, deltaangle = deltaangle, 
attenuation, spectatten = spectatten, 
ackatten, norm_per_subset=norm_per_subset 
onlysubset, pcoeff = pcoeff, fwhm=fwhm
n_elements(onlysubset) eq 0 then onlysubset 
n_elements(startangle) eq 0 then startangle
sino = sinogram > 0 
if n_elements(nriter) 
if n_elements(nrsubsets) 
sinosize = size(sino)
nrangles = sinosize[2]
if sinosize[0] It 3 then nplanes = 1 else nplanes = sinosize[3] 
if n_elements(recon) le 1 then recon = fltarr(sinosize[1], sinosize[1],
nplanes) + 1
n_elements(deltaangle) eq 0 then deltaangle = acos(-l) / nrangles 
# — — — — — _ .
/  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —
;--  Allocate memory for calculated sinogram
/  “  ~  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  -  —  —  —  ___ ___ _________ —  —  —  ____
iter = 0
if n_elements(calcsino) le 1 then calcsino = sino * 0
• ^ .       _ _ .
/  —  —  —  —  —  —  —  —  —  —  «  —  -----  —  —  —  —  —  ------ —  —  —  —  —  —  —  —  —  —  —  —  ------  —  —  —  —  ------  —  ------  —  —  —  —  —
;--  Calculate upper limit of likelihood
• —  -  mmmm mmamt/ — — — — — — — — — — — — - — — — — — — 
if n_elements(likelihood) eq 0 then likelihood = -1 
lik = 1
dummy = sino
isnul = where(dummy le le-15)
if isnul[0] ne -1 then dummy[isnul] = le-15
maxlik = total(-dummy + dummy * alog(dummy))
Precompute the backprojection of the weights if attenuation is 
specified.
If not done, NIml will do it the first time, but then the computation 
is restricted to the subset if one is in use.
;--  If PET-attenuation is required, compute the sum of all weights in
;--  every reconstruction pixel
•  mmm mmm mmm M  — M  ^ —  mmm — __ mmm _ —  —  ^  —— ^  ^
/  —  —  —  “  —  —  —  —  “  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —
if n_elements(attenuation) gt 1 and n_elements(backatten) le 1 and not
keyword_set(norm_per_subset) then begin 
backatten = recon * 0
Nlproj, backatten, attenuation, startangle, deltaangle, nrangles,$
/bil, /back, pcoeff=pcoeff
endif
- If SPECT-attenuation is required, compute the sum of all weights in
- every reconstruction pixel
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end
n elements(spectatten) gt 1 and n_elements(backatten) le 1 and not 
keyword_set(norm_per_subset) then begin 
backatten = recon * 0 
allones = sino * 0 + 1
Nlproj, backatten, allones, startangle, deltaangle, nrangles, /bil,$ 
/back, spectatten=spectatten, pcoeff=pcoeff
/
--  Loop of iterations and subsets
for i = l,nriter do begin 
subsetnum = 0
for s = 0, nrsubsets - 1 do begin
subset = NIsino_subset(nrsubsets, nrangles, subsetnum, $
subsetmask, previoussubset)
keyword_set(norm_per_subset) and nrsubsets gt 1 then $ 
backatten = 0
if (onlysubset eq -1) or (s eq onlysubset) then begin 
NIml, recon, sino, startangle, deltaangle, likeli = lik, $
pcoeff = pcoeff, calc = calcsino, subset = subset,$ 
spectatten=spectatten, backatten = backatten 
lik = lik / maxlik
if iter eq 0 and likelihood[0] eq -1 then $
likelihood = [lik] $ 
else likelihood = [likelihood, lik] 
iter = iter + 1
endif
endfor
endfor
return, recon
********************************************************************************
NAME :
NIml
PURPOSE:
Apply a single ML-EM iteration, possibly restricted to a single subset/
CALLING SEQUENCE:
NIml, recon, sino, firstangle,
INPUTS: 
RE CON
The initial reconstruction image, which may be the result of a previous 
iteration. Note that ML-EM is unable to convert zeros in something else 
since it is a multiplicative algorithm. Do not supply initial images 
with pixels set to zero, unless you want them to stay zero.
SINO
The sinogram: first coordinate points to the detector or line of 
response, the second to the projection angle.
FIRSTANGLE
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First projection angle. Zero for vertical projection.
DELTAANGLE
Angle between the projections (in radians)
KEYWORD PARAMETERS:
LIKELIHOOD
If this array exists, the likelihood of the initial reconstruction image 
is appended. The likelihood of the resulting image is only calculated 
in the next iteration. The likelihood for subiterations is always an 
underestimation. For an accurate calculation of the likelihood, a 
complete projection of the image must be calculated. It is the goal 
of Ordered Subsets to avoid this calculation.
CALCULSINO
Provides and receives the calculated sinogram. If subsets are used, 
the calculation of the likelihood needs the previously calculated 
sinogram to compute a decent value. If you don't provide it, an internal 
one filled with zeros is generated. It then takes one iteration using 
all subsets before the likelihood value is meaningful.
SUBSET
An array indicating the rows of the sinogram that are included in the 
subsets. The routine NIsino_subset generates subsets.
ATTENUATION
An image of the same size as smo, containing the attenuation factors, 
and any other factor affecting the sensitivity of a LOR.
For the ECAT 931 PET, this the inverse (pixel by pixel) of the atn-file, 
which contains the attenuation correction.
Originally designed for PET-applications. For SPECT, however, one may 
may use it to apply uniformity correction.
SPECTATTEN
An image of the same size as the reconstruction image, containing an 
attenuation map. The pixels must contain linear attenuation coefficients 
per pixelsize. (See also NIproj.)
PCOEFF
If the keyword is not set or equal to zero, (back)projections are 
computed with the RIEMANN command.
If the keyword is set to the result of a call to NIkul_coeff, the 
(back)projections are computed by calling a routine from the 
c-library.
BACKATTEN
The backpro^ection of the weighting. This image must be computed when 
attenuation or spectatten or specified. If this variable is set to 
an existing image (more than one element), that image is reused.
Otherwise, the image is computed.
OUTPUTS:
RECON is updated.
OPTIONAL OUTPUTS:
If provided, also CALCULSINO and LIKELIHOOD are updated.
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COMMON BLOCKS 
none
SIDE EFFECTS 
none
PROCEDURE:
Calls NIproj to calculate the projection and the backprojection
MODIFICATION HISTORY:
Written by: Johan Nuyts, K.U.Leuven, Belgium
aug-1995
********************************************************************.***********.**
NIml, recon, sino, firstangle, deltaangle,
likelihood = likelihood, calculsino = 
spectatten=spectatten, pcoeff = pcoeff 
backatten = backatten
calculsino, subset 
, $
= subset, $
small = max(sino) / le6 
sinosize = size(sino) 
nrangles = sinosize[2]
--  Default: 1 subset
n_elements(subset) eg 0 then subset = indgen(nrangles)
;--  Project the current reconstruction
if n_elements(calculsino) eq 0 then
else calculsino[*,subset,*] = 
NIproj, recon, calculsino, firstangle
subset = subset, spectatten =
calculsino = 0 * sino $
0
, deltaangle, nrangles, /bil, $ 
spectatten,
--  Divide measurement by reprojection
noemer = calculsino[*,subset,*]
isnul = where(noemer le small)
if isnul[0] ne -1 then noemer[isnul] = small
ratio = sino
ratio[*,subset,*] = ratio[*,subset,*] / noemer
--  Backproject the ratio-sinogram
back = recon * 0
NIproj, back, ratio, firstangle, deltaangle, nrangles, /bil, /back, $
subset = subset, pcoeff=pcoeff, spectatten = spectatten
--  If SPECT-attenuation is required, compute the sum of all weights in
--  every reconstruction pixel
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n_elements(spectatten) gt 1 and n_elements(backatten) le 1 then begin
backatten = recon * 0 
allones = sino * 0 + 1
NIproj, backatten, allones, firstangle, deltaangle, nrangles, /bil,$
/back, subset = subset, spectatten=spectatten, pcoeff=pcoeff
endif
- If an image backatten has been generated, use it to normali
- the sum of weights.
ze for
if n_elements(spectatten) gt 1 $
then back = back / (backatten > (max(backatten) / 1000.))
;--  Multiply with current reconstruction
recon = recon back
n_elements(likelihood) ne 0 then begin
isnul = where(calculsino le 0)
if isnul[0] ne -1 then calculsino[isnul] = le-15 
likelihood = total(-calculsino + sino * alog(calculsino))
end
*********************************************************************************
NAME :
NIfiIterfunction
PURPOSE:
Calculate the ID frequency representation for the specified 
filter function. The filter can be directly multiplied 
applied to the result of a forward FFT. The function is 
designed to be used for filtered backprojection (nifbp.pro)
CALLING SEQUENCE:
filterarray = NIfilterfunction(filter, nrelements)
INPUTS:
FILTER: 1rect1
1hann' 
'but'
an array of ones is returned 
Hann low pass filter 
Butterworth low pass filter
NRELEMENTS: The number of elements in the returned
filterarray. This value equals the number of elements 
of the array that you want to
KEYWORD PARAMETERS:
CUTOFF_FREQ: The interpretation depends on the filter.
For 'rect': all frequencies > cutoff_freq 
zero, the others to 1.
'hann': the filter becomes zero at the
are set to
cutoff_freq (with zero derivative)
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For ’but’ : the filter amplitude equals 0.5 at the 
; cu to f f_f req.
9
; POWER:
• The power of the Butterworth filter. Ignored when an other
; filter is selected. Default is 10.
/
; RAMP:
• When set, the specified low-pass filter is multiplied by a
; ramp filter.
9
; TWOD:
/ When set, a filter image is returned, which can be directly
; multiplied with the FFT of an image.
> Otherwise, the filter is returned as a one dimensional array,
; to be multiplied with the FFT of a ID array.
9
; OUTPUTS:
/
; FILTERARRAY: a ID array of NRELEMENTS elements, containing the filter 
; amplitude. The first element is the DC point,
; frequencies then increase up to the Nyquist
r frequency. The second half of the array is a mirrored
; version of the first half.
9
; MODIFICATION HISTORY:
; written by: Stefaan Vandenberghe en Swana Vanacker, dec 1995 
; modification:
; jan 1996, Johan Nuyts: several bugs fixed
; mar 1996, Johan Nuyts: adding small constant to the ramp filter,
; to avoid over-attenuation of low frequencies.
9
•                                           a * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
function NIfilterfunction, filter, nrelements, cutoff_freq = cutoff_freq, $
power = power, ramp = ramp, twoD= twoD
;--  An array with frequencies: starting from zero to Nyquist, followed by
;--  -Nyquist to zero. (Same as after FFT).
;--  Note that the sign of the frequencies is irrelevant, the filter is
;--  always a function of the absolute value. So for the two-D frequency
;--  image, we don't care restoring the correct sign as is done in the 1-D
;  frequencyarray.
frequencyarray = findgen(nrelements) 
middle = fix((nrelements - l)/2)
frequencyarray[middle +1:nrelements-1] = $
-reverse(frequencyarray[0:(nrelements-1)- (middle +1)]) 
if keyword_set(twoD) then begin
kwadfreq = frequencyarrayA2 # (fltarr(1,nrelements)+1) 
frequencyarray = sqrt(kwadfreq + transpose(kwadfreq)) 
endif
if n_elements(cutoff_freq) eq 0 then cutoff_freq = 0.5 
cutoff = nrelements * cutoff freq
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--  calculation of the filterarrays for the different filters
filter of
I • begin
filterarray = 
daar = where( 
if daar[0] ne
frequencyarray*0 + 1 
abs(frequencyarray) gt cutoff) 
-1 then filterarray[daar] = 0
end
hann': begin
filterarray = 
daar = where( 
if daar[0] ne
0.5 + 0.5 * cos(!pi * frequencyarray/cutoff) 
(frequencyarray) gt cutoff)
-1 then filterarray[daar] = 0
end
but': begin
if n_elements(power) eq 0 then power = 10
filterarray = 1.0 / (1+ (abs(frequencyarray)/ cutoff)Apower)
end
else: begin
print, 'Illegal
filterarray = -1
end
function: ', filter
-- The DC-amplification should not be set to zero. In the analogue 
-- case, there are an infinite number of projections, and the 
-- DC-amplification of the backprojection goes to infinity. In the 
-- digital case, the number of projections is limited, and the 
-- DC-amplification of the backprojection is a finite value. Hence, the 
-- ramp-filter must be adapted. There is a paper about this, but I 
-- don't have it at the moment, so I solved the problem by adding a 
-- small value, determined heuristically on a simulation. The result is 
-- that decent reconstructions are obtained without having to use large 
-- zeropadding values in the reconstruction (to increase the sampling in 
-- the frequency domain). The influence of the term decreases when the 
-- number of frequency samples is increased. The tests suggest that in all 
-- cases superior reconstructions are obtained with this term, but the 
-- difference becomes negligible for large zeropadding. 0.37
keyword_set(ramp) then $ 
filterarray = filterarray * (abs(frequencyarray) +0.) / nrelements
return, filterarray
end
*********************************************************************************
NAME : 
Nlfbp
PURPOSE:
Computes the reconstruction from a sinogram using backprojection
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CALLING SEQUENCE:
Nlfbp, recon, sinogram
INPUTS:
SINOGRAM
the sinogram image to be reconstructed 
The dimensions are:
fltarr(nrcols, nrrows) 
or, for multiple slices:
fltarr(nrcols, nrrows, nrplanes)
KEYWORD PARAMETERS:
FILTER
The low pass filter to be applied (in combination with the ramp 
filter) for noise suppression. See NIfilterfunction for the 
possible values. Default is 1rect1, a rectangular filter, with 
transition from 1 to 0 at the frequency CUTOFF FREQ.
CUTOFF_FREQ
The cut-off frequency 
the sample frequency i 
interpretation depends 
further comments.
the filter, 
1, the Nyqui 
on the filter
expressed in cycles/pixel: 
t is 0.5. The
See NIfilterfunction for
POWER
See NIfllterfunction
STARTANGLE
the angle of the projection in radians.
DELTAANGLE
angle, in radials, between two consecutive projections.
Filtered backprojection is designed for reconstruction of 180 
degrees projection data. The routine accepts 360 degrees data, 
but it is more efficient to add opposite projections (mirroring 
one of them) and apply a 180 degrees reconstruction. FBP of 
360 degrees data is mathematically identical to FBP of the 
added (not averaged!) opposite projections. Divide by 2 if you 
want the effect of averaging opposite projections. Default is 
pi / number-of-projections.
ZEROPADDING
Number of zeros that must be appended to both sides of the 
sinogram, to improve the Fourier-decomposition of the sinogram 
Default=0
PCOEFF
When set 
compute 
When set 
is used 
call to
to 0 or not provided, the RIEMANN command 
the backprojection.
to the value returned by NIkul coeff, the 
to compute the backprojection. This routi 
the backprojector in our C-library.
is used to
routine NIkul_proj 
contains a
SUBSET
When set, only the projection lines belonging to this subset are 
used. A subset is defined as an array of row indices for the sinogram
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;-- Default values
sinosize = size(sinogram) 
nrdet = sinosize[1] 
nrangles = sinosize[2]
if sinosize[0] eq 3 then nrplanes = sinosize[3] else nrplanes = 1 
pi = acos(-l)
if n_elements(deltaangle) eq 0 then deltaangle = pi / nrangles
if n_elements(startangle) eq 0 then startangle = 0.
if n_elements(power) eq 0 then power = 10
if n_elements(cutoff_freq) eq 0 then cutoff_freq = 0.5
if n_elements(zeropadding) eq 0 then zeropadding = 20
if n_elements(filter) eq 0 then filter = 'rect'
if n_elements(subset) eq 0 then subset = indgen(nrangles)
n subset = n elements(subset)
;--  Allocate a reconstruction image if not available
if n_elements(recon) le 1 then recon = fltarr(nrdet, nrdet, nrplanes) 
tmprecon = fltarr(nrdet, nrdet)
;--  Definition of frequencyvector as an array of the frequencies where the
;--  filter must be calculated
newnrdet = nrdet + 2*zeropadding
filtervector = NIfilterfunction(filter, newnrdet, cutoff_freq =cutoff_freq,$
power = power, /ramp)
for plane = 0, nrplanes-1 do begin
; A new sinogram is created by adding zeros at both sides of the 
;--  old sinogram.
newsinogram = fltarr(newnrdet, nrangles)
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f
; SHOWIMG
; When set, each plane is displayed as soon as it has been reconstructed.
/
; OUTPUTS
r
; IMAGE
> T^e image that is reconstructed from the sinogram
%/
; MODIFICATION HISTORY:
; written by: Swana Vanacker, Stefaan Vandenberghe dec 1995
; Modification:
> ]an 1996, Johan Nuyts: several bugs fixed
• aPr 1996, Johan Nuyts: addition of keyword PCOEFF.
/
' t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
pro NIfbp, recon, sinogram, zeropadding = zeropadding, filter = filter, $
power = power, cutoff_freq = cutoff_freq, startangle = startangle, $ 
deltaangle = deltaangle, pcoeff=pcoeff, subset = subset, $
showimg = showimg, demo=demo
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newsinogram[zeropadding:zeropadding+nrdet-1,*] = sinogram [0:nrdet -$
1, *, plane]
; ID.Fouriertransformation for every angle (row) of the sinogram.
• ^ ^  ^
/ “  “  “  ~  “  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  _  —  —  —  —  —  —  _
fouriersin = complexarr(newnrdet, n_subset)
for i=0, n_subset -1 do fouriersin[*,i]= FFT(newsinogram[*,subset(i]])
; Filtering of the Fouriertransformation of the sinogram •-- ^^
/  ~  —  —  —  “  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  _
for i = 0,n_subset-l do fouriersin[*, i] = fouriersin[*,i] * $
filtervector
; ID inverse fouriertransformation of the sinogram for each angle • ^^ ^^_ _/ — — — — — — — — — — — — — — — — —
filteredsinogram = fltarr(newnrdet, nrangles)
for i = 0,n_subset-l do filteredsinogram[*,subset[i]] = $
FFT(fouriersin[*,i], /inverse)
;--  Reduction of the sinogram to its original size
• - - MM - ^^
/  —  —  —  —  —  —  —  —  —  —  —  —  —
filteredsinogram = filteredsinogram[zeropadding : nrdet+zeropadding $
-1 ,* ]
if not keyword_set(demo) then begin
• - - m m m m  m m m m __ - ....
/  “  —  —  —  —  —  —  —  —  —  — —  —  —  —  —  —  —  —  —  — — — —  -- “  —  —  «
;--  Backprojection of the filtered sinogram
NIproj, tmprecon, filteredsinogram, startangle, deltaangle, $
/new,/bilinear, /backproject, pcoeff=pcoeff,
subset=subset
;--  Multiply with deltaangle, which is the equivalent of d
;--  theta in the analogue integral expression.
if keyword_set(showimg) then NIimage, tmprecon 
endif else begin
tmprecon[*] = 0 
teller = 0.0
for i = 0, n_elements(subset)-1 do begin
NIproj, tmprecon, filteredsinogram, startangle, $
deltaangle, /bilinear, /backproject,
pcoeff=pcoeff,$
subset=subset[i ]
teller = teller + 1.0 / float(n_elements(subset) ) 
if teller gt 1/40. then begin
NIimage, tmprecon, /noerase 
teller = 0.0
endif
endfor
endelse
recon[*,*,plane] = tmprecon * !pi
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end
• • A - * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ***********************************************
function NIconvolgauss, img, fwhm-fwhm, sigma=sigma, showit=showit, $
nrsigma=nrsigma, dimensions= dimensions, maskonly=maskonly
if n_elements(dimensions) eq 0 then dimensions = [0,1,2]
(sigma) eq 0 then begin
(fwhm) eq 0 then sigma = 0 else sigma = fwhm / sqrt(8 * alog(2))
if sigma eq 0 then return, img 
if n_elements(nrsigma) eq 0 then nrsigma = 2 
if n_elements(showit) eq 0 then showit = 0
nrel = round(sigma * nrsigma) > 1
x = findgen(2 * nrel +1) - nrel 
masker = NIgauss(x, 0, sigma) 
masker = masker / total(masker)
if showit then print, masker
if keyword_set(maskonly) then return, masker 
imsize = size(img)
if imsize[0] It 3 then nrplanes = 1 else nrplanes = imsize[3] 
if nrplanes eq 1 then begin
if total(dimensions eq 0) gt 0 $ 
then begin
if 2*nrel+l gt imsize[1] then begin 
eraf = nrel - fix((imsize[1]-1)/2) 
tmpmask = masker[eraf:2*nrel-eraf]
tmpimg = convol(img, reform(tmpmask,2* (nrel-eraf)+1,1), /edge_t) 
endif else begin
tmpimg = convol(img, reform(masker,2*nrel+l,1), /edge_t) 
endelse 
endif $
else tmpimg = img
if total(dimensions eq 1) gt 0 $ 
then begin
if 2*nrel+l gt imsize[2] then begin 
eraf = nrel - fix((imsize[1]-1)/2) 
tmpmask = masker[eraf:2*nrel-eraf]
tmpimg = convol(tmpimg, transpose(tmpmask), /edge_t) 
endif else begin
tmpimg = convol(tmpimg, transpose(masker), /edge_t) 
endelse
return, tmpimg 
endif
center = nrel 
if showit then niwin
tmpimg = fltarr(imsize[1], imsize[2], imsize[3]) 
for plane= 0, nrplanes-1 do begin 
totcoeff = 0.
210
Appendix A Source Code used for the Reconstruction of the Simulated Studies
total(dimensions eq 2) gt 0 then begin 
j= -center, center do begin 
curplane = plane + j 
maski = j + center
if (curplane ge 0) and (curplane It nrplanes) then begin
tmpimg[*,*,plane] = tmpimg[*,*,plane] + masker[maski]
img[*,*,curplane]
totcoeff = totcoeff + masker(maski)
endfor
endif else begin
totcoeff = 1. 
tmpimg[*,*,plane] 
endelse
= img[*,*,plane]
dummy = tmpimg[*,*,plane] / totcoeff 
if total(dimensions eq 0) gt 0 then $
dummy = convol(dummy, reform(masker, 2*nrel + l, 1) , /edge_t) 
if total(dimensions eq 1) gt 0 $
then tmpimg[*,*,plane] = convol(dummy, transpose(masker), /edge 
else tmpimg[*,*,plane] = dummy 
if showit then niimage, tmpimg[*,*,plane] , /noerase
t) $
return, tmpimg
end
; * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *****
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